data_1u6f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1u6f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.487 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG1' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.74 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' CG2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HD2' ' CE2' ' A' ' 49' ' ' TYR . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 106' ' ' GLY . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' HG13 ' A' ' 50' ' ' ILE . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.611 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.629 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 69' ' ' ILE . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.746 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.746 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.726 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.47 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.45 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.41 ' CB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.685 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.577 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CD2' ' HB3' ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG22 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 59' ' ' LEU . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.599 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.45 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.697 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 107' ' ' PHE . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 101' ' ' ILE . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' CE2' ' A' ' 63' ' ' PHE . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.705 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.705 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HB ' HG11 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.711 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.697 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.405 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' HG21 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 44' ' ' ASN . 43.4 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 94' ' ' GLY . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' CD1' ' CB ' ' A' ' 100' ' ' ALA . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.707 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.458 ' CG1' HD12 ' A' ' 69' ' ' ILE . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.756 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 ' CD1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 84' ' ' ARG . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.756 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 42' ' ' LEU . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.783 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.628 ' H ' HG22 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.481 HD12 ' CD2' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 50' ' ' ILE . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.655 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.506 HD12 HG22 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.506 HG22 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.8 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 69' ' ' ILE . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 107' ' ' PHE . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.634 0.255 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 91' ' ' PHE . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.637 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD21 ' CE2' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 69' ' ' ILE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.466 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' LYS . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.456 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 105' ' ' ASN . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 103' ' ' GLY . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.659 ' HA ' ' CE1' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.712 0.292 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.411 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.693 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.693 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.501 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HB ' HG13 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.74 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 73' ' ' LYS . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 105' ' ' ASN . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.706 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.952 0.406 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.51 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.717 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.47 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.557 HD12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 69' ' ' ILE . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' CG1' ' CG1' ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.725 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 107' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.425 ' CB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.572 HD13 ' HG2' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.535 ' CG1' HG13 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.417 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.7 p30 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.558 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 49' ' ' TYR . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.736 0.303 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.425 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.68 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 60' ' ' ARG . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.723 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.582 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.442 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 104' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.443 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.421 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 59' ' ' LEU . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.421 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 73' ' ' LYS . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 101' ' ' ILE . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.467 ' CD2' ' CE2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.422 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' HG13 ' A' ' 50' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.492 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.482 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' HG21 ' A' ' 116' ' ' VAL . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.584 HG21 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.584 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 114' ' ' LEU . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 45' ' ' LEU . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.417 ' CB ' ' ND2' ' A' ' 44' ' ' ASN . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.418 ' HB ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 74' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.478 ' CG1' HD12 ' A' ' 69' ' ' ILE . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.771 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.771 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.637 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.646 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 107' ' ' PHE . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 116' ' ' VAL . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 63' ' ' PHE . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.547 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.587 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' A' ' 85' ' ' GLY . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 84' ' ' ARG . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.482 ' CZ ' ' HG3' ' A' ' 46' ' ' MET . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.526 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 47' ' ' VAL . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.605 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HB ' ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 104' ' ' LEU . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 69' ' ' ILE . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.774 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.774 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.455 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 3.7 m-80 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.481 ' CD2' ' HG ' ' A' ' 62' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.722 0.296 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' HD22 ' A' ' 45' ' ' LEU . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 HD13 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 46' ' ' MET . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.658 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 116' ' ' VAL . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.564 HG21 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.564 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 49' ' ' TYR . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HD11 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.725 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.725 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.429 ' CG1' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.772 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HA ' HG21 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.2 p30 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.629 HG21 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.428 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 t -59.96 -47.52 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -172.24 134.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.0 tp -95.71 102.59 10.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.075 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.42 -11.14 31.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.599 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 65.44 36.36 6.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.82 -47.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -136.17 -177.31 4.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -88.97 -75.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -159.87 84.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -65.41 -60.65 7.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 58.4 Cg_endo -71.86 139.89 34.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 112.317 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -113.27 114.92 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.62 127.96 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -130.08 89.83 2.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -156.71 -46.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.33 124.35 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 110.11 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.06 108.02 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.8 -37.43 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.2 mt 61.28 -175.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 102.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.39 119.4 12.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 60.34 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.01 175.29 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.92 117.03 23.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.19 33.45 21.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 -168.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.44 68.21 66.92 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.49 167.43 25.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.49 61.45 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.818 2.345 . . . . 0.0 112.454 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.2 m 66.23 -70.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.52 103.65 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.845 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 ttt -110.98 -30.72 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.421 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.9 m-80 -177.22 -61.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 36' ' ' ASN . 58.5 Cg_endo -71.77 81.32 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.503 2.135 . . . . 0.0 112.243 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -79.95 144.82 60.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.34 -14.61 22.79 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.589 2.192 . . . . 0.0 112.468 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.09 -12.5 60.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.437 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m -90.73 44.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.423 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.487 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.428 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.719 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.719 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' CG1' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.74 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' CG2' HG12 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.431 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HD2' ' CE2' ' A' ' 49' ' ' TYR . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 106' ' ' GLY . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.6 -28.98 33.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.42 162.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.371 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 110.43 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.74 -170.61 29.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 59.79 44.61 13.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -96.58 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.402 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 4.7 mmm-85 -72.31 -60.38 2.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.41 172.58 14.7 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.558 2.172 . . . . 0.0 112.263 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.53 42.43 1.03 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.467 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.3 pt 41.09 82.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.71 -80.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.94 63.02 2.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.69 147.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 m -137.39 159.26 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.92 92.7 0.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.2 179.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.7 -51.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -173.76 174.27 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.57 41.89 1.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.605 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.87 -58.11 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.908 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.8 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -110.2 129.27 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 60.17 94.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 tt -113.24 125.19 30.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.83 -24.64 19.04 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.428 2.086 . . . . 0.0 112.363 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.58 114.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.3 t 62.87 49.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.1 p -121.25 -43.21 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -161.43 162.98 30.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.15 -177.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.31 143.3 25.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.43 131.9 18.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.451 2.101 . . . . 0.0 112.327 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -88.54 160.92 17.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.97 28.36 73.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -139.7 130.61 26.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.5 172.28 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.66 173.16 5.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.72 -24.41 53.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.96 128.49 33.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.013 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.66 164.39 25.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 60.12 79.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mt -122.44 131.11 53.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.41 151.57 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -115.26 -52.26 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -108.99 -31.7 7.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.02 144.29 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -153.76 37.28 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -86.89 177.18 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -175.87 161.94 2.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 tt -164.3 55.68 0.46 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 159.47 52.42 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.612 2.208 . . . . 0.0 112.276 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.5 81.75 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.597 2.198 . . . . 0.0 112.269 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -87.0 153.9 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 63.63 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.4 ttt 67.78 -69.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 54.48 59.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.229 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.72 39.59 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.794 2.33 . . . . 0.0 112.571 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HB3' ' CG1' ' A' ' 41' ' ' VAL . 9.2 mt-10 -81.55 117.14 67.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -89.36 -73.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.59 2.194 . . . . 0.0 111.786 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.8 -24.75 62.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 38' ' ' GLU . 7.6 p -107.06 73.88 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.478 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.444 ' HA ' HG13 ' A' ' 50' ' ' ILE . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.611 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.629 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.548 ' CD1' HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.548 HG11 ' CD1' ' A' ' 69' ' ' ILE . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.746 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.746 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.726 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -55.19 -27.09 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.46 167.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.357 . . . . 0.0 111.009 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -102.54 95.91 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -136.02 100.09 0.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -59.55 -47.23 86.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.93 -50.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -153.12 107.55 2.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.95 -36.22 18.45 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.36 89.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.538 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.53 152.26 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.018 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.72 -172.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.93 -172.63 28.2 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.559 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.99 81.25 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t 68.53 -68.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 59.47 105.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.45 177.79 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.47 49.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -115.42 -54.33 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.26 6.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.535 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.8 t80 69.02 -66.98 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.877 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.7 m -128.16 101.62 6.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.97 169.84 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 pt -127.43 70.42 76.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.56 63.46 2.95 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.197 . . . . 0.0 112.309 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -144.04 37.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.14 114.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.83 174.08 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.6 125.53 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.61 96.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.45 93.66 4.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -27.18 37.67 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.508 2.139 . . . . 0.0 112.295 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -74.59 92.83 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.4 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -134.49 -46.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.1 m -58.61 143.39 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.57 -46.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.23 136.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.49 -53.48 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 60.31 64.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.31 121.28 44.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 147.6 30.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -63.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 60.74 31.48 20.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.13 -175.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.75 113.31 20.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -121.76 105.47 10.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.01 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.805 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 31' ' ' PRO . 2.0 t60 63.16 131.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.421 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 25.3 mt -138.0 63.96 39.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.209 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 30' ' ' ILE . 23.5 Cg_exo -63.99 159.38 42.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.258 . . . . 0.0 112.108 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.64 86.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.472 2.115 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -129.95 169.78 14.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 66.01 95.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 mmt -102.29 -29.09 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 62.4 75.94 0.4 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.65 85.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.287 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.05 136.19 54.24 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.812 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.28 -27.09 9.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.89 -29.05 69.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.07 29.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.274 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.47 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.45 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.41 ' CB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.577 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CD2' ' HB3' ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 96' ' ' SER . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.661 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.451 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.669 HG22 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG22 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.89 -53.23 42.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 63.26 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.63 30.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . 68.14 175.18 9.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 31.8 p80 44.84 39.6 3.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.903 0.382 . . . . 0.0 111.383 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.82 179.97 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -56.77 109.39 1.67 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 -43.73 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.55 89.4 1.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.38 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.6 mp 64.82 151.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 148.61 33.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.42 -108.14 3.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.86 33.14 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.6 m -123.31 99.04 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.087 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.22 -40.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.03 152.84 19.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -104.07 90.98 0.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -120.73 93.39 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.37 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.457 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.81 -31.57 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.864 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -81.33 106.55 13.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.57 131.57 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.37 111.08 8.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.32 -168.64 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.372 2.048 . . . . 0.0 112.266 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.38 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.27 -46.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -157.21 71.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 -47.35 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 69.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -87.75 -52.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.011 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 11' ' ' ASP . 54.3 Cg_exo -51.95 168.35 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.463 2.109 . . . . 0.0 112.361 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.65 -178.31 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.75 -159.44 9.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -28.87 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.7 m 62.97 97.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.49 116.12 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -98.5 155.86 17.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mt -136.7 108.81 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.07 119.92 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -110.89 -46.56 3.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.91 112.12 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.35 -178.23 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -95.64 108.95 21.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -109.32 168.18 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -176.23 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -78.15 -59.95 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 63.34 142.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -107.46 23.31 14.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.1 mp 53.03 65.44 5.88 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.29 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.43 152.93 66.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.532 2.155 . . . . 0.0 112.374 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.46 89.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.294 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -110.44 172.29 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.53 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.64 59.22 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.04 86.11 0.17 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 86.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 112.248 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -97.0 146.05 30.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -57.66 -19.54 38.21 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.616 2.21 . . . . 0.0 112.436 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -54.92 -22.39 14.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.6 m -67.64 68.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 59' ' ' LEU . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.599 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.505 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.45 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.697 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.697 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 107' ' ' PHE . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.48 -33.79 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.33 -169.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -147.35 92.47 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -104.94 -134.3 7.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.561 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.41 -38.3 6.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.41 132.18 51.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 61.01 77.81 0.35 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.31 108.19 2.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.63 2.22 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.88 86.67 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.02 138.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.8 176.79 7.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.2 -70.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.521 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.58 83.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.767 0.317 . . . . 0.0 111.057 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 m -140.55 170.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.09 40.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.88 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.88 47.17 1.39 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -79.28 87.89 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.58 167.63 14.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.6 -31.52 69.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.887 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.89 -61.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.29 26.32 10.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.0 mt 55.45 91.8 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.232 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.44 139.17 40.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 112.3 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -176.56 111.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.46 151.7 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -87.99 174.58 8.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -114.33 34.41 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -125.49 -47.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -170.28 163.62 6.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 168.09 22.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -134.62 162.51 32.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.61 103.71 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -83.19 -34.06 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 175.16 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.5 78.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.068 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.9 156.29 24.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.98 95.29 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 60.74 101.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -128.0 31.93 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.98 34.76 19.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -96.71 163.37 13.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.49 167.74 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -155.87 165.54 36.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -80.95 -61.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.18 -175.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.98 -177.31 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CG ' ' HG2' ' A' ' 32' ' ' PRO . 2.6 m80 -157.08 98.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' HB ' ' HD3' ' A' ' 31' ' ' PRO . 1.5 mp -88.82 -47.45 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.663 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 30' ' ' ILE . 36.7 Cg_exo -58.15 -48.08 17.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.204 1.936 . . . . 0.0 112.648 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 33.4 Cg_exo -59.89 -23.8 73.82 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.297 1.998 . . . . 0.0 112.334 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.89 84.78 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.6 mtp 69.22 -67.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.05 68.88 1.32 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 86.99 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.637 2.225 . . . . 0.0 112.251 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -61.85 109.75 2.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.972 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.77 -21.46 72.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -55.87 -24.03 34.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.333 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -95.18 40.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 101' ' ' ILE . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 ' CE2' ' A' ' 63' ' ' PHE . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.455 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.705 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.705 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.508 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HB ' HG11 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.711 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.697 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.405 ' CD1' ' CD1' ' A' ' 45' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' HG21 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.44 83.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 m -179.77 99.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.75 -134.49 14.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.62 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.7 t60 61.35 88.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -100.97 -39.23 7.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.416 ' CB ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -179.53 -53.01 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 125' ' ' ARG . 32.7 Cg_exo -59.57 150.0 78.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.275 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -102.75 25.56 27.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.39 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mp 57.98 63.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 111.107 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.77 -30.99 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.32 155.0 30.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.5 169.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.83 -30.79 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.99 -32.8 7.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.64 178.82 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.74 -89.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -175.71 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.36 159.3 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.19 138.12 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.924 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p -175.1 -41.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 61.73 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 pt -134.73 146.8 60.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 168.32 25.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.517 2.145 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.06 21.92 10.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.061 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 t 78.87 -4.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.838 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 p 47.23 -169.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 111.305 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.88 -56.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 66.24 -71.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.41 89.07 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.19 157.97 2.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.606 2.204 . . . . 0.0 112.44 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -163.24 112.47 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.39 -164.34 16.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -81.82 94.0 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.8 m -87.62 144.88 26.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.92 84.18 2.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 60.37 80.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.07 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -83.96 133.39 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.59 98.52 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.6 mt -148.88 104.45 3.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.13 -22.05 14.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 67.77 178.58 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 62.6 27.15 16.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 56.09 177.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.68 31.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 59.86 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m80 58.9 93.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.8 tp -84.28 -29.17 0.43 Allowed Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 52.0 Cg_exo -53.3 -47.13 29.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.867 1.711 . . . . 0.0 112.608 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 7.7 Cg_exo -72.28 -67.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.428 2.085 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t 45.55 28.9 0.56 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.392 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.94 39.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -71.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.417 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 1.2 t-20 -167.35 55.77 0.33 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 36' ' ' ASN . 93.6 Cg_endo -84.49 44.04 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.688 2.259 . . . . 0.0 112.76 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -102.29 86.71 0.94 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.68 -31.54 40.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.534 2.156 . . . . 0.0 112.11 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.47 -27.98 64.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.333 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 44' ' ' ASN . 43.4 t -100.13 80.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.654 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HB2' ' HA3' ' A' ' 94' ' ' GLY . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' CD1' ' CB ' ' A' ' 100' ' ' ALA . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.567 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.422 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.707 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.707 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.458 ' CG1' HD12 ' A' ' 69' ' ' ILE . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.756 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 ' CD1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 84' ' ' ARG . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.756 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 42' ' ' LEU . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.783 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.628 HG22 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.43 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.628 ' H ' HG22 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . -90.5 94.83 9.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.28 -31.11 70.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -162.86 163.89 26.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.24 -90.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -175.11 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -63.45 149.22 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -134.84 145.98 56.93 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 -32.31 9.39 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.52 2.146 . . . . 0.0 112.257 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.02 -151.89 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -140.61 138.65 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.105 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.65 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.01 -142.22 16.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.83 59.63 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.87 101.45 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.25 48.2 7.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 125.69 24.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.5 38.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -86.97 -48.55 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.57 39.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -62.81 -51.48 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.356 . . . . 0.0 110.949 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.836 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.886 0.374 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -120.95 121.18 37.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.831 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.46 171.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.404 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 3.4 mp -65.02 136.48 96.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 4' ' ' ILE . 49.0 Cg_endo -68.83 89.05 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.482 2.121 . . . . 0.0 112.234 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.62 31.14 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.7 m -84.08 116.56 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 60.22 -176.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -112.24 141.44 45.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -100.61 -176.72 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.45 133.97 23.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 112.47 3.54 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.527 2.151 . . . . 0.0 112.356 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.27 102.19 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.06 161.08 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.16 -72.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 t -141.49 -50.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.42 125.56 38.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -81.48 71.78 8.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -120.04 121.43 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 64.55 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -144.16 -57.36 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.34 -73.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -170.56 123.93 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -135.63 129.55 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -154.37 177.76 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -112.07 48.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.86 90.3 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -84.93 152.18 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -86.49 -60.0 2.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.6 92.24 43.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 31.6 Cg_exo -57.84 -46.89 23.48 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.524 2.149 . . . . 0.0 112.633 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 91.4 Cg_endo -81.33 64.15 8.71 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.365 2.043 . . . . 0.0 112.56 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -104.2 88.52 3.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -164.81 -44.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.7 ttm -66.3 106.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -58.95 109.63 2.03 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.06 75.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.412 2.075 . . . . 0.0 112.235 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.86 110.82 3.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.93 -56.34 2.68 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.395 2.064 . . . . 0.0 112.275 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 8.8 t70 -53.53 -25.04 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t -92.07 -36.06 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.481 HD12 ' CD2' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 ' C ' HG13 ' A' ' 50' ' ' ILE . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.655 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.506 HD12 HG22 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.506 HG22 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.8 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.44 HG23 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 69' ' ' ILE . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 107' ' ' PHE . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.53 85.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.16 105.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -142.16 132.5 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.83 -149.38 7.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.514 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -115.85 150.26 37.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.52 38.26 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 62.56 140.03 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.97 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.22 -167.82 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.541 2.161 . . . . 0.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.3 -93.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.6 mm 69.73 -65.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.3 39.21 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.04 33.89 65.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.651 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.76 -179.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 111.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.49 -46.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.4 -110.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 60.72 34.59 19.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.62 142.23 4.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.87 113.99 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.796 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.75 176.46 41.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.503 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -132.36 140.68 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.88 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.774 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -138.16 131.35 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.5 106.07 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pp -93.15 104.18 11.33 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.99 -13.9 41.65 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.446 2.097 . . . . 0.0 112.638 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -162.07 177.54 9.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.761 0.315 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -154.15 -46.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.2 -166.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.75 172.96 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 61.18 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 62.41 149.48 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.35 -57.41 2.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.538 2.159 . . . . 0.0 112.315 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -64.49 -178.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.11 -126.28 2.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.433 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -134.06 -179.04 5.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.93 152.81 38.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.55 -27.92 9.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.94 -78.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.961 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.49 82.77 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.4 -30.31 8.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.33 170.86 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 pp -169.27 157.36 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.48 -178.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -85.58 -62.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.09 178.31 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.9 -65.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -171.26 -71.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 55.07 41.76 31.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.057 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -126.45 28.41 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.9 mp 55.81 87.93 0.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 32.0 Cg_exo -57.35 -45.49 34.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.609 2.206 . . . . 0.0 112.572 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 52.5 Cg_exo -52.75 -38.63 77.68 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.402 2.068 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.9 m -115.77 113.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -103.52 -37.47 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.51 71.83 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.39 123.82 88.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.96 81.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.547 2.164 . . . . 0.0 112.326 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -85.97 110.35 29.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.83 -12.97 37.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.428 2.085 . . . . 0.0 112.5 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.21 -29.4 63.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.64 -9.71 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.558 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 91' ' ' PHE . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.531 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.637 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.659 ' CE1' ' HA ' ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.471 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD21 ' CE2' ' A' ' 49' ' ' TYR . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.647 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 ' CG1' HD11 ' A' ' 69' ' ' ILE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.734 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.466 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.734 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' LYS . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.456 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.679 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 105' ' ' ASN . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.41 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 103' ' ' GLY . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.579 HG22 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.659 ' HA ' ' CE1' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.11 65.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.4 83.9 7.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.167 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.74 -174.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.49 118.49 1.89 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 177.48 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 68.46 -67.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.971 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 112.65 47.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.26 -39.91 63.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.469 2.113 . . . . 0.0 112.222 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.1 72.73 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.302 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 tt -55.73 140.27 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.29 -46.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 157.21 -28.43 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.06 77.11 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.336 . . . . 0.0 111.063 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 m -111.36 -32.23 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.6 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.51 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.45 34.24 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.38 169.32 21.76 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.91 171.68 11.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.26 -69.34 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -114.6 -71.45 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.923 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.794 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -153.92 -55.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -128.19 -45.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 6' ' ' LEU . 7.4 tp -168.22 108.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.84 68.15 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.201 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' ILE . 28.9 mt -152.55 -44.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t 70.94 103.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m 60.94 158.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 62.11 116.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.417 ' CD1' ' HD3' ' A' ' 12' ' ' PRO . 17.3 p90 -134.05 -176.21 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.58 97.73 30.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 10' ' ' TYR . 51.9 Cg_endo -69.26 148.31 68.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.422 2.081 . . . . 0.0 112.253 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -139.63 142.1 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.7 157.36 53.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -86.6 90.13 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -65.18 98.77 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.42 -62.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -171.63 141.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.52 -37.29 6.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 61.07 112.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.76 31.38 4.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.27 -70.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 61.86 151.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.26 88.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.18 16.36 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.74 33.06 15.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -153.05 126.73 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -128.84 75.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.792 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -99.03 -24.96 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' CG2' ' HD2' ' A' ' 32' ' ' PRO . 5.5 mm 64.44 121.52 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 45.4 Cg_exo -54.92 -50.0 14.76 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.764 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 82.1 Cg_endo -77.29 4.55 5.79 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.351 2.034 . . . . 0.0 112.872 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 2.2 t 43.67 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 111.554 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 33' ' ' THR . 0.5 OUTLIER 37.1 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.855 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -48.63 80.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.458 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 179.96 -52.47 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.089 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 23.4 Cg_exo -64.31 73.76 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.792 2.328 . . . . 0.0 112.239 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -102.04 105.49 42.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.32 -26.59 82.41 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.496 2.131 . . . . 0.0 112.171 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.55 -30.04 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -97.72 31.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.258 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.411 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.693 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.693 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.501 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HB ' HG13 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.74 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 73' ' ' LYS . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 105' ' ' ASN . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.706 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.402 ' HB2' ' CG2' ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.565 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.63 65.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.33 -67.16 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.027 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.6 t -149.92 102.34 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.55 -82.27 1.53 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 147.3 32.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -93.31 134.06 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.63 114.09 1.51 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.69 -27.12 38.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.485 2.124 . . . . 0.0 112.289 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.65 40.91 0.3 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.5 mt 57.79 55.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.195 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.61 -50.36 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.52 46.82 66.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.581 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.29 -170.26 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.07 -38.32 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.96 -92.69 0.55 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.97 102.04 8.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.41 -50.23 0.23 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 60.67 164.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.22 131.48 2.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.05 -58.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.87 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.877 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -166.94 111.32 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -108.48 167.26 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.3 pt -146.63 145.5 23.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.67 61.98 4.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.601 2.201 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -149.99 -66.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.0 t 65.6 15.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 173.78 163.6 0.17 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.65 73.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 -49.65 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.16 144.9 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 168.09 24.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -96.55 117.77 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.36 45.54 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.4 -172.27 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.62 40.88 16.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.03 164.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.49 147.95 35.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 122.06 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -144.47 161.28 39.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.96 108.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 mp -80.16 142.65 34.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -148.52 27.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.97 52.33 9.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.97 138.66 57.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -176.01 40.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.21 171.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.55 -32.86 19.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.36 145.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HB ' ' HD2' ' A' ' 32' ' ' PRO . 28.8 pt -122.31 152.45 60.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 51.4 Cg_exo -53.25 -46.85 30.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.685 2.257 . . . . 0.0 112.904 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 91.7 Cg_endo -79.04 53.27 4.63 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.281 1.988 . . . . 0.0 112.691 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.6 m -121.2 49.19 1.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.806 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -166.76 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.945 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.09 95.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -68.17 111.25 7.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 123' ' ' HIS . 21.6 Cg_exo -65.57 67.89 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.258 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -101.92 151.27 37.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.28 -25.11 13.76 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.601 2.201 . . . . 0.0 112.374 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.64 -31.41 69.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 66.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.51 ' CG1' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.483 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.567 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.722 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.722 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.455 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.777 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.717 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.07 -47.04 86.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.41 175.91 7.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -176.27 -40.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.61 142.55 3.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -74.59 178.3 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -129.31 74.23 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -119.32 147.68 43.7 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.02 153.47 20.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.485 2.124 . . . . 0.0 112.275 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -102.75 21.93 38.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.591 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.8 mt 56.04 87.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.797 0.332 . . . . 0.0 111.263 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 91.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.99 -123.37 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.515 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.83 34.64 19.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t 68.82 -67.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.72 -143.36 8.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -156.07 112.89 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.93 -59.8 1.65 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -60.46 155.08 19.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.51 167.77 25.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -65.01 -56.29 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.919 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 59.72 93.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.74 145.38 40.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.92 144.02 49.89 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 130.79 15.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.488 2.126 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 mt -102.85 31.1 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.782 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.02 125.49 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.37 -169.43 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 61.05 -178.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.71 102.07 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -153.37 81.0 5.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 -171.76 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.58 2.187 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -101.67 31.1 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.37 -111.36 3.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.536 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 159.69 13.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.329 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -147.57 156.84 43.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.72 161.58 13.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.73 35.76 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.3 mt -149.49 178.4 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.8 120.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.3 18.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mp 48.29 53.05 12.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.866 0.365 . . . . 0.0 111.205 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 60.41 77.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.55 148.4 52.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 60.92 156.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.36 97.25 4.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -119.76 30.72 6.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.32 -166.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.68 38.11 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.005 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.2 mp -66.76 -54.22 23.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.1 Cg_endo -64.63 173.08 5.92 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 63.71 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.446 2.097 . . . . 0.0 112.166 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.63 117.58 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.026 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 44.78 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.444 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.27 29.74 13.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 56.69 65.84 3.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.069 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.68 55.83 5.68 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 112.423 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.61 112.5 34.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.77 -26.77 75.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.45 2.1 . . . . 0.0 112.221 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.93 -31.41 69.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -93.87 16.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.487 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.47 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.417 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.44 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.557 HD12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 69' ' ' ILE . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.626 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.626 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' CG1' ' CG1' ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.725 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 107' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.32 -31.0 60.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.18 166.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 t -59.7 127.04 30.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.84 -157.58 20.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.56 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 t60 61.02 98.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.821 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -86.97 159.41 19.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 1.5 mtt-85 -72.8 -60.74 1.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.19 -176.53 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 0.0 112.286 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.16 -90.58 1.87 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.438 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 tp -152.97 133.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.086 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -175.18 117.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.09 77.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.89 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 111.161 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.52 167.87 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.75 -41.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -153.88 61.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.87 -175.68 14.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.71 144.51 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.361 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.07 103.06 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.97 -36.1 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.846 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.859 0.361 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 p -76.83 175.17 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -105.11 128.2 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 pt -59.24 146.8 77.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' VAL . 91.1 Cg_endo -83.43 48.66 2.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.778 2.319 . . . . 0.0 112.821 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 6.8 mt 65.17 -66.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.403 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 5' ' ' PRO . 15.1 t 73.11 -67.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.085 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.07 -71.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -137.64 -175.73 4.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.72 31.46 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.58 148.41 55.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.52 -168.17 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.49 2.127 . . . . 0.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -135.47 -179.46 5.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.29 -71.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.537 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 107.57 18.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -152.94 85.71 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.08 137.82 47.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.21 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 mt -148.61 -50.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -153.86 -175.07 5.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -153.43 -46.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.39 -175.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.86 41.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 61.11 100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 135.69 46.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.35 -70.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 68.89 -67.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -150.02 -174.47 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -132.4 118.88 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.9 pt -110.12 96.53 26.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.7 Cg_exo -51.64 -47.91 23.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.579 2.186 . . . . 0.0 112.695 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 57.9 Cg_endo -71.67 -7.81 21.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.188 1.925 . . . . 0.0 112.611 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.5 -163.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.914 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 70.91 -166.41 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.2 ttp 65.6 40.82 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -103.4 161.61 22.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.15 73.44 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.231 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.33 154.48 69.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.839 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.55 -27.36 18.88 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.552 2.168 . . . . 0.0 112.344 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.8 -34.59 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.5 m -97.92 28.86 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.425 ' CB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.572 HD13 ' HG2' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG11 HD13 ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.535 ' CG1' HG13 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.427 ' CE2' ' HA3' ' A' ' 67' ' ' GLY . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.417 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.7 p30 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.558 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 ' CD2' ' CD2' ' A' ' 49' ' ' TYR . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 88' ' ' PHE . . . -70.07 66.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.39 125.67 25.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 m 60.52 178.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.928 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.97 -60.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.97 117.43 14.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -105.51 32.23 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -123.8 161.08 48.46 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.51 -43.14 14.32 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.562 2.175 . . . . 0.0 112.296 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.71 -63.04 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.547 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.1 mt 69.04 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.37 124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.18 -111.15 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.591 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -110.85 173.98 6.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -154.75 153.0 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.061 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 -57.69 5.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.89 140.56 46.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.95 162.08 33.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -97.21 -32.34 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.11 0.86 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -64.73 -67.16 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.896 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -144.58 39.83 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.56 157.35 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.9 tt -134.8 100.55 12.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.62 114.13 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.428 2.085 . . . . 0.0 112.411 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.9 -166.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.473 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.87 126.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.061 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 m -105.44 -66.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.31 155.7 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.38 143.41 50.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -72.81 -60.65 1.86 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 59.7 Cg_endo -72.53 -43.89 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.315 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.94 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.975 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.44 141.34 2.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.528 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -101.6 -49.56 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -176.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.77 -170.51 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -122.34 92.62 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.87 124.0 24.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -142.69 179.87 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -31.56 14.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 mt 60.07 178.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -134.04 173.35 11.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -76.41 166.08 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -111.77 106.13 14.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -165.82 34.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.1 122.72 8.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 63.86 130.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -60.26 165.57 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.67 89.3 31.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.66 156.71 6.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.578 2.186 . . . . 0.0 112.295 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 63.38 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.252 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -127.73 164.77 21.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.63 -174.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.57 68.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -124.79 62.8 36.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.93 61.32 3.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.548 2.165 . . . . 0.0 112.318 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -101.92 141.67 23.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.98 -22.01 15.3 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.513 2.142 . . . . 0.0 112.438 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.34 -26.5 52.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -96.83 29.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.258 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.582 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.425 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.641 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' CD2' ' CD1' ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.641 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.68 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.468 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 60' ' ' ARG . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.723 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.582 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.442 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.539 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 104' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -94.34 28.69 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.51 136.72 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.172 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.24 161.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.9 -139.12 6.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.569 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -118.3 -43.69 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.15 -170.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -128.94 140.56 38.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.45 -43.76 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.447 2.098 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.24 -67.61 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 128' ' ' ILE . 22.1 mm 59.29 37.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.5 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.9 -171.88 18.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -119.7 89.68 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.27 132.91 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -105.29 -45.72 1.31 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.544 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.3 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.49 -126.25 6.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -80.45 159.92 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.08 76.89 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -65.71 -32.89 74.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.13 143.77 33.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 60.31 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.7 tp -157.65 70.84 4.27 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.12 -57.3 2.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.279 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mt -71.19 143.54 50.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.85 82.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.104 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.78 -70.09 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.01 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -153.32 -178.38 6.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -110.55 96.11 26.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.61 -25.03 13.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.629 2.22 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -55.91 -45.76 78.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.57 36.0 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.434 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 95.36 6.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -98.81 110.31 22.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.59 171.52 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.49 156.2 18.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.93 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.91 38.07 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.39 -179.2 4.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.6 mt -72.83 -55.03 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 59.7 31.66 20.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -107.25 169.28 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -143.4 114.7 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.24 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.41 98.94 9.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 60.16 159.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -87.72 117.43 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.0 mt -144.42 76.95 14.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.37 170.17 19.9 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.599 2.2 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.38 42.54 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.865 2.376 . . . . 0.0 112.699 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -121.56 70.36 0.94 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.791 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.75 -39.05 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.817 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 mmt -85.28 -30.68 23.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 31.9 m-20 60.39 53.22 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 36' ' ' ASN . 74.3 Cg_endo -74.89 60.65 5.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -100.58 122.75 48.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 -19.53 23.24 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.458 2.105 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.98 -26.48 36.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -70.78 64.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.436 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.443 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.421 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 59' ' ' LEU . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' CG1' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.421 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.699 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.482 ' O ' ' O ' ' A' ' 73' ' ' LYS . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.487 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.636 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 101' ' ' ILE . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.467 ' CD2' ' CE2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.68 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.97 106.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -174.5 36.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.24 -58.14 0.41 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.2 t60 60.18 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -135.44 -172.03 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -143.98 107.87 4.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.66 -47.13 2.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.397 2.065 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.12 -70.97 0.49 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.558 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.5 mm 69.33 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 -53.14 39.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.26 128.82 6.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.579 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.73 125.58 25.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.327 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.18 -42.62 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.151 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 59.74 87.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.438 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.67 146.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.32 -164.41 10.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.47 57.27 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -59.5 134.6 57.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.905 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptm . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.694 0.283 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -118.92 103.74 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.817 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -170.09 109.23 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 mt 63.29 95.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.29 97.81 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.464 2.11 . . . . 0.0 112.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.69 73.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.94 138.08 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.146 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 p -157.81 160.73 38.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -98.56 30.58 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.69 79.6 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.85 117.22 50.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.54 155.71 62.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.338 2.025 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 6.6 p90 -170.41 90.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.88 -126.46 8.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 60.25 100.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.807 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -130.22 -46.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.0 177.62 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -96.63 145.59 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.01 152.54 22.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.87 141.57 28.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -98.82 85.19 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -106.35 -53.51 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 59.92 30.24 19.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -69.88 94.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -98.73 76.36 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -96.47 20.44 10.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -117.42 -31.55 5.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 27' ' ' GLN . 24.7 pt20 46.52 -172.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -127.8 37.77 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.026 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp -134.85 71.01 70.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.97 158.63 54.87 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.147 . . . . 0.0 112.255 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.72 73.13 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.623 2.216 . . . . 0.0 112.318 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t 178.82 -52.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -90.75 81.5 5.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.0 ttp -68.8 92.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.5 127.83 85.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.98 81.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.427 2.085 . . . . 0.0 112.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -74.0 144.88 82.91 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.26 -6.86 17.62 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.489 2.126 . . . . 0.0 112.715 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.11 -29.37 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.14 61.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.422 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' HA ' HG13 ' A' ' 50' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.492 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 ' CG1' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.583 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.438 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.482 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.714 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.714 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.412 ' HA ' HG21 ' A' ' 116' ' ' VAL . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.584 HG21 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.584 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 114' ' ' LEU . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 45' ' ' LEU . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.559 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.417 ' CB ' ' ND2' ' A' ' 44' ' ' ASN . . . -49.59 -29.44 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -108.04 -63.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.36 -65.73 0.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.34 -28.07 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.631 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 64.21 116.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -93.0 -31.41 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -65.87 154.93 88.07 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 -38.02 7.58 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.95 78.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mt 63.96 119.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.06 -45.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.62 123.73 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.601 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.47 -18.43 61.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.383 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 t 67.11 26.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.165 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 93.17 -40.52 2.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.634 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.02 63.33 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.68 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.511 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.7 t30 64.32 79.54 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -164.73 -100.77 0.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.529 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -127.63 -50.2 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.851 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -103.15 45.81 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -81.21 73.7 8.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 4.1 mt -76.77 -48.26 2.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 4' ' ' ILE . 91.3 Cg_endo -78.83 -24.89 6.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.265 1.977 . . . . 0.0 112.442 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.43 34.53 12.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.7 t -99.37 133.23 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -96.05 119.1 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 104.08 3.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -62.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.0 109.77 2.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 140.79 41.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.404 2.069 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -101.19 129.11 47.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.5 -51.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 40.41 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -30.09 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 132.46 53.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 60.17 165.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.7 tp -173.45 -57.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -177.07 -39.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.46 127.98 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.51 92.0 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 60.22 175.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -176.49 120.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.762 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -154.13 95.63 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -117.39 30.61 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -136.6 -45.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 65.02 98.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.25 75.54 15.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.93 177.65 1.32 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.541 2.16 . . . . 0.0 112.139 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.76 -22.05 12.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.524 2.149 . . . . 0.0 112.466 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.88 83.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -89.97 99.9 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.049 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 mtp 47.67 29.15 1.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.1 m120 -59.71 -61.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 73.7 Cg_endo -85.22 46.74 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.776 2.318 . . . . 0.0 112.512 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -94.48 123.19 59.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.932 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.17 -12.51 25.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.08 . . . . 0.0 112.517 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -55.26 -32.01 62.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.824 0.345 . . . . 0.0 111.095 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 m -75.95 62.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.457 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.465 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.418 ' HB ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 HG23 HG21 ' A' ' 74' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.597 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.576 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 91' ' ' PHE . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.478 ' CG1' HD12 ' A' ' 69' ' ' ILE . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.771 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.771 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG2' ' CG2' ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.637 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.646 ' HB3' ' CE2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 107' ' ' PHE . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -59.22 -25.65 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.13 145.83 20.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.243 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m -67.72 -169.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.82 29.46 4.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.87 -41.83 51.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.24 -47.58 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -96.37 109.2 46.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.87 -47.98 23.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.425 2.083 . . . . 0.0 112.305 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.42 43.34 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.5 mt 59.24 30.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 111.157 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 59.16 -169.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 164.91 -145.49 10.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.506 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.69 106.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.4 144.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.42 -43.97 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.4 79.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 128.92 171.14 12.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.02 109.52 16.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -99.87 156.15 19.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 65.28 -73.78 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 111.081 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.89 124.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.51 -79.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.455 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 1.7 mt -84.43 -47.22 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' ILE . 85.2 Cg_endo -82.28 165.38 16.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.33 2.02 . . . . 0.0 112.481 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.21 -46.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 t 64.98 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -75.18 130.11 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -150.2 166.58 29.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 -48.79 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -57.33 108.75 1.35 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.76 128.79 30.47 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.461 2.108 . . . . 0.0 112.227 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -132.95 159.44 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.67 96.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -73.57 -59.6 2.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.47 114.51 27.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.29 145.87 29.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.29 101.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.06 -65.53 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.22 127.53 32.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -98.27 -46.92 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 mp 59.84 75.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.86 -63.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -76.46 178.97 6.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -104.69 -34.93 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -145.46 151.64 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -91.21 -31.05 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -135.89 119.31 16.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.446 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -160.1 164.57 32.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 14.9 mm -95.71 -46.07 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 61.6 Cg_exo -50.37 -45.74 32.63 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 113.031 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 13.1 Cg_exo -69.93 -30.83 20.86 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m 62.24 35.13 15.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -89.08 107.19 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 ptp -163.16 79.81 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.93 108.45 1.16 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.37 52.23 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.653 2.235 . . . . 0.0 112.502 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -88.65 149.0 43.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.66 -39.05 77.13 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.69 2.26 . . . . 0.0 112.453 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.99 -34.41 71.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 120' ' ' ALA . 14.3 m -106.59 27.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' A' ' 116' ' ' VAL . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 63' ' ' PHE . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.547 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ARG . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.73 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.587 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' HB3' ' H ' ' A' ' 85' ' ' GLY . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 84' ' ' ARG . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.482 ' CZ ' ' HG3' ' A' ' 46' ' ' MET . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' CE2' ' CB ' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.692 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.526 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 47' ' ' VAL . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.509 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.99 -74.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . . . 173.27 -169.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 83.3 p -135.43 171.83 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.27 68.98 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.536 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -125.58 110.88 14.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -59.17 165.62 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.7 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 125' ' ' ARG . 36.5 Cg_endo -65.39 -26.83 55.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.359 2.039 . . . . 0.0 112.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.14 86.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.55 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 tt -78.71 132.16 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.991 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.4 -175.86 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 129.8 91.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.93 -171.55 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.051 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.4 m -88.23 160.16 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.79 153.21 25.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 60.52 36.71 19.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.48 139.73 7.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -72.48 125.52 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.61 -115.0 4.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -149.26 -66.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.905 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -171.96 -64.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.47 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -134.48 122.73 15.98 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 148.34 73.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.407 2.071 . . . . 0.0 112.287 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.26 -63.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.24 137.83 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.01 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 61.09 -173.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.25 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.92 99.88 46.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 172.31 11.21 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.421 2.081 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.3 t80 61.16 93.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.01 116.79 7.51 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.14 95.93 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.14 -169.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.03 -44.12 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.63 -66.35 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.43 160.45 14.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.23 31.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 64.76 -78.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.36 85.2 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -107.69 -29.27 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.96 102.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -96.43 -74.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -89.11 84.74 6.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -104.9 -61.63 1.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -135.11 -73.99 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.54 -171.44 2.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.7 mp 65.42 91.69 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.3 171.64 11.29 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 112.212 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 67.54 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.575 2.184 . . . . 0.0 112.321 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.84 -35.68 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 60.66 81.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.3 mtm -110.62 -30.17 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.22 67.31 1.24 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.19 73.5 3.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.643 2.228 . . . . 0.0 112.427 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -101.97 105.77 43.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.35 -13.15 38.31 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.631 2.22 . . . . 0.0 112.622 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -56.54 -27.61 58.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.354 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -97.58 31.48 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.605 ' HB ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HB ' ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.628 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.628 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' HG ' ' CD2' ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.507 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.426 ' HB2' HD13 ' A' ' 104' ' ' LEU . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.553 HD13 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 69' ' ' ILE . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.774 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.774 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.455 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.638 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.567 HG21 ' O ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 3.7 m-80 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.567 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.481 ' CD2' ' HG ' ' A' ' 62' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' HB1' ' CZ ' ' A' ' 88' ' ' PHE . . . -57.51 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 173.05 -70.84 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.93 0.395 . . . . 0.0 111.136 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.03 70.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.812 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.21 -159.14 14.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -128.3 146.61 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.0 148.67 26.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -175.21 -62.29 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.9 Cg_endo -72.47 -44.74 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.488 2.125 . . . . 0.0 112.319 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.98 54.37 2.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mt 64.06 113.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.077 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 164.65 17.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.46 -93.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.418 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -171.9 124.44 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -41.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.87 -28.88 2.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.19 164.86 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.98 77.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -82.04 96.07 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.65 -33.73 2.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 63.55 -78.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.749 0.309 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.851 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -88.36 -53.97 4.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.65 -60.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tt -118.73 134.1 23.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 95.27 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.509 2.14 . . . . 0.0 112.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.6 85.19 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.75 147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.1 -175.77 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 69.01 -65.87 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.64 143.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.24 74.45 67.69 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.36 150.81 19.35 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -126.84 169.02 13.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 -152.61 31.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.08 75.73 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -143.7 98.81 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.24 158.75 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 60.29 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -31.06 46.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -91.71 -3.51 56.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.439 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 65.91 -76.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.4 mt 60.66 111.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -106.83 135.42 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -149.56 169.91 19.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 103.2 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 60.11 179.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.51 136.77 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -109.19 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.976 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -108.01 146.45 32.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 19.0 mt -92.68 -44.58 0.34 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 72.7 Cg_exo -48.01 -45.57 24.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.299 1.999 . . . . 0.0 113.178 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.455 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 11.3 Cg_exo -71.43 -66.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.222 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.08 159.84 8.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -165.59 -67.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 tmm? 54.67 31.33 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -106.72 131.91 21.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.13 54.26 5.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.56 2.173 . . . . 0.0 112.434 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -101.99 120.34 54.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.22 -26.2 7.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.406 2.07 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.24 -27.74 68.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.3 m -96.38 27.29 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' HD22 ' A' ' 45' ' ' LEU . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 HD13 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' CG2' ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.463 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.753 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 47' ' ' VAL . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.503 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.567 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.44 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 46' ' ' MET . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.658 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 105' ' ' ASN . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 116' ' ' VAL . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.564 HG21 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.564 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 49' ' ' TYR . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.08 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 174.9 -165.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.909 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.6 t -71.7 -32.14 67.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.95 85.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 171.51 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -105.81 -49.42 3.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.826 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -172.36 63.46 0.33 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.0 -39.94 88.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.565 2.177 . . . . 0.0 112.284 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.27 52.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.393 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 tt 43.67 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.532 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.67 38.49 18.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.43 76.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -87.09 175.07 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.071 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.18 112.82 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.105 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.99 61.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.452 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.14 87.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.15 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.35 174.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.94 -139.03 7.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.18 -45.79 58.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.876 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.82 109.27 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -92.22 -69.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.71 87.88 4.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.19 150.77 18.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.509 2.139 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -121.69 -58.63 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.22 -31.61 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.34 168.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -161.35 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -162.62 109.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -177.59 -62.19 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 11' ' ' ASP . 17.9 Cg_endo -59.63 -25.25 78.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.463 2.109 . . . . 0.0 112.392 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -172.28 153.12 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.39 170.79 17.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.408 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -119.52 -49.64 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m 60.65 105.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.95 116.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.17 111.84 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.57 172.4 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -124.03 117.13 24.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -152.15 -46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt 68.66 -67.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.24 84.13 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -80.62 -68.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -68.68 -177.47 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.83 37.58 12.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -120.72 160.64 22.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -99.58 166.26 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.66 -175.44 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt 41.66 62.12 7.49 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.723 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.25 156.95 4.88 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.567 2.178 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.3 64.84 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.577 2.185 . . . . 0.0 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 p -142.91 -47.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.18 172.47 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.21 31.39 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.53 88.7 7.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.48 80.82 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -89.32 149.4 42.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.78 -25.22 24.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.371 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.25 -28.83 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.2 38.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.296 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.491 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 54' ' ' VAL . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.421 ' O ' HD11 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 50' ' ' ILE . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.725 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.725 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 60' ' ' ARG . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.429 ' CG1' HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.772 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.772 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 104' ' ' LEU . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HA ' HG21 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.2 p30 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.629 HG21 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.428 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.629 ' H ' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.44 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.435 ' CD1' ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 46' ' ' MET . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' ASN . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . . . -74.17 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.38 161.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.35 -77.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.11 -133.02 3.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.97 160.05 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -71.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 96.73 49.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.18 -27.36 35.28 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.517 2.145 . . . . 0.0 112.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 97.97 66.25 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.594 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pp -157.77 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 111.142 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.7 79.18 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.078 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.6 -158.62 15.24 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.92 147.1 24.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.59 166.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.17 -32.5 7.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.6 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -173.03 -65.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 166.76 -72.03 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.509 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -155.92 170.03 23.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.74 -124.37 1.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 68.11 -69.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.69 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.9 t-20 -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.906 HD12 HG12 ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 84' ' ' ARG . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 50' ' ' ILE . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 51' ' ' PRO . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.873 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 47' ' ' VAL . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 114' ' ' LEU . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 104' ' ' LEU . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.919 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.873 HD11 ' N ' ' A' ' 56' ' ' GLU . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 52' ' ' THR . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.652 ' CD1' HD21 ' A' ' 118' ' ' LEU . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 62' ' ' LEU . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.906 HG12 HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 41' ' ' VAL . 7.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.8 t-20 -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.821 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 59' ' ' LEU . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.845 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' HD23 ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.89 HD13 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 89' ' ' VAL . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.845 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 82' ' ' GLN . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 80' ' ' THR . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 52' ' ' THR . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.769 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.822 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.873 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.822 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.79 HG13 HD11 ' A' ' 45' ' ' LEU . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.555 ' HB2' HG23 ' A' ' 101' ' ' ILE . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.821 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 101' ' ' ILE . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 118' ' ' LEU . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 t-20 -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 116' ' ' VAL . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.902 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.902 ' HD2' HG22 ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.713 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.92 ' N ' HD11 ' A' ' 74' ' ' ILE . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.915 HD22 ' CE2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.944 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD22 ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.944 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.92 HD11 ' N ' ' A' ' 56' ' ' GLU . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.503 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.942 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.942 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.866 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 116' ' ' VAL . 16.4 t-20 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.818 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.818 ' H ' HG23 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 62' ' ' LEU . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 45' ' ' LEU . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.866 HD21 ' CD1' ' A' ' 101' ' ' ILE . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 41' ' ' VAL . 29.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG12 ' A' ' 116' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 59' ' ' LEU . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.484 HG23 ' HG3' ' A' ' 84' ' ' ARG . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.851 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.958 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.596 ' CD ' HD11 ' A' ' 50' ' ' ILE . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 47' ' ' VAL . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.776 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.62 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 114' ' ' LEU . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.725 ' HA ' HD11 ' A' ' 104' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.789 HG22 ' CD1' ' A' ' 91' ' ' PHE . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.958 HD11 ' N ' ' A' ' 56' ' ' GLU . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.748 ' CG2' HG21 ' A' ' 69' ' ' ILE . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.968 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.401 ' N ' ' HD3' ' A' ' 43' ' ' ARG . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.968 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.765 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 116' ' ' VAL . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.578 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HB2' ' NH1' ' A' ' 113' ' ' ARG . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 62' ' ' LEU . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 45' ' ' LEU . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.765 HD21 ' CD1' ' A' ' 101' ' ' ILE . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 118' ' ' LEU . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.617 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 3.1 t-20 -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.798 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.868 HG21 HD13 ' A' ' 59' ' ' LEU . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' A' ' 84' ' ' ARG . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.814 ' H ' HD11 ' A' ' 74' ' ' ILE . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.868 HD13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.918 ' HG2' HD11 ' A' ' 69' ' ' ILE . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CD2' HD13 ' A' ' 104' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.658 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.814 HD11 ' H ' ' A' ' 56' ' ' GLU . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 52' ' ' THR . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.485 ' CG1' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.972 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.704 HG13 HD21 ' A' ' 118' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HA ' HG23 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.66 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.66 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.792 HD11 HD21 ' A' ' 62' ' ' LEU . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 101' ' ' ILE . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG13 ' HB2' ' A' ' 44' ' ' ASN . 43.4 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.552 ' O ' HD11 ' A' ' 118' ' ' LEU . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.744 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 118' ' ' LEU . 3.2 t-20 -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 116' ' ' VAL . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.895 ' CG1' HD13 ' A' ' 59' ' ' LEU . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 86' ' ' TYR . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.865 ' N ' HD11 ' A' ' 74' ' ' ILE . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.895 HD13 ' CG1' ' A' ' 47' ' ' VAL . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.888 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CE1' HD23 ' A' ' 114' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.677 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.64 ' CG2' HG12 ' A' ' 89' ' ' VAL . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.865 HD11 ' N ' ' A' ' 56' ' ' GLU . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.668 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.785 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.64 HG12 ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 118' ' ' LEU . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.704 ' HD2' HD23 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.808 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.808 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 45' ' ' LEU . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 90' ' ' LYS . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.4 t-20 -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.707 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.848 ' CD2' HG23 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.875 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.598 ' O ' HG22 ' A' ' 53' ' ' THR . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.854 ' N ' HD11 ' A' ' 74' ' ' ILE . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.764 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 114' ' ' LEU . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.835 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.117 HD12 HG21 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.117 HG21 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.854 HD11 ' N ' ' A' ' 56' ' ' GLU . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.844 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.844 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.576 HG13 HD21 ' A' ' 118' ' ' LEU . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.835 HD11 ' HA ' ' A' ' 63' ' ' PHE . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.762 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.762 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 62' ' ' LEU . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.707 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.576 HD21 HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.634 0.255 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.849 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 3.1 t-20 -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 118' ' ' LEU . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 59' ' ' LEU . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.948 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' HG22 ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.627 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.89 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.824 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' TYR . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CE2' HG12 ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 88' ' ' PHE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.89 HD11 ' N ' ' A' ' 56' ' ' GLU . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.687 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.589 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.902 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.902 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.652 HG13 HD21 ' A' ' 118' ' ' LEU . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.57 ' HB2' HG23 ' A' ' 101' ' ' ILE . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.442 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.681 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 HG13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.687 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.712 0.292 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.73 ' O ' HD21 ' A' ' 118' ' ' LEU . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.94 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 116' ' ' VAL . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 59' ' ' LEU . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CD2' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.796 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.904 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 114' ' ' LEU . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.904 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.634 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.796 HD11 ' N ' ' A' ' 56' ' ' GLU . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG23 ' HD1' ' A' ' 88' ' ' PHE . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.541 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.916 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.94 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.916 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.041 HD11 HD23 ' A' ' 118' ' ' LEU . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.573 ' HB2' HG23 ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 114' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' H ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.639 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 62' ' ' LEU . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.041 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.724 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 41' ' ' VAL . 27.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.952 0.406 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.614 ' O ' HD11 ' A' ' 118' ' ' LEU . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 118' ' ' LEU . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 59' ' ' LEU . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.507 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.863 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 114' ' ' LEU . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.776 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.616 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.863 HD11 ' N ' ' A' ' 56' ' ' GLU . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.572 HG23 ' HD1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 52' ' ' THR . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.917 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 118' ' ' LEU . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.507 ' HB2' HG23 ' A' ' 101' ' ' ILE . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.481 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.817 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.814 HD11 HD23 ' A' ' 62' ' ' LEU . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.987 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.675 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.4 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.539 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.8 t-20 -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.732 HD22 ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.607 HG22 ' HG3' ' A' ' 84' ' ' ARG . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.902 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.702 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.63 ' HD3' HD12 ' A' ' 62' ' ' LEU . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 89' ' ' VAL . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.902 HD11 ' N ' ' A' ' 56' ' ' GLU . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.607 ' HG3' HG22 ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HE2' ' ND2' ' A' ' 44' ' ' ASN . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.831 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 118' ' ' LEU . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 63' ' ' PHE . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.667 ' OD1' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.718 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.732 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.9 t-20 -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 118' ' ' LEU . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 116' ' ' VAL . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 27.4 t30 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.574 ' CD2' HD23 ' A' ' 114' ' ' LEU . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.945 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' HG22 ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.795 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 74' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 114' ' ' LEU . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CD2' HD13 ' A' ' 104' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.889 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.82 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.673 ' HA ' HG12 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.704 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.899 HD11 HD11 ' A' ' 118' ' ' LEU . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 107' ' ' PHE . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.82 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 2.9 p-10 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 HD11 ' A' ' 101' ' ' ILE . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.82 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.736 0.303 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.831 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.6 t-20 -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.812 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.938 HG21 HD22 ' A' ' 59' ' ' LEU . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' CD ' HG22 ' A' ' 50' ' ' ILE . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.422 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.765 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.783 ' N ' HD11 ' A' ' 74' ' ' ILE . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.938 HD22 HG21 ' A' ' 47' ' ' VAL . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.891 HD21 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.666 ' HA ' HD11 ' A' ' 104' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.661 HD12 ' CG1' ' A' ' 72' ' ' VAL . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.783 HD11 ' N ' ' A' ' 56' ' ' GLU . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG23 ' HD2' ' A' ' 88' ' ' PHE . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.422 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.692 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.943 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.943 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 118' ' ' LEU . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' A' ' 101' ' ' ILE . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.738 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.738 ' H ' HG23 ' A' ' 109' ' ' ILE . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.891 HD11 HD21 ' A' ' 62' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 101' ' ' ILE . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 41' ' ' VAL . 31.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 4.3 t-20 -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.427 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 63' ' ' PHE . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.77 ' CD2' HD22 ' A' ' 114' ' ' LEU . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.874 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.874 ' HD2' HG22 ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.928 ' N ' HD11 ' A' ' 74' ' ' ILE . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.603 HD22 ' CZ ' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.985 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 47' ' ' VAL . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.985 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.687 ' HB ' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.928 HD11 ' N ' ' A' ' 56' ' ' GLU . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 1.003 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 1.003 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.66 HD11 ' CD2' ' A' ' 45' ' ' LEU . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 116' ' ' VAL . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.782 ' CG1' HD22 ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.684 HD13 HD23 ' A' ' 45' ' ' LEU . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 41' ' ' VAL . 34.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 118' ' ' LEU . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 116' ' ' VAL . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 25.6 t30 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.751 ' CD2' HD13 ' A' ' 114' ' ' LEU . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 74' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.671 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 47' ' ' VAL . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.702 ' CD2' HD13 ' A' ' 104' ' ' LEU . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.943 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.667 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.831 HD11 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.622 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.918 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.92 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.918 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.77 HD11 HD11 ' A' ' 118' ' ' LEU . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 101' ' ' ILE . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.056 HG21 HD13 ' A' ' 59' ' ' LEU . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.791 HG22 ' CD ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.593 ' O ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.795 ' H ' HD11 ' A' ' 74' ' ' ILE . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.056 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.922 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 114' ' ' LEU . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.751 ' HA ' HD11 ' A' ' 104' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 89' ' ' VAL . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.677 ' HB ' HG23 ' A' ' 89' ' ' VAL . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.797 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 82' ' ' GLN . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.708 ' O ' HG23 ' A' ' 52' ' ' THR . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 118' ' ' LEU . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.832 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.475 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.832 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' H ' ' A' ' 106' ' ' GLY . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.82 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 101' ' ' ILE . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 118' ' ' LEU . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 118' ' ' LEU . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 HD22 ' A' ' 59' ' ' LEU . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.862 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.771 ' HD2' HG22 ' A' ' 50' ' ' ILE . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 52' ' ' THR . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 50' ' ' ILE . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.867 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD21 HD11 ' A' ' 114' ' ' LEU . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.744 ' CD2' HD13 ' A' ' 104' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.867 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.628 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 84' ' ' ARG . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 80' ' ' THR . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.424 ' H ' ' HA ' ' A' ' 76' ' ' CYS . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.86 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 75' ' ' VAL . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.725 HD11 HD11 ' A' ' 118' ' ' LEU . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.744 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.629 HD22 HG23 ' A' ' 101' ' ' ILE . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.644 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.726 HD11 HD21 ' A' ' 62' ' ' LEU . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.87 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.8 t-20 -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.791 HG21 HD13 ' A' ' 59' ' ' LEU . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.524 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.669 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.829 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 47' ' ' VAL . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.746 ' CD2' HD21 ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HD1' HD13 ' A' ' 104' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 65' ' ' ARG . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.814 HG13 ' CG1' ' A' ' 89' ' ' VAL . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.829 HD11 ' N ' ' A' ' 56' ' ' GLU . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 82' ' ' GLN . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 80' ' ' THR . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HD2' HG23 ' A' ' 52' ' ' THR . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.808 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.814 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.827 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.87 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.827 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.776 HG13 HD21 ' A' ' 118' ' ' LEU . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.748 ' CD2' HD22 ' A' ' 114' ' ' LEU . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.571 ' HA ' HG23 ' A' ' 116' ' ' VAL . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.769 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 8.7 m120 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.769 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 108' ' ' ASN . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.748 HD22 ' CD2' ' A' ' 104' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.788 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.776 HD21 HG13 ' A' ' 101' ' ' ILE . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.722 0.296 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG12 ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.608 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' HD23 ' A' ' 114' ' ' LEU . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.557 ' O ' HG22 ' A' ' 53' ' ' THR . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.793 ' HA ' HD12 ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.854 ' HG2' HD11 ' A' ' 69' ' ' ILE . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 114' ' ' LEU . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.682 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.964 HD12 HG11 ' A' ' 72' ' ' VAL . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 82' ' ' GLN . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' A' ' 80' ' ' THR . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.919 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 45' ' ' LEU . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 63' ' ' PHE . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.475 ' HB2' HG23 ' A' ' 101' ' ' ILE . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.797 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.623 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.623 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG12 HD12 ' A' ' 45' ' ' LEU . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.621 HD13 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 118' ' ' LEU . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.7 t-20 -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.871 HG21 HD13 ' A' ' 59' ' ' LEU . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 50' ' ' ILE . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 84' ' ' ARG . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.836 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.843 ' N ' HD11 ' A' ' 74' ' ' ILE . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.871 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.81 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 72' ' ' VAL . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.843 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HG3' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.748 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.785 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.799 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.799 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 HD21 ' A' ' 118' ' ' LEU . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HA ' HG23 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 114' ' ' LEU . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 2.7 p-10 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.768 HG23 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.768 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 45' ' ' LEU . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 t -59.96 -47.52 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -172.24 134.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 4' ' ' ILE . 8.0 tp -95.71 102.59 10.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.42 -11.14 31.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.599 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 65.44 36.36 6.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.82 -47.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -136.17 -177.31 4.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -88.97 -75.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -159.87 84.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -65.41 -60.65 7.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 58.4 Cg_endo -71.86 139.89 34.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 112.317 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -113.27 114.92 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.62 127.96 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -130.08 89.83 2.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -156.71 -46.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.33 124.35 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -142.17 110.11 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.06 108.02 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.8 -37.43 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.2 mt 61.28 -175.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 102.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.39 119.4 12.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.34 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.01 175.29 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.92 117.03 23.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.19 33.45 21.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 -168.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.44 68.21 66.92 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.49 167.43 25.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.49 61.45 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.818 2.345 . . . . 0.0 112.454 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 34' ' ' GLN . 5.2 m 66.23 -70.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' HG22 ' A' ' 33' ' ' THR . 31.3 mt-30 -139.52 103.65 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 ttt -110.98 -30.72 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.421 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.9 m-80 -177.22 -61.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 36' ' ' ASN . 58.5 Cg_endo -71.77 81.32 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.503 2.135 . . . . 0.0 112.243 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.854 ' O ' HG22 ' A' ' 41' ' ' VAL . 20.7 mt-10 -79.95 144.82 60.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.34 -14.61 22.79 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.589 2.192 . . . . 0.0 112.468 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.09 -12.5 60.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.437 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.9 m -90.73 44.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.69 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.9 t-20 -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.906 HD12 HG12 ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 84' ' ' ARG . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 50' ' ' ILE . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 51' ' ' PRO . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.873 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 47' ' ' VAL . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 114' ' ' LEU . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 104' ' ' LEU . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.919 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.873 HD11 ' N ' ' A' ' 56' ' ' GLU . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 52' ' ' THR . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.652 ' CD1' HD21 ' A' ' 118' ' ' LEU . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 62' ' ' LEU . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.906 HG12 HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -81.6 -28.98 33.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -54.42 162.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.371 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 110.43 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.74 -170.61 29.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 59.79 44.61 13.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -96.58 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 4.7 mmm-85 -72.31 -60.38 2.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.41 172.58 14.7 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.558 2.172 . . . . 0.0 112.263 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.53 42.43 1.03 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.467 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.3 pt 41.09 82.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.71 -80.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.94 63.02 2.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.69 147.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 m -137.39 159.26 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.92 92.7 0.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.2 179.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.7 -51.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -173.76 174.27 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.57 41.89 1.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.605 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.87 -58.11 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.908 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.8 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -110.2 129.27 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 60.17 94.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.64 ' O ' HD12 ' A' ' 6' ' ' LEU . 2.8 tt -113.24 125.19 30.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.83 -24.64 19.04 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.428 2.086 . . . . 0.0 112.363 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 61.58 114.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 7' ' ' VAL . 25.3 t 62.87 49.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.1 p -121.25 -43.21 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -161.43 162.98 30.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.15 -177.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.31 143.3 25.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.43 131.9 18.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.451 2.101 . . . . 0.0 112.327 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -88.54 160.92 17.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.97 28.36 73.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -139.7 130.61 26.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -143.5 172.28 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 16' ' ' THR . . . -68.66 173.16 5.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.72 -24.41 53.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.96 128.49 33.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.013 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.66 164.39 25.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 60.12 79.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mt -122.44 131.11 53.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.41 151.57 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -115.26 -52.26 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -108.99 -31.7 7.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.02 144.29 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -153.76 37.28 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -86.89 177.18 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -175.87 161.94 2.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 6.8 tt -164.3 55.68 0.46 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 159.47 52.42 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.612 2.208 . . . . 0.0 112.276 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.5 81.75 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.597 2.198 . . . . 0.0 112.269 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -87.0 153.9 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' NE2' ' OD1' ' A' ' 36' ' ' ASN . 0.4 OUTLIER 63.63 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.4 ttt 67.78 -69.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 15.3 m120 54.48 59.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.229 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.72 39.59 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.794 2.33 . . . . 0.0 112.571 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.861 ' HB3' HG13 ' A' ' 41' ' ' VAL . 9.2 mt-10 -81.55 117.14 67.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -89.36 -73.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.59 2.194 . . . . 0.0 111.786 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.8 -24.75 62.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 38' ' ' GLU . 7.6 p -107.06 73.88 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 38' ' ' GLU . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.8 t-20 -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.821 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 59' ' ' LEU . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.845 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' HD23 ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.89 HD13 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 89' ' ' VAL . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.845 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 82' ' ' GLN . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 80' ' ' THR . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 52' ' ' THR . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.769 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.822 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.873 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.822 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.79 HG13 HD11 ' A' ' 45' ' ' LEU . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.555 ' HB2' HG23 ' A' ' 101' ' ' ILE . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.656 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.821 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 101' ' ' ILE . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -55.19 -27.09 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 119' ' ' ALA . . . 66.46 167.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.357 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -102.54 95.91 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -136.02 100.09 0.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -59.55 -47.23 86.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.93 -50.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -153.12 107.55 2.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.95 -36.22 18.45 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.36 89.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.538 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.53 152.26 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.018 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.72 -172.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.93 -172.63 28.2 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.559 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.99 81.25 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t 68.53 -68.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 59.47 105.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.45 177.79 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.47 49.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -115.42 -54.33 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.26 6.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.535 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.8 t80 69.02 -66.98 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.877 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.7 m -128.16 101.62 6.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.97 169.84 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 pt -127.43 70.42 76.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.56 63.46 2.95 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.197 . . . . 0.0 112.309 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -144.04 37.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.14 114.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.83 174.08 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.6 125.53 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.61 96.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.45 93.66 4.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -27.18 37.67 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.508 2.139 . . . . 0.0 112.295 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -74.59 92.83 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.4 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -134.49 -46.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.1 m -58.61 143.39 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.57 -46.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.23 136.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.4 mp -70.49 -53.48 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 60.31 64.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.31 121.28 44.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 147.6 30.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -63.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 60.74 31.48 20.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.13 -175.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.75 113.31 20.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -121.76 105.47 10.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.01 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.805 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.439 ' CD2' ' HG3' ' A' ' 31' ' ' PRO . 2.0 t60 63.16 131.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 25.3 mt -138.0 63.96 39.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.209 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 29' ' ' HIS . 23.5 Cg_exo -63.99 159.38 42.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.258 . . . . 0.0 112.108 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.64 86.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.472 2.115 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -129.95 169.78 14.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 66.01 95.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 mmt -102.29 -29.09 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 62.4 75.94 0.4 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.65 85.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.287 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.05 136.19 54.24 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.812 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 73.9 Cg_endo -75.28 -27.09 9.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.89 -29.05 69.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.07 29.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.274 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 118' ' ' LEU . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.1 t-20 -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 116' ' ' VAL . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.902 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.902 ' HD2' HG22 ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.713 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.92 ' N ' HD11 ' A' ' 74' ' ' ILE . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.915 HD22 ' CE2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.944 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD22 ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.944 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.92 HD11 ' N ' ' A' ' 56' ' ' GLU . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.503 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.942 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.942 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.866 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 116' ' ' VAL . 16.4 t-20 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.818 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 110' ' ' LEU . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.818 ' H ' HG23 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 62' ' ' LEU . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 45' ' ' LEU . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.866 HD21 ' CD1' ' A' ' 101' ' ' ILE . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -65.89 -53.23 42.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 63.26 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.63 30.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . 68.14 175.18 9.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 31.8 p80 44.84 39.6 3.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.903 0.382 . . . . 0.0 111.383 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.82 179.97 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -56.77 109.39 1.67 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 -43.73 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.617 ' C ' HD12 ' A' ' 128' ' ' ILE . . . 119.55 89.4 1.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.38 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.617 HD12 ' C ' ' A' ' 127' ' ' GLY . 3.6 mp 64.82 151.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 148.61 33.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.42 -108.14 3.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.86 33.14 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.6 m -123.31 99.04 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.22 -40.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.03 152.84 19.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -104.07 90.98 0.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -120.73 93.39 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.37 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.457 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.81 -31.57 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.864 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -81.33 106.55 13.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.57 131.57 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.37 111.08 8.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.32 -168.64 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.372 2.048 . . . . 0.0 112.266 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.38 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.27 -46.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -157.21 71.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 -47.35 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 69.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -87.75 -52.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.011 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 11' ' ' ASP . 54.3 Cg_exo -51.95 168.35 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.463 2.109 . . . . 0.0 112.361 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.65 -178.31 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.75 -159.44 9.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -28.87 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.7 m 62.97 97.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.49 116.12 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -98.5 155.86 17.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mt -136.7 108.81 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.07 119.92 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -110.89 -46.56 3.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.91 112.12 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.35 -178.23 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -95.64 108.95 21.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -109.32 168.18 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -176.23 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -78.15 -59.95 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 63.34 142.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -107.46 23.31 14.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.1 mp 53.03 65.44 5.88 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.29 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 56.2 Cg_endo -70.43 152.93 66.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.532 2.155 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 31' ' ' PRO . 50.2 Cg_exo -53.46 89.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -110.44 172.29 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.53 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.64 59.22 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.04 86.11 0.17 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 86.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 112.248 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.0 mm-40 -97.0 146.05 30.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 33.8 Cg_exo -57.66 -19.54 38.21 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.616 2.21 . . . . 0.0 112.436 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -54.92 -22.39 14.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 120' ' ' ALA . 29.6 m -67.64 68.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG12 ' A' ' 116' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 59' ' ' LEU . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.484 HG23 ' HG3' ' A' ' 84' ' ' ARG . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.851 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.958 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.596 ' CD ' HD11 ' A' ' 50' ' ' ILE . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 47' ' ' VAL . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.776 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.62 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 114' ' ' LEU . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.725 ' HA ' HD11 ' A' ' 104' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.789 HG22 ' CD1' ' A' ' 91' ' ' PHE . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.958 HD11 ' N ' ' A' ' 56' ' ' GLU . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.748 ' CG2' HG21 ' A' ' 69' ' ' ILE . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.968 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.401 ' N ' ' HD3' ' A' ' 43' ' ' ARG . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.968 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.765 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 116' ' ' VAL . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.578 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HB2' ' NH1' ' A' ' 113' ' ' ARG . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 62' ' ' LEU . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 45' ' ' LEU . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.765 HD21 ' CD1' ' A' ' 101' ' ' ILE . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.48 -33.79 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -64.33 -169.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -147.35 92.47 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -104.94 -134.3 7.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.561 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.41 -38.3 6.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.41 132.18 51.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 61.01 77.81 0.35 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.31 108.19 2.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.63 2.22 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.88 86.67 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.424 ' H ' HD12 ' A' ' 128' ' ' ILE . 3.1 mp -71.02 138.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.8 176.79 7.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.2 -70.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.521 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.58 83.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.767 0.317 . . . . 0.0 111.057 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 m -140.55 170.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.09 40.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.88 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.88 47.17 1.39 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -79.28 87.89 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.58 167.63 14.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.6 -31.52 69.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.887 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.89 -61.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.29 26.32 10.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.709 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.0 mt 55.45 91.8 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.232 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.44 139.17 40.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 112.3 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -176.56 111.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.46 151.7 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -87.99 174.58 8.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -114.33 34.41 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -125.49 -47.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -170.28 163.62 6.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 168.09 22.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -134.62 162.51 32.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.61 103.71 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -83.19 -34.06 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 175.16 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.5 78.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.068 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -81.9 156.29 24.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.98 95.29 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 60.74 101.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -128.0 31.93 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.98 34.76 19.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -96.71 163.37 13.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.49 167.74 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -155.87 165.54 36.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -80.95 -61.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.18 -175.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.98 -177.31 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.436 ' CG ' ' HG2' ' A' ' 32' ' ' PRO . 6.8 m-70 -157.08 98.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.5 mp -88.82 -47.45 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.663 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 30' ' ' ILE . 36.7 Cg_exo -58.15 -48.08 17.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.204 1.936 . . . . 0.0 112.648 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HD3' ' CB ' ' A' ' 31' ' ' PRO . 33.4 Cg_exo -59.89 -23.8 73.82 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.297 1.998 . . . . 0.0 112.334 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.89 84.78 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.6 mtp 69.22 -67.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.05 68.88 1.32 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 86.99 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.637 2.225 . . . . 0.0 112.251 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 41' ' ' VAL . 13.8 mm-40 -61.85 109.75 2.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.77 -21.46 72.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.798 ' OD1' HG13 ' A' ' 41' ' ' VAL . 5.7 p30 -55.87 -24.03 34.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.333 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -95.18 40.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 118' ' ' LEU . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.617 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 3.1 t-20 -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.798 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.868 HG21 HD13 ' A' ' 59' ' ' LEU . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' A' ' 84' ' ' ARG . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 54' ' ' VAL . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.814 ' H ' HD11 ' A' ' 74' ' ' ILE . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.868 HD13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.918 ' HG2' HD11 ' A' ' 69' ' ' ILE . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CD2' HD13 ' A' ' 104' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.658 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.814 HD11 ' H ' ' A' ' 56' ' ' GLU . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 52' ' ' THR . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.485 ' CG1' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.972 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.704 HG13 HD21 ' A' ' 118' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HA ' HG23 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.66 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.66 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.792 HD11 HD21 ' A' ' 62' ' ' LEU . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 101' ' ' ILE . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.44 83.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 m -179.77 99.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.75 -134.49 14.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.62 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.7 t60 61.35 88.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -100.97 -39.23 7.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -179.53 -53.01 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 125' ' ' ARG . 32.7 Cg_exo -59.57 150.0 78.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.275 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 128' ' ' ILE . . . -102.75 25.56 27.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.39 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 127' ' ' GLY . 3.4 mp 57.98 63.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 111.107 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.77 -30.99 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.32 155.0 30.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.5 169.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.83 -30.79 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.99 -32.8 7.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.64 178.82 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.74 -89.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -175.71 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.36 159.3 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.19 138.12 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.924 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p -175.1 -41.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 61.73 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 pt -134.73 146.8 60.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 168.32 25.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.517 2.145 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' C ' HG23 ' A' ' 7' ' ' VAL . 1.3 mt -122.06 21.92 10.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 6' ' ' LEU . 3.9 t 78.87 -4.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.838 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 p 47.23 -169.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 111.305 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.88 -56.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 66.24 -71.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.41 89.07 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.19 157.97 2.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.606 2.204 . . . . 0.0 112.44 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -163.24 112.47 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.39 -164.34 16.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -81.82 94.0 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.818 HG23 ' HG2' ' A' ' 20' ' ' GLN . 35.8 m -87.62 144.88 26.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.92 84.18 2.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 60.37 80.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.07 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.818 ' HG2' HG23 ' A' ' 16' ' ' THR . 10.6 mm-40 -83.96 133.39 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.59 98.52 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 22' ' ' LEU . 17.6 mt -148.88 104.45 3.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.13 -22.05 14.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 67.77 178.58 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 62.6 27.15 16.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 56.09 177.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.68 31.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 59.86 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m80 58.9 93.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.8 tp -84.28 -29.17 0.43 Allowed Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 52.0 Cg_exo -53.3 -47.13 29.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.867 1.711 . . . . 0.0 112.608 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 33' ' ' THR . 7.7 Cg_exo -72.28 -67.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.428 2.085 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 32' ' ' PRO . 14.8 t 45.55 28.9 0.56 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.392 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.94 39.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -71.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 1.2 t-20 -167.35 55.77 0.33 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 36' ' ' ASN . 93.6 Cg_endo -84.49 44.04 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.688 2.259 . . . . 0.0 112.76 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.0 mm-40 -102.29 86.71 0.94 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' PRO . 39.3 Cg_endo -66.68 -31.54 40.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.534 2.156 . . . . 0.0 112.11 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.47 -27.98 64.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.333 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 120' ' ' ALA . 43.4 t -100.13 80.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.654 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.552 ' O ' HD11 ' A' ' 118' ' ' LEU . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.744 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 118' ' ' LEU . 3.2 t-20 -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 116' ' ' VAL . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.895 ' CG1' HD13 ' A' ' 59' ' ' LEU . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 86' ' ' TYR . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.865 ' N ' HD11 ' A' ' 74' ' ' ILE . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.895 HD13 ' CG1' ' A' ' 47' ' ' VAL . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.888 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CE1' HD23 ' A' ' 114' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.677 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.64 ' CG2' HG12 ' A' ' 89' ' ' VAL . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.865 HD11 ' N ' ' A' ' 56' ' ' GLU . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.668 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.785 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.64 HG12 ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 118' ' ' LEU . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.704 ' HD2' HD23 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.808 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.808 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 45' ' ' LEU . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . -90.5 94.83 9.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.679 ' HA ' HG11 ' A' ' 41' ' ' VAL . . . -68.28 -31.11 70.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -162.86 163.89 26.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.24 -90.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -175.11 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -63.45 149.22 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -134.84 145.98 56.93 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 -32.31 9.39 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.52 2.146 . . . . 0.0 112.257 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.02 -151.89 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.66 ' H ' HD13 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -140.61 138.65 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.105 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.65 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.01 -142.22 16.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.83 59.63 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.87 101.45 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.25 48.2 7.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 125.69 24.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.5 38.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -86.97 -48.55 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.57 39.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -62.81 -51.48 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.356 . . . . 0.0 110.949 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.615 HD12 ' OXT' ' A' ' 139' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.886 0.374 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -120.95 121.18 37.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.831 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.46 171.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.4 mp -65.02 136.48 96.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 4' ' ' ILE . 49.0 Cg_endo -68.83 89.05 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.482 2.121 . . . . 0.0 112.234 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.62 31.14 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 7' ' ' VAL . 26.7 m -84.08 116.56 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 60.22 -176.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -112.24 141.44 45.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -100.61 -176.72 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.45 133.97 23.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 112.47 3.54 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.527 2.151 . . . . 0.0 112.356 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.27 102.19 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.06 161.08 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.16 -72.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 t -141.49 -50.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.42 125.56 38.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -81.48 71.78 8.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -120.04 121.43 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 64.55 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 22' ' ' LEU . 22.0 mt-30 -144.16 -57.36 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -157.34 -73.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -170.56 123.93 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -135.63 129.55 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -154.37 177.76 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -112.07 48.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.86 90.3 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -84.93 152.18 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -86.49 -60.0 2.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.6 92.24 43.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 31.6 Cg_exo -57.84 -46.89 23.48 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.524 2.149 . . . . 0.0 112.633 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 91.4 Cg_endo -81.33 64.15 8.71 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.365 2.043 . . . . 0.0 112.56 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -104.2 88.52 3.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -164.81 -44.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.7 ttm -66.3 106.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -58.95 109.63 2.03 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.06 75.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.412 2.075 . . . . 0.0 112.235 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.86 110.82 3.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.93 -56.34 2.68 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.395 2.064 . . . . 0.0 112.275 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 8.8 t70 -53.53 -25.04 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 120' ' ' ALA . 17.2 t -92.07 -36.06 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.4 t-20 -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.707 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.848 ' CD2' HG23 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.875 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.598 ' O ' HG22 ' A' ' 53' ' ' THR . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.854 ' N ' HD11 ' A' ' 74' ' ' ILE . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.764 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 114' ' ' LEU . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.835 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.117 HD12 HG21 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.117 HG21 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.854 HD11 ' N ' ' A' ' 56' ' ' GLU . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.844 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.844 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.576 HG13 HD21 ' A' ' 118' ' ' LEU . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.835 HD11 ' HA ' ' A' ' 63' ' ' PHE . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.762 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.762 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 62' ' ' LEU . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.707 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.576 HD21 HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.53 85.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 41' ' ' VAL . . . 61.16 105.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -142.16 132.5 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.83 -149.38 7.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.514 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -115.85 150.26 37.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.52 38.26 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 62.56 140.03 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.97 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.22 -167.82 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.541 2.161 . . . . 0.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.3 -93.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.6 mm 69.73 -65.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.3 39.21 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.04 33.89 65.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.651 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.76 -179.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 111.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.49 -46.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.4 -110.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 60.72 34.59 19.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.62 142.23 4.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.87 113.99 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.796 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.75 176.46 41.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.503 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -132.36 140.68 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.88 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.774 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -138.16 131.35 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.5 106.07 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.659 HD13 ' CG2' ' A' ' 7' ' ' VAL . 1.6 pp -93.15 104.18 11.33 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HG2' HD23 ' A' ' 6' ' ' LEU . 38.7 Cg_endo -66.99 -13.9 41.65 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.446 2.097 . . . . 0.0 112.638 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HG2' ' A' ' 5' ' ' PRO . 2.6 pt? -162.07 177.54 9.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.761 0.315 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.659 ' CG2' HD13 ' A' ' 4' ' ' ILE . 39.4 t -154.15 -46.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.2 -166.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.75 172.96 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 61.18 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 62.41 149.48 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.35 -57.41 2.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.538 2.159 . . . . 0.0 112.315 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -64.49 -178.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.11 -126.28 2.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.433 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -134.06 -179.04 5.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.93 152.81 38.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.55 -27.92 9.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.94 -78.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.961 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.49 82.77 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.4 -30.31 8.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.33 170.86 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.598 HD12 ' HB2' ' A' ' 23' ' ' GLN . 2.8 pp -169.27 157.36 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.598 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 61.48 -178.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -85.58 -62.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.09 178.31 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.9 -65.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -171.26 -71.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 55.07 41.76 31.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.057 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -126.45 28.41 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 33' ' ' THR . 2.9 mp 55.81 87.93 0.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 32.0 Cg_exo -57.35 -45.49 34.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.609 2.206 . . . . 0.0 112.572 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 52.5 Cg_exo -52.75 -38.63 77.68 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.402 2.068 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 30' ' ' ILE . 32.9 m -115.77 113.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -103.52 -37.47 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.51 71.83 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.39 123.82 88.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.96 81.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.547 2.164 . . . . 0.0 112.326 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.1 mm-40 -85.97 110.35 29.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.83 -12.97 37.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.428 2.085 . . . . 0.0 112.5 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.21 -29.4 63.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' GLU . 33.5 m -84.64 -9.71 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.558 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.849 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 3.1 t-20 -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 118' ' ' LEU . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 59' ' ' LEU . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.948 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' HG22 ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.627 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.89 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.824 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' TYR . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CE2' HG12 ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 88' ' ' PHE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.89 HD11 ' N ' ' A' ' 56' ' ' GLU . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.687 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.589 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.902 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.902 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.652 HG13 HD21 ' A' ' 118' ' ' LEU . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.57 ' HB2' HG23 ' A' ' 101' ' ' ILE . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.442 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.681 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 HG13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.687 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -70.11 65.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.4 83.9 7.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.167 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.74 -174.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.49 118.49 1.89 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 177.48 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 68.46 -67.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.971 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 112.65 47.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.26 -39.91 63.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.469 2.113 . . . . 0.0 112.222 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.1 72.73 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.302 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 tt -55.73 140.27 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.29 -46.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 157.21 -28.43 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.06 77.11 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.336 . . . . 0.0 111.063 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 m -111.36 -32.23 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.6 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.51 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.45 34.24 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.38 169.32 21.76 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.91 171.68 11.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.26 -69.34 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -114.6 -71.45 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.923 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.794 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -153.92 -55.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -128.19 -45.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.4 tp -168.22 108.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.84 68.15 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.201 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' ILE . 28.9 mt -152.55 -44.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t 70.94 103.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m 60.94 158.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 62.11 116.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CD1' ' HD3' ' A' ' 12' ' ' PRO . 17.3 p90 -134.05 -176.21 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.58 97.73 30.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 10' ' ' TYR . 51.9 Cg_endo -69.26 148.31 68.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.422 2.081 . . . . 0.0 112.253 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -139.63 142.1 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.7 157.36 53.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -86.6 90.13 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -65.18 98.77 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.42 -62.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -171.63 141.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.52 -37.29 6.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 61.07 112.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.76 31.38 4.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.27 -70.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 61.86 151.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.26 88.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.18 16.36 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.74 33.06 15.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -153.05 126.73 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -128.84 75.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.792 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -99.03 -24.96 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.929 HG22 ' HD2' ' A' ' 32' ' ' PRO . 5.5 mm 64.44 121.52 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 45.4 Cg_exo -54.92 -50.0 14.76 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.764 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 30' ' ' ILE . 82.1 Cg_endo -77.29 4.55 5.79 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.351 2.034 . . . . 0.0 112.872 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.2 t 43.67 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 111.554 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 37.1 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.455 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -59.62 -48.63 80.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.76 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.4 m-80 179.96 -52.47 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.089 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 23.4 Cg_exo -64.31 73.76 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.792 2.328 . . . . 0.0 112.239 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 43.2 mm-40 -102.04 105.49 42.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.32 -26.59 82.41 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.496 2.131 . . . . 0.0 112.171 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.55 -30.04 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.6 m -97.72 31.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.258 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.73 ' O ' HD21 ' A' ' 118' ' ' LEU . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.94 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 116' ' ' VAL . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 59' ' ' LEU . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CD2' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.796 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.904 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 114' ' ' LEU . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.904 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.634 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.796 HD11 ' N ' ' A' ' 56' ' ' GLU . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG23 ' HD1' ' A' ' 88' ' ' PHE . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.541 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.916 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.94 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.916 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.041 HD11 HD23 ' A' ' 118' ' ' LEU . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.573 ' HB2' HG23 ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 114' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' H ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.639 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 62' ' ' LEU . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.041 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.724 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -70.97 -44.63 65.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . . . 69.33 -67.16 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.027 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.6 t -149.92 102.34 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.55 -82.27 1.53 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 147.3 32.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -93.31 134.06 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.63 114.09 1.51 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.69 -27.12 38.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.485 2.124 . . . . 0.0 112.289 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.65 40.91 0.3 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 128' ' ' ILE . 30.5 mt 57.79 55.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.61 -50.36 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.52 46.82 66.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.581 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.29 -170.26 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.07 -38.32 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.96 -92.69 0.55 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.97 102.04 8.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.41 -50.23 0.23 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 60.67 164.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.22 131.48 2.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.05 -58.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.87 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.877 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -166.94 111.32 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -108.48 167.26 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.3 pt -146.63 145.5 23.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.67 61.98 4.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.601 2.201 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -149.99 -66.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 7' ' ' VAL . 16.0 t 65.6 15.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.375 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 173.78 163.6 0.17 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.65 73.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 -49.65 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.16 144.9 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 168.09 24.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -96.55 117.77 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.36 45.54 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.4 -172.27 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.62 40.88 16.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.03 164.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.49 147.95 35.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 122.06 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -144.47 161.28 39.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.96 108.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.9 mp -80.16 142.65 34.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -148.52 27.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.97 52.33 9.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.97 138.66 57.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -176.01 40.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.21 171.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.55 -32.86 19.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.36 145.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HG2' ' A' ' 32' ' ' PRO . 28.8 pt -122.31 152.45 60.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 51.4 Cg_exo -53.25 -46.85 30.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.685 2.257 . . . . 0.0 112.904 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HG2' HD12 ' A' ' 30' ' ' ILE . 91.7 Cg_endo -79.04 53.27 4.63 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.281 1.988 . . . . 0.0 112.691 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 33' ' ' THR . 62.6 m -121.2 49.19 1.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.806 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -166.76 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.945 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.09 95.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -68.17 111.25 7.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' HIS . 21.6 Cg_exo -65.57 67.89 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.258 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.3 mm-40 -101.92 151.27 37.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.28 -25.11 13.76 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.601 2.201 . . . . 0.0 112.374 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.64 -31.41 69.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.7 m -86.03 66.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.614 ' O ' HD11 ' A' ' 118' ' ' LEU . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 118' ' ' LEU . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 59' ' ' LEU . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.507 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.863 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 114' ' ' LEU . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.776 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.616 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.863 HD11 ' N ' ' A' ' 56' ' ' GLU . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.572 HG23 ' HD1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 52' ' ' THR . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.917 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 118' ' ' LEU . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.507 ' HB2' HG23 ' A' ' 101' ' ' ILE . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.481 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.817 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.814 HD11 HD23 ' A' ' 62' ' ' LEU . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.987 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.675 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -62.07 -47.04 86.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 41' ' ' VAL . . . -127.41 175.91 7.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -176.27 -40.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.61 142.55 3.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -74.59 178.3 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -129.31 74.23 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -119.32 147.68 43.7 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.02 153.47 20.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.485 2.124 . . . . 0.0 112.275 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -102.75 21.93 38.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.591 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.8 mt 56.04 87.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.797 0.332 . . . . 0.0 111.263 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 91.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.99 -123.37 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.515 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.83 34.64 19.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t 68.82 -67.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.72 -143.36 8.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -156.07 112.89 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.93 -59.8 1.65 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -60.46 155.08 19.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.51 167.77 25.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -65.01 -56.29 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.919 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 59.72 93.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.74 145.38 40.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -127.92 144.02 49.89 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 130.79 15.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.488 2.126 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 mt -102.85 31.1 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.782 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.02 125.49 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.37 -169.43 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 61.05 -178.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.71 102.07 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -153.37 81.0 5.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 -171.76 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.58 2.187 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -101.67 31.1 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.37 -111.36 3.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.536 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 159.69 13.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.329 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.435 ' CG2' HD12 ' A' ' 19' ' ' LEU . 26.6 m -147.57 156.84 43.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.72 161.58 13.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.73 35.76 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' CG2' ' A' ' 16' ' ' THR . 11.3 mt -149.49 178.4 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.8 120.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.3 18.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mp 48.29 53.05 12.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.866 0.365 . . . . 0.0 111.205 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 60.41 77.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.55 148.4 52.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 60.92 156.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.36 97.25 4.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -119.76 30.72 6.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.32 -166.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.68 38.11 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.005 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.2 mp -66.76 -54.22 23.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.1 Cg_endo -64.63 173.08 5.92 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 63.71 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.446 2.097 . . . . 0.0 112.166 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.808 HG22 ' OE1' ' A' ' 34' ' ' GLN . 0.5 OUTLIER -107.63 117.58 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.026 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.808 ' OE1' HG22 ' A' ' 33' ' ' THR . 6.4 pm0 44.78 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.444 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.27 29.74 13.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 18.8 m-20 56.69 65.84 3.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.069 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.68 55.83 5.68 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 112.423 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.61 112.5 34.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 42' ' ' LEU . 25.3 Cg_exo -62.77 -26.77 75.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.45 2.1 . . . . 0.0 112.221 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.93 -31.41 69.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.4 t -93.87 16.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.487 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.539 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.8 t-20 -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.732 HD22 ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.607 HG22 ' HG3' ' A' ' 84' ' ' ARG . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.902 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.702 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.63 ' HD3' HD12 ' A' ' 62' ' ' LEU . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 89' ' ' VAL . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.902 HD11 ' N ' ' A' ' 56' ' ' GLU . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.607 ' HG3' HG22 ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HE2' ' ND2' ' A' ' 44' ' ' ASN . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.831 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 118' ' ' LEU . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 63' ' ' PHE . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.667 ' OD1' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.718 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.732 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -75.32 -31.0 60.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 36' ' ' ASN . . . 62.18 166.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 t -59.7 127.04 30.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.84 -157.58 20.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.56 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 t60 61.02 98.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.821 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -86.97 159.41 19.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 1.5 mtt-85 -72.8 -60.74 1.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.19 -176.53 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 0.0 112.286 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.16 -90.58 1.87 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.438 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 tp -152.97 133.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.086 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -175.18 117.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.09 77.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.89 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 111.161 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.52 167.87 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.75 -41.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -153.88 61.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.87 -175.68 14.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.71 144.51 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.361 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.07 103.06 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.97 -36.1 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.846 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.859 0.361 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 p -76.83 175.17 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -105.11 128.2 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 pt -59.24 146.8 77.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' VAL . 91.1 Cg_endo -83.43 48.66 2.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.778 2.319 . . . . 0.0 112.821 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 6.8 mt 65.17 -66.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.403 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 5' ' ' PRO . 15.1 t 73.11 -67.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.085 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.07 -71.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -137.64 -175.73 4.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.72 31.46 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.58 148.41 55.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.52 -168.17 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.49 2.127 . . . . 0.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -135.47 -179.46 5.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.29 -71.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.537 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 107.57 18.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -152.94 85.71 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.08 137.82 47.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.21 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 mt -148.61 -50.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -153.86 -175.07 5.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -153.43 -46.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.39 -175.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.86 41.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 61.11 100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 135.69 46.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.35 -70.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 68.89 -67.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -150.02 -174.47 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -132.4 118.88 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 33' ' ' THR . 4.9 pt -110.12 96.53 26.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.7 Cg_exo -51.64 -47.91 23.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.579 2.186 . . . . 0.0 112.695 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 57.9 Cg_endo -71.67 -7.81 21.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.188 1.925 . . . . 0.0 112.611 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER 63.5 -163.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 70.91 -166.41 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.2 ttp 65.6 40.82 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -103.4 161.61 22.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.15 73.44 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.231 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB2' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -82.33 154.48 69.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.839 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 42' ' ' LEU . 58.2 Cg_endo -71.55 -27.36 18.88 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.552 2.168 . . . . 0.0 112.344 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.8 -34.59 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 38' ' ' GLU . 35.5 m -97.92 28.86 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.9 t-20 -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 118' ' ' LEU . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 116' ' ' VAL . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 27.4 t30 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.574 ' CD2' HD23 ' A' ' 114' ' ' LEU . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.945 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' HG22 ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.795 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 74' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 114' ' ' LEU . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CD2' HD13 ' A' ' 104' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.889 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.82 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.673 ' HA ' HG12 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.704 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.899 HD11 HD11 ' A' ' 118' ' ' LEU . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 107' ' ' PHE . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.82 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 2.9 p-10 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 HD11 ' A' ' 101' ' ' ILE . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.82 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -70.07 66.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.39 125.67 25.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 m 60.52 178.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.928 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.97 -60.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.97 117.43 14.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -105.51 32.23 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.4 ' CD ' ' HD2' ' A' ' 126' ' ' PRO . 17.3 mmt85 -123.8 161.08 48.46 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HD2' ' CD ' ' A' ' 125' ' ' ARG . 33.6 Cg_endo -64.51 -43.14 14.32 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.562 2.175 . . . . 0.0 112.296 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.71 -63.04 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.547 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.1 mt 69.04 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.37 124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.18 -111.15 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.591 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -110.85 173.98 6.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -154.75 153.0 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.061 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 -57.69 5.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.89 140.56 46.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.95 162.08 33.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -97.21 -32.34 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.11 0.86 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -64.73 -67.16 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.896 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -144.58 39.83 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.56 157.35 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.9 tt -134.8 100.55 12.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' C ' HD23 ' A' ' 6' ' ' LEU . 77.8 Cg_exo -50.62 114.13 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.428 2.085 . . . . 0.0 112.411 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 5' ' ' PRO . 0.6 OUTLIER 43.9 -166.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.473 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 7' ' ' VAL . 11.1 p -162.87 126.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.061 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 m -105.44 -66.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.31 155.7 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.38 143.41 50.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -72.81 -60.65 1.86 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 59.7 Cg_endo -72.53 -43.89 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.315 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.94 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.975 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.44 141.34 2.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.528 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -101.6 -49.56 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -176.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.77 -170.51 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -122.34 92.62 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.87 124.0 24.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -142.69 179.87 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -31.56 14.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 mt 60.07 178.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -134.04 173.35 11.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -76.41 166.08 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -111.77 106.13 14.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -165.82 34.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.1 122.72 8.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 63.86 130.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -60.26 165.57 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.67 89.3 31.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.66 156.71 6.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.578 2.186 . . . . 0.0 112.295 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 63.38 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.252 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -127.73 164.77 21.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.63 -174.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.57 68.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -124.79 62.8 36.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.93 61.32 3.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.548 2.165 . . . . 0.0 112.318 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.3 mm-40 -101.92 141.67 23.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 73.9 Cg_endo -74.98 -22.01 15.3 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.513 2.142 . . . . 0.0 112.438 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.34 -26.5 52.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.1 m -96.83 29.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.258 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' PRO . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.831 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.6 t-20 -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.812 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.938 HG21 HD22 ' A' ' 59' ' ' LEU . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' CD ' HG22 ' A' ' 50' ' ' ILE . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.422 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.765 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 54' ' ' VAL . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.783 ' N ' HD11 ' A' ' 74' ' ' ILE . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.938 HD22 HG21 ' A' ' 47' ' ' VAL . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.891 HD21 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.666 ' HA ' HD11 ' A' ' 104' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.661 HD12 ' CG1' ' A' ' 72' ' ' VAL . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.783 HD11 ' N ' ' A' ' 56' ' ' GLU . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG23 ' HD2' ' A' ' 88' ' ' PHE . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.422 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.692 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.943 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.943 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 118' ' ' LEU . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' A' ' 101' ' ' ILE . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.738 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.738 ' H ' HG23 ' A' ' 109' ' ' ILE . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.891 HD11 HD21 ' A' ' 62' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 101' ' ' ILE . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -94.34 28.69 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.51 136.72 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.172 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.24 161.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.9 -139.12 6.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.569 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -118.3 -43.69 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.15 -170.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -128.94 140.56 38.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.45 -43.76 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.447 2.098 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.24 -67.61 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.541 ' O ' HG22 ' A' ' 128' ' ' ILE . 22.1 mm 59.29 37.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.5 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.9 -171.88 18.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -119.7 89.68 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.27 132.91 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -105.29 -45.72 1.31 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.544 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.3 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.49 -126.25 6.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -80.45 159.92 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.08 76.89 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -65.71 -32.89 74.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.13 143.77 33.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 60.31 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.7 tp -157.65 70.84 4.27 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.12 -57.3 2.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.279 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mt -71.19 143.54 50.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -154.85 82.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.104 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.78 -70.09 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.01 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -153.32 -178.38 6.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -110.55 96.11 26.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.61 -25.03 13.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.629 2.22 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -55.91 -45.76 78.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.57 36.0 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.434 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 95.36 6.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -98.81 110.31 22.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.59 171.52 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.49 156.2 18.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.93 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.91 38.07 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.39 -179.2 4.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.6 mt -72.83 -55.03 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 59.7 31.66 20.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -107.25 169.28 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -143.4 114.7 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.24 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.41 98.94 9.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 60.16 159.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -87.72 117.43 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.0 mt -144.42 76.95 14.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.37 170.17 19.9 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.599 2.2 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.38 42.54 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.865 2.376 . . . . 0.0 112.699 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -121.56 70.36 0.94 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.791 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.75 -39.05 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.817 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 mmt -85.28 -30.68 23.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 31.9 m-20 60.39 53.22 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 36' ' ' ASN . 74.3 Cg_endo -74.89 60.65 5.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 41' ' ' VAL . 10.8 mm-40 -100.58 122.75 48.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 -19.53 23.24 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.458 2.105 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.98 -26.48 36.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 38' ' ' GLU . 31.7 m -70.78 64.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 4.3 t-20 -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.427 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 63' ' ' PHE . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.77 ' CD2' HD22 ' A' ' 114' ' ' LEU . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.874 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.874 ' HD2' HG22 ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.928 ' N ' HD11 ' A' ' 74' ' ' ILE . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.603 HD22 ' CZ ' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.985 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 47' ' ' VAL . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.985 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.687 ' HB ' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.928 HD11 ' N ' ' A' ' 56' ' ' GLU . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 1.003 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.003 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.66 HD11 ' CD2' ' A' ' 45' ' ' LEU . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 116' ' ' VAL . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.782 ' CG1' HD22 ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.684 HD13 HD23 ' A' ' 45' ' ' LEU . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.68 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -58.97 106.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -174.5 36.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.24 -58.14 0.41 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.2 t60 60.18 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -135.44 -172.03 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -143.98 107.87 4.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.66 -47.13 2.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.397 2.065 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.12 -70.97 0.49 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.558 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.5 mm 69.33 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 -53.14 39.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.26 128.82 6.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.579 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.73 125.58 25.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.327 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 133' ' ' GLY . 22.9 m -122.18 -42.62 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 132' ' ' VAL . . . 59.74 87.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.438 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.67 146.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.32 -164.41 10.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.47 57.27 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -59.5 134.6 57.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.905 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptm . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.694 0.283 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -118.92 103.74 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.817 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -170.09 109.23 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 mt 63.29 95.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.29 97.81 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.464 2.11 . . . . 0.0 112.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.69 73.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.94 138.08 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.146 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 p -157.81 160.73 38.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -98.56 30.58 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.69 79.6 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.85 117.22 50.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.54 155.71 62.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.338 2.025 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 6.6 p90 -170.41 90.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.88 -126.46 8.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 60.25 100.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.807 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -130.22 -46.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.0 177.62 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -96.63 145.59 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.01 152.54 22.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.87 141.57 28.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -98.82 85.19 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -106.35 -53.51 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 59.92 30.24 19.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -69.88 94.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -98.73 76.36 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -96.47 20.44 10.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -117.42 -31.55 5.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 27' ' ' GLN . 24.7 pt20 46.52 -172.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -127.8 37.77 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.026 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD13 ' OE1' ' A' ' 28' ' ' GLN . 3.7 mp -134.85 71.01 70.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.97 158.63 54.87 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.147 . . . . 0.0 112.255 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.72 73.13 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.623 2.216 . . . . 0.0 112.318 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 34' ' ' GLN . 1.3 t 178.82 -52.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' H ' HG23 ' A' ' 33' ' ' THR . 29.7 mt-30 -90.75 81.5 5.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.0 ttp -68.8 92.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.5 127.83 85.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.98 81.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.427 2.085 . . . . 0.0 112.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.8 mm-40 -74.0 144.88 82.91 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.26 -6.86 17.62 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.489 2.126 . . . . 0.0 112.715 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.11 -29.37 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 38' ' ' GLU . 34.5 m -76.14 61.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 118' ' ' LEU . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 116' ' ' VAL . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 25.6 t30 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.751 ' CD2' HD13 ' A' ' 114' ' ' LEU . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 74' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.671 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 47' ' ' VAL . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.702 ' CD2' HD13 ' A' ' 104' ' ' LEU . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.943 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.667 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.831 HD11 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.622 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.918 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.92 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.918 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.77 HD11 HD11 ' A' ' 118' ' ' LEU . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 101' ' ' ILE . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -49.59 -29.44 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . . . -108.04 -63.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.126 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.36 -65.73 0.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.34 -28.07 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.631 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 64.21 116.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -93.0 -31.41 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -65.87 154.93 88.07 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 -38.02 7.58 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.95 78.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mt 63.96 119.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.06 -45.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 161.62 123.73 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.601 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.47 -18.43 61.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.383 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.596 ' O ' HG12 ' A' ' 132' ' ' VAL . 15.3 t 67.11 26.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.165 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 93.17 -40.52 2.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.634 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.02 63.33 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.68 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.511 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.7 t30 64.32 79.54 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -164.73 -100.77 0.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.529 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -127.63 -50.2 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.851 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -103.15 45.81 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -81.21 73.7 8.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 4.1 mt -76.77 -48.26 2.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.715 ' HB2' HG23 ' A' ' 7' ' ' VAL . 91.3 Cg_endo -78.83 -24.89 6.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.265 1.977 . . . . 0.0 112.442 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.43 34.53 12.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 5' ' ' PRO . 29.7 t -99.37 133.23 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -96.05 119.1 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 104.08 3.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -62.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.0 109.77 2.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 140.79 41.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.404 2.069 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -101.19 129.11 47.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.5 -51.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 40.41 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -30.09 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 132.46 53.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 60.17 165.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.7 tp -173.45 -57.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.665 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.4 tm0? -177.07 -39.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.46 127.98 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 20' ' ' GLN . 4.8 mp -129.51 92.0 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 60.22 175.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -176.49 120.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.762 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -154.13 95.63 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -117.39 30.61 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -136.6 -45.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m80 65.02 98.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 30' ' ' ILE . 3.3 mp -119.25 75.54 15.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.93 177.65 1.32 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.541 2.16 . . . . 0.0 112.139 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.76 -22.05 12.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.524 2.149 . . . . 0.0 112.466 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 36' ' ' ASN . 0.2 OUTLIER 62.88 83.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -89.97 99.9 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.049 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 mtp 47.67 29.15 1.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.741 ' HB2' HG22 ' A' ' 33' ' ' THR . 1.1 m120 -59.71 -61.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 73.7 Cg_endo -85.22 46.74 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.776 2.318 . . . . 0.0 112.512 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.7 mm-40 -94.48 123.19 59.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.17 -12.51 25.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.08 . . . . 0.0 112.517 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -55.26 -32.01 62.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.824 0.345 . . . . 0.0 111.095 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 120' ' ' ALA . 10.6 m -75.95 62.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.056 HG21 HD13 ' A' ' 59' ' ' LEU . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.791 HG22 ' CD ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.593 ' O ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.795 ' H ' HD11 ' A' ' 74' ' ' ILE . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.056 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.922 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 114' ' ' LEU . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.751 ' HA ' HD11 ' A' ' 104' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 89' ' ' VAL . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.677 ' HB ' HG23 ' A' ' 89' ' ' VAL . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.797 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 82' ' ' GLN . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.708 ' O ' HG23 ' A' ' 52' ' ' THR . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 118' ' ' LEU . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.832 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.475 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.832 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' H ' ' A' ' 106' ' ' GLY . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.82 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 101' ' ' ILE . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -59.22 -25.65 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -55.13 145.83 20.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.243 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m -67.72 -169.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.82 29.46 4.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.87 -41.83 51.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.24 -47.58 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -96.37 109.2 46.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.87 -47.98 23.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.425 2.083 . . . . 0.0 112.305 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.42 43.34 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.585 ' O ' HG22 ' A' ' 128' ' ' ILE . 19.5 mt 59.24 30.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 111.157 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 59.16 -169.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 164.91 -145.49 10.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.506 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.69 106.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.4 144.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.42 -43.97 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.4 79.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 128.92 171.14 12.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.02 109.52 16.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.597 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -99.87 156.15 19.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 65.28 -73.78 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 111.081 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.848 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.89 124.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.51 -79.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 1.7 mt -84.43 -47.22 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 85.2 Cg_endo -82.28 165.38 16.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.33 2.02 . . . . 0.0 112.481 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.21 -46.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 t 64.98 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -75.18 130.11 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -150.2 166.58 29.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 -48.79 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -57.33 108.75 1.35 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.76 128.79 30.47 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.461 2.108 . . . . 0.0 112.227 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -132.95 159.44 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.67 96.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -73.57 -59.6 2.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.47 114.51 27.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.29 145.87 29.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.29 101.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.06 -65.53 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.22 127.53 32.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -98.27 -46.92 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 mp 59.84 75.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.86 -63.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -76.46 178.97 6.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -104.69 -34.93 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -145.46 151.64 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -91.21 -31.05 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -135.89 119.31 16.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -160.1 164.57 32.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 14.9 mm -95.71 -46.07 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 61.6 Cg_exo -50.37 -45.74 32.63 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 113.031 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 13.1 Cg_exo -69.93 -30.83 20.86 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m 62.24 35.13 15.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -89.08 107.19 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 ptp -163.16 79.81 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.93 108.45 1.16 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.37 52.23 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.653 2.235 . . . . 0.0 112.502 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -88.65 149.0 43.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.705 ' HA ' HD12 ' A' ' 42' ' ' LEU . 53.2 Cg_exo -52.66 -39.05 77.13 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.69 2.26 . . . . 0.0 112.453 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.99 -34.41 71.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 121' ' ' SER . 14.3 m -106.59 27.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 39' ' ' PRO . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 118' ' ' LEU . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 HD22 ' A' ' 59' ' ' LEU . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.862 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.771 ' HD2' HG22 ' A' ' 50' ' ' ILE . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 52' ' ' THR . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 50' ' ' ILE . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.867 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD21 HD11 ' A' ' 114' ' ' LEU . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.744 ' CD2' HD13 ' A' ' 104' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.867 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.628 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 84' ' ' ARG . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 80' ' ' THR . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' H ' ' HA ' ' A' ' 76' ' ' CYS . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.86 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 75' ' ' VAL . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.725 HD11 HD11 ' A' ' 118' ' ' LEU . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.744 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.629 HD22 HG23 ' A' ' 101' ' ' ILE . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 110' ' ' LEU . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.644 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.726 HD11 HD21 ' A' ' 62' ' ' LEU . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -81.99 -74.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 173.27 -169.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.738 ' N ' HG12 ' A' ' 41' ' ' VAL . 83.3 p -135.43 171.83 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.27 68.98 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.536 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -125.58 110.88 14.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -59.17 165.62 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.7 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 125' ' ' ARG . 36.5 Cg_endo -65.39 -26.83 55.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.359 2.039 . . . . 0.0 112.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.14 86.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.55 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 tt -78.71 132.16 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.991 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.4 -175.86 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 129.8 91.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.93 -171.55 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.051 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.4 m -88.23 160.16 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.79 153.21 25.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 60.52 36.71 19.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.48 139.73 7.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -72.48 125.52 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.61 -115.0 4.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -149.26 -66.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.905 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -171.96 -64.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.47 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.1 tt -134.48 122.73 15.98 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 148.34 73.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.407 2.071 . . . . 0.0 112.287 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.26 -63.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.24 137.83 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.01 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 61.09 -173.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.25 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.92 99.88 46.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 172.31 11.21 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.421 2.081 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.3 t80 61.16 93.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.01 116.79 7.51 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.14 95.93 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -137.14 -169.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 16' ' ' THR . . . -124.03 -44.12 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.63 -66.35 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.43 160.45 14.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.23 31.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.478 ' HB3' HD22 ' A' ' 22' ' ' LEU . 2.4 mt-30 64.76 -78.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 22' ' ' LEU . 3.5 mm? -68.36 85.2 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -107.69 -29.27 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.96 102.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -96.43 -74.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -89.11 84.74 6.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -104.9 -61.63 1.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -135.11 -73.99 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.644 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.54 -171.44 2.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 29' ' ' HIS . 3.7 mp 65.42 91.69 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.3 171.64 11.29 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 112.212 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 67.54 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.575 2.184 . . . . 0.0 112.321 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.84 -35.68 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 60.66 81.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.3 mtm -110.62 -30.17 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.22 67.31 1.24 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.19 73.5 3.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.643 2.228 . . . . 0.0 112.427 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 41' ' ' VAL . 31.4 mm-40 -101.97 105.77 43.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.478 ' HB3' HD12 ' A' ' 42' ' ' LEU . 21.4 Cg_exo -65.35 -13.15 38.31 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.631 2.22 . . . . 0.0 112.622 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' HG13 ' A' ' 41' ' ' VAL . 44.3 p-10 -56.54 -27.61 58.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 40' ' ' ASP . 30.1 m -97.58 31.48 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 39' ' ' PRO . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.87 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.8 t-20 -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.791 HG21 HD13 ' A' ' 59' ' ' LEU . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.524 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.669 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.829 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 47' ' ' VAL . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.746 ' CD2' HD21 ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HD1' HD13 ' A' ' 104' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 65' ' ' ARG . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.814 HG13 ' CG1' ' A' ' 89' ' ' VAL . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.829 HD11 ' N ' ' A' ' 56' ' ' GLU . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 82' ' ' GLN . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 80' ' ' THR . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HD2' HG23 ' A' ' 52' ' ' THR . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.808 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.451 ' CE2' ' HG3' ' A' ' 46' ' ' MET . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.814 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.827 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.87 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.827 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.776 HG13 HD21 ' A' ' 118' ' ' LEU . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.748 ' CD2' HD22 ' A' ' 114' ' ' LEU . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.571 ' HA ' HG23 ' A' ' 116' ' ' VAL . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.769 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 110' ' ' LEU . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 8.7 m120 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.769 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 108' ' ' ASN . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.748 HD22 ' CD2' ' A' ' 104' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.788 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.776 HD21 HG13 ' A' ' 101' ' ' ILE . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -57.51 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 173.05 -70.84 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.93 0.395 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.03 70.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.812 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.21 -159.14 14.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -128.3 146.61 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.0 148.67 26.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -175.21 -62.29 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.9 Cg_endo -72.47 -44.74 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.488 2.125 . . . . 0.0 112.319 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.98 54.37 2.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mt 64.06 113.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.077 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 164.65 17.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.46 -93.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.418 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -171.9 124.44 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -41.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.87 -28.88 2.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.19 164.86 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.98 77.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -82.04 96.07 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.65 -33.73 2.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 63.55 -78.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.749 0.309 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.851 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -88.36 -53.97 4.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.65 -60.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tt -118.73 134.1 23.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 95.27 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.509 2.14 . . . . 0.0 112.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.6 85.19 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.75 147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.1 -175.77 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 69.01 -65.87 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.64 143.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.24 74.45 67.69 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.36 150.81 19.35 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -126.84 169.02 13.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 -152.61 31.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.08 75.73 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -143.7 98.81 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.24 158.75 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 60.29 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -31.06 46.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -91.71 -3.51 56.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.439 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 65.91 -76.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.4 mt 60.66 111.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -106.83 135.42 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -149.56 169.91 19.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 103.2 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 60.11 179.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.51 136.77 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -109.19 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.976 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.426 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -108.01 146.45 32.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 19.0 mt -92.68 -44.58 0.34 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 72.7 Cg_exo -48.01 -45.57 24.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.299 1.999 . . . . 0.0 113.178 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 11.3 Cg_exo -71.43 -66.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.222 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.08 159.84 8.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -165.59 -67.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 tmm? 54.67 31.33 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -106.72 131.91 21.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.13 54.26 5.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.56 2.173 . . . . 0.0 112.434 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB2' HG22 ' A' ' 41' ' ' VAL . 19.2 mm-40 -101.99 120.34 54.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.22 -26.2 7.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.406 2.07 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.24 -27.74 68.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.572 HG12 ' CA ' ' A' ' 121' ' ' SER . 30.3 m -96.38 27.29 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG12 ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.608 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' HD23 ' A' ' 114' ' ' LEU . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.557 ' O ' HG22 ' A' ' 53' ' ' THR . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.793 ' HA ' HD12 ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.854 ' HG2' HD11 ' A' ' 69' ' ' ILE . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 114' ' ' LEU . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.682 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.964 HD12 HG11 ' A' ' 72' ' ' VAL . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 82' ' ' GLN . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' A' ' 80' ' ' THR . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.919 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 45' ' ' LEU . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 63' ' ' PHE . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' HB2' HG23 ' A' ' 101' ' ' ILE . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.797 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.623 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.623 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG12 HD12 ' A' ' 45' ' ' LEU . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.621 HD13 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -62.08 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 174.9 -165.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.909 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.572 ' CA ' HG12 ' A' ' 41' ' ' VAL . 22.6 t -71.7 -32.14 67.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.95 85.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 171.51 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -105.81 -49.42 3.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.826 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 126' ' ' PRO . 1.2 ttt85 -172.36 63.46 0.33 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 52.8 Cg_exo -55.0 -39.94 88.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.565 2.177 . . . . 0.0 112.284 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.743 ' HA3' ' HB2' ' A' ' 131' ' ' ALA . . . 110.27 52.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.393 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' GLY . 1.8 tt 43.67 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.532 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.67 38.49 18.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.43 76.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB2' ' HA3' ' A' ' 127' ' ' GLY . . . -87.09 175.07 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.071 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.0 p -142.18 112.82 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.105 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.99 61.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.452 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.14 87.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.15 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.35 174.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.94 -139.03 7.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.18 -45.79 58.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.876 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.82 109.27 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -92.22 -69.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.71 87.88 4.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.19 150.77 18.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.509 2.139 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 6' ' ' LEU . 1.1 mp -121.69 -58.63 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.22 -31.61 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.34 168.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -161.35 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -162.62 109.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -177.59 -62.19 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 11' ' ' ASP . 17.9 Cg_endo -59.63 -25.25 78.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.463 2.109 . . . . 0.0 112.392 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -172.28 153.12 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.39 170.79 17.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.408 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -119.52 -49.64 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m 60.65 105.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.95 116.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.17 111.84 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.57 172.4 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -124.03 117.13 24.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -152.15 -46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt 68.66 -67.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.24 84.13 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -80.62 -68.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -68.68 -177.47 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.83 37.58 12.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -120.72 160.64 22.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -99.58 166.26 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.66 -175.44 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt 41.66 62.12 7.49 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.723 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.25 156.95 4.88 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.567 2.178 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.3 64.84 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.577 2.185 . . . . 0.0 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 p -142.91 -47.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.18 172.47 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.21 31.39 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.53 88.7 7.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.48 80.82 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -89.32 149.4 42.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.78 -25.22 24.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.371 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.25 -28.83 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.2 38.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.296 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 118' ' ' LEU . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 1.7 t-20 -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.871 HG21 HD13 ' A' ' 59' ' ' LEU . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 50' ' ' ILE . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 84' ' ' ARG . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.836 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.843 ' N ' HD11 ' A' ' 74' ' ' ILE . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.871 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.81 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 72' ' ' VAL . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.843 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HG3' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.748 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.785 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.799 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.799 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 HD21 ' A' ' 118' ' ' LEU . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HA ' HG23 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 114' ' ' LEU . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 2.7 p-10 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.768 HG23 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.768 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 45' ' ' LEU . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -74.17 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.38 161.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.35 -77.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.11 -133.02 3.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.97 160.05 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -71.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 96.73 49.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.18 -27.36 35.28 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.517 2.145 . . . . 0.0 112.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 97.97 66.25 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.594 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 129' ' ' ALA . 2.5 pp -157.77 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 128' ' ' ILE . . . -83.7 79.18 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.6 -158.62 15.24 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.92 147.1 24.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.59 166.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.17 -32.5 7.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.6 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -173.03 -65.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 166.76 -72.03 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.509 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -155.92 170.03 23.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.74 -124.37 1.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.753 ' HB3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER 68.11 -69.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 138' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.69 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.906 HD12 HG12 ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 84' ' ' ARG . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 50' ' ' ILE . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 51' ' ' PRO . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.873 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 47' ' ' VAL . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 114' ' ' LEU . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 104' ' ' LEU . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.919 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.873 HD11 ' N ' ' A' ' 56' ' ' GLU . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 52' ' ' THR . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.652 ' CD1' HD21 ' A' ' 118' ' ' LEU . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 62' ' ' LEU . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.906 HG12 HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 41' ' ' VAL . 7.6 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.821 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 59' ' ' LEU . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.845 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' HD23 ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.89 HD13 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 89' ' ' VAL . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.845 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 82' ' ' GLN . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 80' ' ' THR . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 52' ' ' THR . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.769 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.822 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.873 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.822 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.79 HG13 HD11 ' A' ' 45' ' ' LEU . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.555 ' HB2' HG23 ' A' ' 101' ' ' ILE . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.821 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 101' ' ' ILE . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 118' ' ' LEU . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 116' ' ' VAL . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.902 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.902 ' HD2' HG22 ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.713 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.92 ' N ' HD11 ' A' ' 74' ' ' ILE . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.915 HD22 ' CE2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.944 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD22 ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.944 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.92 HD11 ' N ' ' A' ' 56' ' ' GLU . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.503 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.942 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.942 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.866 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.818 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.818 ' H ' HG23 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 62' ' ' LEU . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 45' ' ' LEU . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.866 HD21 ' CD1' ' A' ' 101' ' ' ILE . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 41' ' ' VAL . 29.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG12 ' A' ' 116' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 59' ' ' LEU . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.484 HG23 ' HG3' ' A' ' 84' ' ' ARG . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.851 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.958 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.596 ' CD ' HD11 ' A' ' 50' ' ' ILE . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 47' ' ' VAL . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.776 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.62 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 114' ' ' LEU . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.725 ' HA ' HD11 ' A' ' 104' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.789 HG22 ' CD1' ' A' ' 91' ' ' PHE . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.958 HD11 ' N ' ' A' ' 56' ' ' GLU . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.748 ' CG2' HG21 ' A' ' 69' ' ' ILE . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.968 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.401 ' N ' ' HD3' ' A' ' 43' ' ' ARG . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.968 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.765 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 116' ' ' VAL . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.578 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HB2' ' NH1' ' A' ' 113' ' ' ARG . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 62' ' ' LEU . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 45' ' ' LEU . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.765 HD21 ' CD1' ' A' ' 101' ' ' ILE . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 118' ' ' LEU . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.617 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.798 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.868 HG21 HD13 ' A' ' 59' ' ' LEU . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' A' ' 84' ' ' ARG . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.814 ' H ' HD11 ' A' ' 74' ' ' ILE . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.868 HD13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.918 ' HG2' HD11 ' A' ' 69' ' ' ILE . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CD2' HD13 ' A' ' 104' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.658 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.814 HD11 ' H ' ' A' ' 56' ' ' GLU . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 52' ' ' THR . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.485 ' CG1' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.972 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.704 HG13 HD21 ' A' ' 118' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HA ' HG23 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.66 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.66 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.792 HD11 HD21 ' A' ' 62' ' ' LEU . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 101' ' ' ILE . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.648 HG13 ' HB2' ' A' ' 44' ' ' ASN . 43.4 t . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.808 0.337 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.552 ' O ' HD11 ' A' ' 118' ' ' LEU . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.744 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 116' ' ' VAL . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.895 ' CG1' HD13 ' A' ' 59' ' ' LEU . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 86' ' ' TYR . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.865 ' N ' HD11 ' A' ' 74' ' ' ILE . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.895 HD13 ' CG1' ' A' ' 47' ' ' VAL . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.888 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CE1' HD23 ' A' ' 114' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.677 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.64 ' CG2' HG12 ' A' ' 89' ' ' VAL . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.865 HD11 ' N ' ' A' ' 56' ' ' GLU . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.668 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.785 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.64 HG12 ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 118' ' ' LEU . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.704 ' HD2' HD23 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.808 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.808 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 45' ' ' LEU . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' HG3' ' HG3' ' A' ' 90' ' ' LYS . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.707 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.848 ' CD2' HG23 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.875 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.598 ' O ' HG22 ' A' ' 53' ' ' THR . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.854 ' N ' HD11 ' A' ' 74' ' ' ILE . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.764 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 114' ' ' LEU . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.835 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.117 HD12 HG21 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.117 HG21 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.854 HD11 ' N ' ' A' ' 56' ' ' GLU . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.659 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.844 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.844 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.576 HG13 HD21 ' A' ' 118' ' ' LEU . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.835 HD11 ' HA ' ' A' ' 63' ' ' PHE . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.762 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.762 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 62' ' ' LEU . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.707 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.576 HD21 HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.634 0.255 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.849 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 118' ' ' LEU . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 59' ' ' LEU . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.948 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' HG22 ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.627 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.89 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.824 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' TYR . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CE2' HG12 ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 88' ' ' PHE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.89 HD11 ' N ' ' A' ' 56' ' ' GLU . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.687 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.589 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.902 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.902 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.652 HG13 HD21 ' A' ' 118' ' ' LEU . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.57 ' HB2' HG23 ' A' ' 101' ' ' ILE . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.442 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.681 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 HG13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.687 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.712 0.292 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.73 ' O ' HD21 ' A' ' 118' ' ' LEU . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.94 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 116' ' ' VAL . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 59' ' ' LEU . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CD2' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.796 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.904 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 114' ' ' LEU . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.904 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.634 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.796 HD11 ' N ' ' A' ' 56' ' ' GLU . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG23 ' HD1' ' A' ' 88' ' ' PHE . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.541 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.724 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.916 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.94 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.916 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.041 HD11 HD23 ' A' ' 118' ' ' LEU . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.573 ' HB2' HG23 ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 114' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' H ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.639 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 62' ' ' LEU . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.041 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.724 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 41' ' ' VAL . 27.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.952 0.406 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.614 ' O ' HD11 ' A' ' 118' ' ' LEU . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 118' ' ' LEU . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 59' ' ' LEU . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.507 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.863 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 114' ' ' LEU . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.776 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.616 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.863 HD11 ' N ' ' A' ' 56' ' ' GLU . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.572 HG23 ' HD1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 52' ' ' THR . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.917 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 118' ' ' LEU . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.507 ' HB2' HG23 ' A' ' 101' ' ' ILE . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.481 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.817 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.814 HD11 HD23 ' A' ' 62' ' ' LEU . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.987 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.675 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.4 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.711 0.291 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.539 ' O ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.732 HD22 ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.607 HG22 ' HG3' ' A' ' 84' ' ' ARG . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.902 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.702 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.63 ' HD3' HD12 ' A' ' 62' ' ' LEU . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 89' ' ' VAL . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.902 HD11 ' N ' ' A' ' 56' ' ' GLU . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.607 ' HG3' HG22 ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.831 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 118' ' ' LEU . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 63' ' ' PHE . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.667 ' OD1' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.718 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.732 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 118' ' ' LEU . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 116' ' ' VAL . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 5.0 t-20 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.574 ' CD2' HD23 ' A' ' 114' ' ' LEU . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.945 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' HG22 ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.795 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 74' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 114' ' ' LEU . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CD2' HD13 ' A' ' 104' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.889 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.82 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.673 ' HA ' HG12 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.704 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.899 HD11 HD11 ' A' ' 118' ' ' LEU . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 107' ' ' PHE . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.82 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.7 p30 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 HD11 ' A' ' 101' ' ' ILE . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.82 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.736 0.303 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 118' ' ' LEU . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.831 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.812 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.938 HG21 HD22 ' A' ' 59' ' ' LEU . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.55 ' CD ' HG22 ' A' ' 50' ' ' ILE . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.422 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.765 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.783 ' N ' HD11 ' A' ' 74' ' ' ILE . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.938 HD22 HG21 ' A' ' 47' ' ' VAL . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.891 HD21 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.666 ' HA ' HD11 ' A' ' 104' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.661 HD12 ' CG1' ' A' ' 72' ' ' VAL . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.783 HD11 ' N ' ' A' ' 56' ' ' GLU . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG23 ' HD2' ' A' ' 88' ' ' PHE . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.422 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.692 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.943 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.943 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 97' ' ' ALA . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' A' ' 101' ' ' ILE . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.738 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.738 ' H ' HG23 ' A' ' 109' ' ' ILE . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.891 HD11 HD21 ' A' ' 62' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 101' ' ' ILE . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 41' ' ' VAL . 31.7 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.427 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 63' ' ' PHE . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.77 ' CD2' HD22 ' A' ' 114' ' ' LEU . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.874 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.874 ' HD2' HG22 ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.928 ' N ' HD11 ' A' ' 74' ' ' ILE . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.603 HD22 ' CZ ' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.985 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 47' ' ' VAL . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.985 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.687 ' HB ' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.928 HD11 ' N ' ' A' ' 56' ' ' GLU . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 1.003 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 1.003 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.66 HD11 ' CD2' ' A' ' 45' ' ' LEU . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 116' ' ' VAL . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.782 ' CG1' HD22 ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.684 HD13 HD23 ' A' ' 45' ' ' LEU . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 41' ' ' VAL . 34.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 118' ' ' LEU . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 116' ' ' VAL . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 4.6 t-20 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.751 ' CD2' HD13 ' A' ' 114' ' ' LEU . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 74' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.671 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 47' ' ' VAL . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.702 ' CD2' HD13 ' A' ' 104' ' ' LEU . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.943 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.667 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.831 HD11 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.622 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.918 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.92 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.918 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.77 HD11 HD11 ' A' ' 118' ' ' LEU . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 101' ' ' ILE . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.901 0.381 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.056 HG21 HD13 ' A' ' 59' ' ' LEU . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.791 HG22 ' CD ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.593 ' O ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.795 ' H ' HD11 ' A' ' 74' ' ' ILE . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.056 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.922 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 114' ' ' LEU . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.751 ' HA ' HD11 ' A' ' 104' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 89' ' ' VAL . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.677 ' HB ' HG23 ' A' ' 89' ' ' VAL . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.797 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 82' ' ' GLN . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.708 ' O ' HG23 ' A' ' 52' ' ' THR . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 118' ' ' LEU . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.832 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.475 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.832 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' H ' ' A' ' 106' ' ' GLY . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.82 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 101' ' ' ILE . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.674 HD23 ' HG ' ' A' ' 118' ' ' LEU . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 118' ' ' LEU . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 HD22 ' A' ' 59' ' ' LEU . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.862 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.771 ' HD2' HG22 ' A' ' 50' ' ' ILE . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 52' ' ' THR . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 50' ' ' ILE . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.738 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.867 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD21 HD11 ' A' ' 114' ' ' LEU . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.744 ' CD2' HD13 ' A' ' 104' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.867 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.628 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 84' ' ' ARG . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 80' ' ' THR . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.424 ' H ' ' HA ' ' A' ' 76' ' ' CYS . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.86 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 75' ' ' VAL . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.725 HD11 HD11 ' A' ' 118' ' ' LEU . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.744 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.629 HD22 HG23 ' A' ' 101' ' ' ILE . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.644 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.726 HD11 HD21 ' A' ' 62' ' ' LEU . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.87 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.788 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.791 HG21 HD13 ' A' ' 59' ' ' LEU . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.524 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.669 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.829 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 47' ' ' VAL . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.746 ' CD2' HD21 ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HD1' HD13 ' A' ' 104' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 65' ' ' ARG . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.814 HG13 ' CG1' ' A' ' 89' ' ' VAL . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.829 HD11 ' N ' ' A' ' 56' ' ' GLU . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 82' ' ' GLN . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 80' ' ' THR . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HD2' HG23 ' A' ' 52' ' ' THR . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.808 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.455 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.814 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.827 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.87 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.827 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.776 HG13 HD21 ' A' ' 118' ' ' LEU . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.748 ' CD2' HD22 ' A' ' 114' ' ' LEU . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.571 ' HA ' HG23 ' A' ' 116' ' ' VAL . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.769 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 3.7 m-80 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.769 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 108' ' ' ASN . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.748 HD22 ' CD2' ' A' ' 104' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.788 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.776 HD21 HG13 ' A' ' 101' ' ' ILE . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.722 0.296 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG12 ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.608 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' HD23 ' A' ' 114' ' ' LEU . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.557 ' O ' HG22 ' A' ' 53' ' ' THR . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.793 ' HA ' HD12 ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.854 ' HG2' HD11 ' A' ' 69' ' ' ILE . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 114' ' ' LEU . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.682 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.964 HD12 HG11 ' A' ' 72' ' ' VAL . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 82' ' ' GLN . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' A' ' 80' ' ' THR . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.919 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 45' ' ' LEU . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 63' ' ' PHE . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.475 ' HB2' HG23 ' A' ' 101' ' ' ILE . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.797 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.623 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.623 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG12 HD12 ' A' ' 45' ' ' LEU . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.621 HD13 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.853 0.359 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 118' ' ' LEU . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.871 HG21 HD13 ' A' ' 59' ' ' LEU . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 50' ' ' ILE . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 84' ' ' ARG . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.836 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.843 ' N ' HD11 ' A' ' 74' ' ' ILE . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.871 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.81 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 72' ' ' VAL . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.843 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HG3' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.748 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.785 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.799 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.799 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 HD21 ' A' ' 118' ' ' LEU . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HA ' HG23 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 114' ' ' LEU . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.2 p30 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.768 HG23 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.768 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 45' ' ' LEU . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 t -59.96 -47.52 85.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -172.24 134.61 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.902 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 4' ' ' ILE . 8.0 tp -95.71 102.59 10.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.42 -11.14 31.09 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.447 2.098 . . . . 0.0 112.599 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 65.44 36.36 6.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.82 -47.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -136.17 -177.31 4.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -88.97 -75.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -159.87 84.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -65.41 -60.65 7.23 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 58.4 Cg_endo -71.86 139.89 34.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.501 2.134 . . . . 0.0 112.317 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -113.27 114.92 27.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.62 127.96 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -130.08 89.83 2.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.0 t -156.71 -46.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.33 124.35 48.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.17 110.11 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.06 108.02 17.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.67 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.8 -37.43 5.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.2 mt 61.28 -175.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.82 102.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.39 119.4 12.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 60.34 -178.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -98.01 175.29 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.92 117.03 23.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.947 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 60.19 33.45 21.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 60.52 -168.71 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.814 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.44 68.21 66.92 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.49 167.43 25.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.498 2.132 . . . . 0.0 112.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.49 61.45 0.78 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.818 2.345 . . . . 0.0 112.454 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 34' ' ' GLN . 5.2 m 66.23 -70.69 0.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.535 ' HG3' HG22 ' A' ' 33' ' ' THR . 31.3 mt-30 -139.52 103.65 4.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.845 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.5 ttt -110.98 -30.72 7.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.421 ' CB ' ' CD ' ' A' ' 37' ' ' PRO . 5.9 m-80 -177.22 -61.74 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 36' ' ' ASN . 58.5 Cg_endo -71.77 81.32 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.503 2.135 . . . . 0.0 112.243 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.854 ' O ' HG22 ' A' ' 41' ' ' VAL . 20.7 mt-10 -79.95 144.82 60.15 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.34 -14.61 22.79 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.589 2.192 . . . . 0.0 112.468 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.09 -12.5 60.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.437 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG22 ' O ' ' A' ' 38' ' ' GLU . 35.9 m -90.73 44.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.883 0.373 . . . . 0.0 111.327 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 18.7 mt -93.54 -26.34 17.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.829 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.69 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.22 -7.71 32.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.87 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.04 105.85 6.26 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.906 HD12 HG12 ' A' ' 116' ' ' VAL . 4.5 mm? -109.65 120.53 42.77 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.5 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -91.19 113.51 25.79 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG11 ' CE2' ' A' ' 63' ' ' PHE . 15.2 m -102.53 136.84 32.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.254 0.55 . . . . 0.0 111.886 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 40.2 t30 -149.28 143.9 26.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.047 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.504 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 19.8 t80 -165.94 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.492 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.507 HD12 ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.49 159.24 29.98 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.888 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.587 ' O ' HG12 ' A' ' 54' ' ' VAL . 57.2 Cg_endo -86.99 -85.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.611 2.207 . . . . 0.0 112.056 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 84' ' ' ARG . 47.6 p -78.09 -5.8 52.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.524 0.202 . . . . 0.0 111.435 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.507 ' HB ' HD12 ' A' ' 50' ' ' ILE . 2.2 m -102.55 2.74 36.63 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 51' ' ' PRO . 9.0 p -69.46 111.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.01 128.67 56.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 111.652 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.873 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.3 pt-20 -60.41 -23.49 64.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.271 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.99 -56.67 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.055 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.64 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -38.64 70.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.478 0.656 . . . . 0.0 109.365 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.682 HD13 HG21 ' A' ' 47' ' ' VAL . 11.6 mt -78.45 -21.8 48.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.54 179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.919 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -68.84 -55.67 10.4 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.395 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 6.9 mt-30 -72.88 -41.57 64.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 114' ' ' LEU . 13.6 tp -61.69 -48.19 81.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CE2' HG11 ' A' ' 47' ' ' VAL . 25.2 m-85 -84.84 -46.6 11.18 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.5 pt-20 -57.13 -24.3 53.19 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.388 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 8.9 ptp180 -56.92 -48.88 77.22 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.992 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' HD2' HD11 ' A' ' 104' ' ' LEU . 70.1 m-85 -85.89 -8.85 57.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.228 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -170.1 93.72 0.1 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.19 123.24 4.16 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.466 2.11 . . . . 0.0 112.208 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.919 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.3 pt -80.57 145.6 8.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.846 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -43.14 5.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.2 t -140.01 105.91 5.18 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.429 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.702 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -109.11 138.93 33.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.837 179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.3 tttt -156.04 153.9 30.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.366 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.873 HD11 ' N ' ' A' ' 56' ' ' GLU . 70.5 mt -104.63 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 111.178 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' TYR . 35.4 t -84.36 94.99 3.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.23 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.3 p -78.3 170.57 16.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.407 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -88.26 124.78 34.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -71.79 -9.55 58.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.445 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.49 -51.11 31.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.94 5.18 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.282 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 53.88 33.92 18.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.894 0.378 . . . . 0.0 110.761 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -110.51 157.08 20.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.079 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 t -64.72 114.49 4.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.47 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.436 ' HG3' HG22 ' A' ' 52' ' ' THR . 2.1 ttp85 -168.5 -162.36 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.71 -84.17 0.11 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.059 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -171.45 175.61 4.07 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.31 -176.02 18.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.052 -1.07 . . . . 0.0 113.156 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.725 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.03 142.06 27.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.304 -0.448 . . . . 0.0 109.995 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -140.35 109.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.788 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -89.52 109.76 20.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.331 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.1 m-30 -70.33 152.64 43.92 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -49.23 63.0 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 61.5 m -129.39 144.62 51.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.883 0.373 . . . . 0.0 111.419 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.7 -26.65 17.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.984 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 m -63.19 -22.77 67.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.321 . . . . 0.0 110.577 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.1 t -77.92 -30.96 50.82 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.936 0.398 . . . . 0.0 110.47 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.69 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.37 -42.45 82.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.692 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -53.78 -37.88 63.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.485 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.07 -29.58 55.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.432 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.34 -55.29 9.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.652 ' CD1' HD21 ' A' ' 118' ' ' LEU . 1.9 mt -65.39 -26.24 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.774 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.29 -43.89 54.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.532 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -131.19 23.88 4.28 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 119.85 -1.166 . . . . 0.0 114.517 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 9.2 mt -136.02 -30.03 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.379 0.589 . . . . 0.0 112.077 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 116' ' ' VAL . 44.9 t30 -68.52 121.64 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 66.18 15.5 63.22 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.013 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.441 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -52.77 86.44 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 121.027 0.441 . . . . 0.0 110.075 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 106' ' ' GLY . 26.5 p-10 -67.35 83.48 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.627 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 112' ' ' LYS . 3.1 tt -77.86 161.79 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.438 ' N ' ' CG1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -49.32 -34.27 15.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -176.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -120.4 -7.92 9.68 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.556 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.4 mtmm -142.44 168.12 20.49 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -126.87 114.52 18.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.629 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.843 HD21 HD21 ' A' ' 62' ' ' LEU . 6.1 mp -85.41 85.62 7.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.544 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 6.5 ttmm -81.06 119.01 23.0 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.998 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.906 HG12 HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.38 123.91 58.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.844 0.354 . . . . 0.0 111.456 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.37 132.81 45.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.661 HD13 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -63.07 144.69 56.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 111.07 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.725 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -81.6 -28.98 33.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.236 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -54.42 162.97 0.96 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.371 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.81 110.43 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.854 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.74 -170.61 29.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 59.79 44.61 13.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -96.58 41.0 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 4.7 mmm-85 -72.31 -60.38 2.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.41 172.58 14.7 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.558 2.172 . . . . 0.0 112.263 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.53 42.43 1.03 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.467 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.3 pt 41.09 82.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.71 -80.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.239 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.94 63.02 2.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.437 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.69 147.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 111.089 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 m -137.39 159.26 35.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -109.92 92.7 0.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.2 179.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.858 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.7 -51.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.468 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -173.76 174.27 3.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.57 41.89 1.19 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.605 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.87 -58.11 2.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.908 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.8 0.333 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -110.2 129.27 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 60.17 94.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.64 ' O ' HD12 ' A' ' 6' ' ' LEU . 2.8 tt -113.24 125.19 30.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.83 -24.64 19.04 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.428 2.086 . . . . 0.0 112.363 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 61.58 114.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.909 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 7' ' ' VAL . 25.3 t 62.87 49.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.078 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 71.1 p -121.25 -43.21 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -161.43 162.98 30.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.15 -177.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.31 143.3 25.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.43 131.9 18.31 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.451 2.101 . . . . 0.0 112.327 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -88.54 160.92 17.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.97 28.36 73.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.492 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -139.7 130.61 26.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -143.5 172.28 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' H ' HG22 ' A' ' 16' ' ' THR . . . -68.66 173.16 5.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -76.72 -24.41 53.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 mp -54.96 128.49 33.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.013 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.66 164.39 25.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 60.12 79.39 0.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 mt -122.44 131.11 53.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -67.41 151.57 47.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -115.26 -52.26 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -108.99 -31.7 7.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.02 144.29 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.918 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 31.9 tp60 -153.76 37.28 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -86.89 177.18 7.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -175.87 161.94 2.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 6.8 tt -164.3 55.68 0.46 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.044 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 159.47 52.42 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.612 2.208 . . . . 0.0 112.276 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.5 81.75 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.597 2.198 . . . . 0.0 112.269 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -87.0 153.9 21.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.989 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 63.63 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.03 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.4 ttt 67.78 -69.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.922 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 54.48 59.91 10.94 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.229 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.72 39.59 0.63 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.794 2.33 . . . . 0.0 112.571 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.861 ' HB3' HG13 ' A' ' 41' ' ' VAL . 9.2 mt-10 -81.55 117.14 67.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.41 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -89.36 -73.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.59 2.194 . . . . 0.0 111.786 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -70.8 -24.75 62.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.861 HG13 ' HB3' ' A' ' 38' ' ' GLU . 7.6 p -107.06 73.88 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-O 120.943 0.401 . . . . 0.0 111.685 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 38' ' ' GLU . 25.4 mt -111.31 -41.76 4.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.972 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.873 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -68.4 -3.57 11.68 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -79.25 105.96 10.94 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.821 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -110.81 119.73 40.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.022 0.439 . . . . 0.0 112.12 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.6 tmm? -91.47 114.77 27.39 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.756 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -102.22 134.23 43.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.208 0.528 . . . . 0.0 111.604 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -144.63 134.89 24.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.223 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -161.15 -67.1 0.06 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.634 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.44 148.11 35.47 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.087 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.83 -91.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 122.361 2.04 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.3 OUTLIER -78.25 -12.25 59.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 50' ' ' ILE . 6.4 m -91.87 9.16 34.03 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.9 p -69.53 116.19 9.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 110.566 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 59' ' ' LEU . 10.5 m-20 -114.93 119.41 36.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.024 0.44 . . . . 0.0 111.544 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.845 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -56.82 -23.8 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 40.0 t -69.66 -56.18 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.993 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -48.72 -45.26 39.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.18 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.756 HD22 HG21 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -78.4 -24.91 46.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.757 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.637 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -58.33 -55.03 40.22 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.918 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.571 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 6.0 mt-30 -79.19 -37.22 38.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.123 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD23 HD21 ' A' ' 114' ' ' LEU . 14.1 tp -70.85 -39.81 72.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 0.0 112.536 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.71 ' CE1' HD23 ' A' ' 59' ' ' LEU . 5.5 m-85 -86.27 -47.27 9.56 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.593 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -61.86 -25.26 67.43 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.606 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.607 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 10.2 ptm180 -50.77 -36.39 36.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.111 0.481 . . . . 0.0 110.519 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -93.13 -17.82 23.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.284 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -168.86 97.08 0.12 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 21.5 Cg_exo -43.41 130.14 6.67 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.577 2.185 . . . . 0.0 112.957 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.89 HD13 HG11 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -80.54 146.32 7.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.21 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.26 -36.8 8.36 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 t -153.02 107.2 3.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.718 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 89' ' ' VAL . 2.7 m -105.73 143.59 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.699 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 88' ' ' PHE . 21.0 tttt -156.44 147.18 21.81 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.324 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.845 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.2 mt -99.69 142.63 14.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 86' ' ' TYR . 21.5 t -88.49 98.25 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.408 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.4 m -78.59 171.46 15.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.173 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.04 123.03 31.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.799 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -9.72 58.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -72.11 -51.13 22.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 110.898 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.44 HG23 ' HG3' ' A' ' 82' ' ' GLN . 9.2 t -116.88 4.64 12.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.0 mmt-85 54.29 36.02 24.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.828 0.347 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 80' ' ' THR . 16.6 mt-30 -110.57 153.67 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.7 t -64.68 112.88 3.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.47 ' HG3' HG23 ' A' ' 52' ' ' THR . 2.6 ttp180 -170.01 -159.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.26 0.11 Allowed Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.003 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.5 OUTLIER -171.52 175.46 4.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.769 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.97 -177.95 19.2 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.02 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.28 140.84 25.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.918 HG12 HG12 ' A' ' 72' ' ' VAL . 13.3 m -142.49 109.93 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.068 0.461 . . . . 0.0 111.603 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.77 117.82 28.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.667 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.822 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -77.92 158.82 29.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -51.87 -55.23 21.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.962 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 m -125.3 150.93 46.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 111.258 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.51 -29.36 53.5 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.128 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.4 t -61.11 -23.93 65.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.7 m -79.04 -29.0 43.31 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.579 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.873 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -62.49 -46.06 90.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.996 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -52.97 -43.96 66.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.673 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -74.11 -28.64 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.426 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.822 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.6 -56.04 7.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.115 0.483 . . . . 0.0 110.181 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.79 HG13 HD11 ' A' ' 45' ' ' LEU . 2.6 mt -61.99 -26.48 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.175 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -37.95 63.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.661 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -115.0 13.58 19.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.471 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.728 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 25.1 mt -134.38 -37.22 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.271 0.536 . . . . 0.0 112.062 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.555 ' HB2' HG23 ' A' ' 101' ' ' ILE . 53.4 t-20 -56.32 121.09 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.876 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.21 16.71 54.32 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.505 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t80 -52.11 87.76 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 117.102 0.451 . . . . 0.0 110.311 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' GLY . 34.2 p-10 -75.32 86.22 2.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.708 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.636 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.5 tt -78.35 161.89 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -49.92 -20.94 1.02 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.48 -42.29 4.84 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.636 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.44 3.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 11.1 ttp180 -126.46 114.43 18.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.575 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.705 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -79.17 102.67 8.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.918 0.39 . . . . 0.0 110.819 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.3 ttmm -88.08 119.87 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.817 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.821 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -126.87 123.7 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.073 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.58 135.94 42.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.758 HD11 HD11 ' A' ' 101' ' ' ILE . 1.8 mm? -64.45 141.61 58.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.707 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -55.19 -27.09 43.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.813 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 119' ' ' ALA . . . 66.46 167.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.357 . . . . 0.0 111.009 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 p -102.54 95.91 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -136.02 100.09 0.33 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -59.55 -47.23 86.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.93 -50.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -153.12 107.55 2.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.827 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.95 -36.22 18.45 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.472 2.115 . . . . 0.0 112.225 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 133.36 89.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.538 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.53 152.26 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.805 0.336 . . . . 0.0 111.018 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.72 -172.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.93 -172.63 28.2 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.559 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.99 81.25 0.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.789 0.328 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t 68.53 -68.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.158 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 59.47 105.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.478 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.45 177.79 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.47 49.83 0.57 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -115.42 -54.33 2.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.26 6.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.535 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.8 t80 69.02 -66.98 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.877 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.7 m -128.16 101.62 6.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.97 169.84 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 pt -127.43 70.42 76.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.56 63.46 2.95 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.596 2.197 . . . . 0.0 112.309 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -144.04 37.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.14 114.88 42.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.83 174.08 11.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.6 125.53 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 60.61 96.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.45 93.66 4.26 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.83 -27.18 37.67 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.508 2.139 . . . . 0.0 112.295 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -74.59 92.83 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.4 45.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -134.49 -46.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 110.942 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.1 m -58.61 143.39 46.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.952 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.57 -46.93 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.23 136.35 1.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.795 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 19' ' ' LEU . 1.4 mp -70.49 -53.48 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 60.31 64.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.31 121.28 44.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 147.6 30.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.7 -63.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 60.74 31.48 20.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.13 -175.1 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.75 113.31 20.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -121.76 105.47 10.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.01 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.805 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.439 ' CD2' ' HG3' ' A' ' 31' ' ' PRO . 2.0 t60 63.16 131.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.425 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 25.3 mt -138.0 63.96 39.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.209 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HG3' ' CD2' ' A' ' 29' ' ' HIS . 23.5 Cg_exo -63.99 159.38 42.69 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.688 2.258 . . . . 0.0 112.108 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -56.64 86.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.472 2.115 . . . . 0.0 112.14 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -129.95 169.78 14.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 66.01 95.86 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.2 mmt -102.29 -29.09 11.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 62.4 75.94 0.4 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.65 85.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.591 2.194 . . . . 0.0 112.287 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.05 136.19 54.24 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.812 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 73.9 Cg_endo -75.28 -27.09 9.87 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.525 2.15 . . . . 0.0 112.368 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.89 -29.05 69.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.07 29.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.274 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 118' ' ' LEU . 14.0 mt -88.17 -32.81 18.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.855 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 31.2 ptt180 -65.28 -12.66 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.641 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.03 105.73 6.18 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 116' ' ' VAL . 4.6 mm? -111.01 121.38 45.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.963 0.411 . . . . 0.0 111.746 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.467 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 22.7 ttm -90.9 109.77 21.0 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG11 ' CE2' ' A' ' 63' ' ' PHE . 26.9 m -103.82 133.26 48.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -131.1 134.78 46.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.801 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 1.8 t80 -165.2 -59.0 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.2 0.524 . . . . 0.0 110.42 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.902 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.56 148.67 36.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.732 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.902 ' HD2' HG22 ' A' ' 50' ' ' ILE . 56.5 Cg_endo -88.65 -88.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.489 2.126 . . . . 0.0 111.659 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.51 -18.27 55.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.746 0.308 . . . . 0.0 111.252 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.713 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -98.25 15.15 25.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.776 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.5 p -68.65 108.15 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.972 0.415 . . . . 0.0 110.912 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -115.12 132.76 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.32 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.92 ' N ' HD11 ' A' ' 74' ' ' ILE . 13.2 pt-20 -61.41 -23.7 66.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.249 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 t -72.82 -56.65 9.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.509 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.01 -38.22 64.87 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.915 HD22 ' CE2' ' A' ' 63' ' ' PHE . 86.9 mt -78.22 -27.79 47.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.084 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.944 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -59.92 -55.81 29.47 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.532 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.5 mt-30 -69.83 -44.67 69.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.933 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 114' ' ' LEU . 11.2 tp -61.48 -46.7 88.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.004 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.915 ' CE2' HD22 ' A' ' 59' ' ' LEU . 23.2 m-85 -84.48 -49.39 8.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 7.2 pt-20 -54.11 -25.05 20.01 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.57 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.64 -49.12 73.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.811 0.338 . . . . 0.0 110.802 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -81.33 -10.5 59.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -174.86 99.73 0.14 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.63 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.06 119.42 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.443 2.095 . . . . 0.0 112.237 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.944 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.1 pt -80.62 145.81 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.122 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -103.94 -47.24 4.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.58 106.03 7.93 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.228 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -113.0 141.27 29.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.875 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 88' ' ' PHE . 4.9 tttm -155.87 164.8 38.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.113 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.92 HD11 ' N ' ' A' ' 56' ' ' GLU . 47.2 mt -113.0 145.51 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 0.0 110.948 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 66.7 t -94.03 100.75 11.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.427 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 60.4 m -76.55 178.1 6.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.87 124.66 32.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.775 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -72.23 -9.74 58.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.513 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.05 -51.16 9.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.787 0.327 . . . . 0.0 111.323 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.3 p -116.95 5.19 12.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.644 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 54.01 30.61 12.1 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.783 0.325 . . . . 0.0 110.982 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -97.97 149.22 22.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.62 103.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.492 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HA ' ' A' ' 52' ' ' THR . 14.3 mtp180 -167.74 -166.13 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.106 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 79.12 -82.85 1.33 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.886 -0.673 . . . . 0.0 113.007 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -171.63 175.48 4.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.578 0.228 . . . . 0.0 110.612 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.707 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.93 -171.17 16.71 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.203 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.534 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.2 m-85 -146.93 147.06 30.38 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.971 0.508 . . . . 0.0 109.787 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.503 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -144.49 109.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.919 0.39 . . . . 0.0 111.04 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -90.97 109.96 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.009 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.942 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -72.25 151.96 42.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.177 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -51.72 -24.08 5.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 m -154.92 141.55 18.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.38 -26.73 14.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.981 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -65.11 -23.92 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.1 t -78.32 -28.99 47.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.896 0.379 . . . . 0.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -55.84 -43.95 77.51 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.0 mm-40 -56.0 -36.22 67.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.448 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -74.14 -32.88 63.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.942 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.4 -55.96 7.8 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.291 0.567 . . . . 0.0 110.169 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.866 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.3 mt -60.09 -26.0 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.964 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.04 -38.74 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.508 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.95 18.91 6.17 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.075 -1.06 . . . . 0.0 114.003 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 10.7 mt -136.09 -36.08 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.193 0.497 . . . . 0.0 111.741 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.55 121.4 9.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.895 0.379 . . . . 0.0 110.083 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.27 17.41 56.1 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.923 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.8 t80 -53.29 91.03 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 117.274 0.537 . . . . 0.0 109.863 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.0 p-10 -67.51 93.82 0.37 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.082 -178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.818 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.2 tt -84.09 162.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.703 178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.8 OUTLIER -49.84 -23.92 2.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -115.55 -35.48 4.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.818 ' H ' HG23 ' A' ' 109' ' ' ILE . 13.5 mmtt -142.03 -169.22 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.036 0.446 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -127.12 116.91 21.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.244 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.109 HD21 HD21 ' A' ' 62' ' ' LEU . 6.8 mp -70.9 84.13 0.67 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -80.78 119.61 23.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.788 0.328 . . . . 0.0 110.952 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 45' ' ' LEU . 1.8 t -125.88 123.61 64.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.696 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -131.62 135.06 46.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.743 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.866 HD21 ' CD1' ' A' ' 101' ' ' ILE . 1.8 mm? -65.27 128.01 34.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.932 0.396 . . . . 0.0 110.966 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -65.89 -53.23 42.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 63.26 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.63 30.98 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.894 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . 68.14 175.18 9.1 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 122' ' ' GLY . 31.8 p80 44.84 39.6 3.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.903 0.382 . . . . 0.0 111.383 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -71.82 179.97 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 47.1 ttt85 -56.77 109.39 1.67 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.12 -43.73 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.617 ' C ' HD12 ' A' ' 128' ' ' ILE . . . 119.55 89.4 1.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.38 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.617 HD12 ' C ' ' A' ' 127' ' ' GLY . 3.6 mp 64.82 151.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 148.61 33.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.073 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -105.42 -108.14 3.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.86 33.14 21.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.869 0.366 . . . . 0.0 111.043 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 132' ' ' VAL . 5.6 m -123.31 99.04 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -176.22 -40.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.03 152.84 19.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -104.07 90.98 0.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -120.73 93.39 4.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.926 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.37 -69.34 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.457 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.81 -31.57 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.864 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.857 0.361 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -81.33 106.55 13.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.57 131.57 53.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.855 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -70.37 111.08 8.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.104 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.32 -168.64 0.22 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.372 2.048 . . . . 0.0 112.266 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.38 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.27 -46.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.187 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 t -157.21 71.85 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 -47.35 2.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.68 69.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -87.75 -52.62 0.39 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.011 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 11' ' ' ASP . 54.3 Cg_exo -51.95 168.35 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.463 2.109 . . . . 0.0 112.361 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -123.65 -178.31 3.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.75 -159.44 9.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.537 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -28.87 18.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.764 0.316 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.7 m 62.97 97.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.49 116.12 2.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -98.5 155.86 17.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.919 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.4 mt -136.7 108.81 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -81.07 119.92 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -110.89 -46.56 3.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.91 112.12 21.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.35 -178.23 3.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -95.64 108.95 21.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -109.32 168.18 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -176.23 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -78.15 -59.95 2.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 63.34 142.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -107.46 23.31 14.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.1 mp 53.03 65.44 5.88 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.29 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 56.2 Cg_endo -70.43 152.93 66.16 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.532 2.155 . . . . 0.0 112.374 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 31' ' ' PRO . 50.2 Cg_exo -53.46 89.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.294 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.9 p -110.44 172.29 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.53 96.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.64 59.22 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 58.04 86.11 0.17 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.005 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 86.38 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 112.248 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.619 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.0 mm-40 -97.0 146.05 30.63 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.021 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 38' ' ' GLU . 33.8 Cg_exo -57.66 -19.54 38.21 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.616 2.21 . . . . 0.0 112.436 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -54.92 -22.39 14.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.361 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.038 HG23 ' HB2' ' A' ' 120' ' ' ALA . 29.6 m -67.64 68.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.913 0.387 . . . . 0.0 111.292 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.5 mt -77.03 -31.76 56.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.726 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptt-85 -71.71 -4.25 26.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.86 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.71 107.99 7.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.842 HD12 HG12 ' A' ' 116' ' ' VAL . 4.1 mm? -110.8 119.87 40.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.959 0.409 . . . . 0.0 112.067 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 2.4 ttt -91.19 112.0 23.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 59' ' ' LEU . 3.1 m -103.17 132.68 48.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 40.7 t-20 -135.72 134.55 39.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.451 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 112' ' ' LYS . 5.2 t80 -163.1 -62.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.282 0.563 . . . . 0.0 110.743 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.32 158.6 31.6 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.032 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.59 -100.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.309 2.006 . . . . 0.0 111.58 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.484 HG23 ' HG3' ' A' ' 84' ' ' ARG . 1.2 m -78.43 -5.98 53.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.724 0.297 . . . . 0.0 111.172 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.851 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -92.31 14.6 15.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.2 m -68.68 108.97 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.397 . . . . 0.0 110.838 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 4.4 m-20 -114.77 123.59 49.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.07 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.958 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.9 pt-20 -59.0 -23.66 62.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.898 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.1 t -69.6 -56.49 11.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.773 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.596 ' CD ' HD11 ' A' ' 50' ' ' ILE . 9.0 pt20 -53.08 -38.99 62.99 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.111 0.481 . . . . 0.0 109.754 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 47' ' ' VAL . 4.9 mt -78.49 -26.87 46.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.126 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.776 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -61.7 -55.42 30.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.475 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.62 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -69.98 -41.45 74.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.842 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD23 HD21 ' A' ' 114' ' ' LEU . 5.7 tp -67.87 -42.91 80.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.193 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.725 ' HA ' HD11 ' A' ' 104' ' ' LEU . 7.5 m-85 -84.75 -46.6 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.719 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -59.12 -28.73 66.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.825 -0.75 . . . . 0.0 111.004 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.62 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 11.5 tpp180 -57.03 -50.47 72.64 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.851 0.358 . . . . 0.0 110.67 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -77.83 -9.33 58.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.085 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.61 102.81 0.16 Allowed Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.477 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.8 115.51 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.475 2.116 . . . . 0.0 112.407 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.789 HG22 ' CD1' ' A' ' 91' ' ' PHE . 2.3 pt -80.44 146.81 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.008 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.44 -59.63 1.67 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.5 m -109.33 104.9 14.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.27 177.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.472 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.62 128.75 62.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.377 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.0 tttt -156.1 166.03 34.68 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.666 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.958 HD11 ' N ' ' A' ' 56' ' ' GLU . 45.6 mt -121.25 143.9 32.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.885 0.374 . . . . 0.0 111.084 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 48.9 t -92.12 99.86 10.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.231 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 m -68.01 172.94 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.306 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -87.36 133.37 33.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.568 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.7 ttp-105 -71.33 -9.33 57.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.686 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.25 -51.33 12.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 111.281 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.3 p -117.15 -3.47 11.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.393 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 61.38 33.88 18.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.93 0.395 . . . . 0.0 110.387 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -110.51 171.36 7.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.288 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -64.69 109.82 2.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.449 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.0 -162.73 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 -179.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.4 -85.1 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.083 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -171.42 175.69 4.06 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.718 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.75 162.03 12.68 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.844 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.4 m-85 -122.15 128.58 51.42 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.748 ' CG2' HG21 ' A' ' 69' ' ' ILE . 3.3 p -134.68 120.87 33.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.079 0.466 . . . . 0.0 111.665 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -101.41 115.36 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.437 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.968 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.6 m-30 -71.85 154.77 41.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -51.58 -53.77 34.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.7 140.54 52.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.32 . . . . 0.0 111.017 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.401 ' N ' ' HD3' ' A' ' 43' ' ' ARG . . . -51.05 -27.32 13.9 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.947 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -21.07 66.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.686 0.279 . . . . 0.0 110.566 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 3.5 t -78.55 -28.88 46.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.888 0.375 . . . . 0.0 110.483 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.07 -37.57 69.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.841 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -58.68 -42.47 88.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.644 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -71.59 -30.0 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.968 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.42 -55.42 9.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.249 0.547 . . . . 0.0 110.214 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.765 ' CD1' HD21 ' A' ' 118' ' ' LEU . 3.7 mt -60.18 -26.41 36.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.88 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.37 -48.97 24.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -119.53 21.42 9.18 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.111 -1.042 . . . . 0.0 114.306 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.2 mt -136.16 -38.23 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.418 0.609 . . . . 0.0 111.602 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.51 ' HA ' HG23 ' A' ' 116' ' ' VAL . 35.6 t30 -63.53 121.24 13.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.39 14.19 74.32 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.745 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CB ' ' HB2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -47.83 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.278 0.539 . . . . 0.0 110.015 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.1 p30 -72.7 85.98 1.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.527 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 112' ' ' LYS . 16.4 tt -87.4 161.92 2.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.85 -37.49 43.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -79.79 -57.31 3.72 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.578 ' O ' HG22 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -143.63 -167.78 2.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.381 -179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.406 ' HB2' ' NH1' ' A' ' 113' ' ' ARG . 4.9 ttp-105 -122.62 114.78 21.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.477 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.759 HD21 HD23 ' A' ' 62' ' ' LEU . 5.2 mp -68.91 91.08 0.45 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.584 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.08 119.6 23.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.619 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.842 HG12 HD12 ' A' ' 45' ' ' LEU . 2.7 t -121.74 123.44 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.772 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.6 141.33 51.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.765 HD21 ' CD1' ' A' ' 101' ' ' ILE . 2.9 mm? -72.65 116.36 13.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.36 . . . . 0.0 110.82 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.48 -33.79 66.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.244 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 1.038 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -64.33 -169.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.179 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -147.35 92.47 2.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -104.94 -134.3 7.99 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.561 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.41 -38.3 6.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.41 132.18 51.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 61.01 77.81 0.35 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.31 108.19 2.13 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.63 2.22 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.88 86.67 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.561 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.424 ' H ' HD12 ' A' ' 128' ' ' ILE . 3.1 mp -71.02 138.87 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.8 176.79 7.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -138.2 -70.52 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.521 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.58 83.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.767 0.317 . . . . 0.0 111.057 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.7 m -140.55 170.51 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 176.09 40.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.88 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.88 47.17 1.39 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.496 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -79.28 87.89 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.58 167.63 14.04 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.6 -31.52 69.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.887 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.854 0.359 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.89 -61.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.29 26.32 10.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.074 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.709 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.0 mt 55.45 91.8 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.232 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.44 139.17 40.65 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 112.3 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 4' ' ' ILE . 0.7 OUTLIER -176.56 111.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.46 151.7 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -87.99 174.58 8.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -114.33 34.41 4.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.789 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.0 m-85 -125.49 -47.69 1.71 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -170.28 163.62 6.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.64 168.09 22.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.545 2.163 . . . . 0.0 112.265 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -134.62 162.51 32.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.61 103.71 0.21 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -83.19 -34.06 26.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.888 0.375 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.83 175.16 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.5 78.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.068 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.9 156.29 24.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.98 95.29 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 60.74 101.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -128.0 31.93 5.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.98 34.76 19.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -96.71 163.37 13.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -117.49 167.74 11.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.94 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -155.87 165.54 36.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -80.95 -61.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.18 -175.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.98 -177.31 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.441 ' CD2' ' HG2' ' A' ' 32' ' ' PRO . 2.6 m80 -157.08 98.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.5 mp -88.82 -47.45 0.43 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.663 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 30' ' ' ILE . 36.7 Cg_exo -58.15 -48.08 17.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.204 1.936 . . . . 0.0 112.648 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.441 ' HG2' ' CD2' ' A' ' 29' ' ' HIS . 33.4 Cg_exo -59.89 -23.8 73.82 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.297 1.998 . . . . 0.0 112.334 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.89 84.78 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -172.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.6 mtp 69.22 -67.45 0.22 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 60.05 68.88 1.32 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.75 86.99 0.69 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.637 2.225 . . . . 0.0 112.251 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.837 ' O ' HG22 ' A' ' 41' ' ' VAL . 13.8 mm-40 -61.85 109.75 2.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -61.77 -21.46 72.22 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.798 ' OD1' HG13 ' A' ' 41' ' ' VAL . 5.7 p30 -55.87 -24.03 34.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.333 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.3 m -95.18 40.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 118' ' ' LEU . 9.3 mt -93.82 -33.81 13.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.783 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.617 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 4.1 ptt180 -59.95 -15.52 22.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.654 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -74.74 105.91 6.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.709 0.29 . . . . 0.0 110.267 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.798 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -105.25 117.37 33.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.588 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 31.5 ttp -90.73 112.54 24.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.868 HG21 HD13 ' A' ' 59' ' ' LEU . 4.7 m -102.92 133.57 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 112.229 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -140.04 134.76 31.85 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.306 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -162.35 -61.26 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.674 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.29 143.96 27.73 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.055 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.4 -90.94 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.29 1.993 . . . . 0.0 112.43 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.404 ' N ' ' HG2' ' A' ' 84' ' ' ARG . 2.2 m -78.34 -16.29 57.84 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.662 0.268 . . . . 0.0 111.453 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.472 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.92 14.3 12.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.653 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.3 p -68.71 112.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.875 0.369 . . . . 0.0 110.565 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -115.03 118.9 34.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.866 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.814 ' H ' HD11 ' A' ' 74' ' ' ILE . 4.8 pt-20 -55.01 -24.37 24.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.862 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.6 t -69.83 -56.25 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.084 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.79 -45.95 30.05 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.129 0.49 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.868 HD13 HG21 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.36 -27.28 46.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.227 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.918 ' HG2' HD11 ' A' ' 69' ' ' ILE . 1.7 tmm_? -55.25 -55.25 33.53 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.639 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 14.2 mt-30 -74.97 -43.28 54.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.136 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 114' ' ' LEU . 14.5 tp -62.89 -44.29 96.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.984 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.829 ' CD2' HD13 ' A' ' 104' ' ' LEU . 28.7 m-85 -84.33 -50.07 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.564 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.6 pt-20 -53.99 -24.72 17.78 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.611 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -56.73 -52.08 66.36 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-O 120.926 0.393 . . . . 0.0 110.733 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -82.92 -7.58 59.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.427 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.37 96.08 0.1 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.861 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -44.27 122.74 3.91 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.541 2.16 . . . . 0.0 112.31 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.69 145.75 8.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.768 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.94 -47.57 4.97 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -137.29 105.78 5.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.349 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.658 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.41 140.53 25.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.026 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -156.07 161.13 40.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.037 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.814 HD11 ' H ' ' A' ' 56' ' ' GLU . 23.6 mt -108.94 146.83 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 111.019 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 86' ' ' TYR . 19.7 t -94.43 99.28 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.726 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 17.7 p -86.06 176.0 8.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.093 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -84.66 117.88 24.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -71.6 -9.93 59.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -50.99 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.11 7.46 14.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.489 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 53.73 32.57 15.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.767 0.317 . . . . 0.0 111.209 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -102.08 140.87 35.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.5 m -64.55 110.16 2.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.506 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 52' ' ' THR . 13.2 mtm-85 -170.19 -166.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.79 -83.93 1.24 Allowed Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.71 -0.677 . . . . 0.0 113.143 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.472 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.75 175.53 3.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 -179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.732 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.84 -177.32 19.28 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.887 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -146.93 128.75 15.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.485 ' CG1' HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -123.01 109.58 24.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.891 0.376 . . . . 0.0 110.578 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -86.8 109.93 19.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.65 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.972 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.3 m-30 -74.09 154.63 39.1 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.117 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -51.68 -55.11 21.4 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.8 149.27 45.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.928 0.394 . . . . 0.0 111.326 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.02 -28.71 49.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.013 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -25.22 67.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.672 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 3.8 m -74.86 -28.99 60.89 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.582 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.51 -45.11 81.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.934 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 11.2 mt-30 -55.79 -35.71 66.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -75.45 -33.74 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.411 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.49 -56.28 6.96 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.704 HG13 HD21 ' A' ' 118' ' ' LEU . 34.2 mm -60.74 -26.04 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.801 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.22 -40.75 62.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.148 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -120.72 18.44 9.22 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.716 -179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.829 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.3 mt -135.65 -36.17 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.269 0.534 . . . . 0.0 111.968 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HA ' HG23 ' A' ' 116' ' ' VAL . 14.0 t-20 -60.02 121.24 11.35 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.99 21.29 58.85 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.32 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.2 t80 -56.95 72.59 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.611 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.0 t-20 -67.42 83.64 0.16 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.543 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.66 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.1 tt -78.26 161.9 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.633 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -50.02 -20.38 0.94 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -106.08 -42.98 4.95 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.66 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.87 -174.24 4.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 10.4 ttp180 -126.66 114.67 18.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.981 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.792 HD11 HD21 ' A' ' 62' ' ' LEU . 33.5 mt -78.78 101.83 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.86 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -88.08 119.9 28.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 0.0 110.583 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.798 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.5 t -128.38 123.93 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.453 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.7 132.89 44.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.223 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.704 HD21 HG13 ' A' ' 101' ' ' ILE . 1.8 mm? -66.33 142.1 57.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.899 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.44 83.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.83 -81.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 m -179.77 99.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.954 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.75 -134.49 14.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.62 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.7 t60 61.35 88.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -100.97 -39.23 7.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' CB ' ' HD3' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -179.53 -53.01 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 125' ' ' ARG . 32.7 Cg_exo -59.57 150.0 78.75 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.447 2.098 . . . . 0.0 112.275 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 128' ' ' ILE . . . -102.75 25.56 27.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.39 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 127' ' ' GLY . 3.4 mp 57.98 63.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 111.107 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.77 -30.99 10.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.32 155.0 30.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.5 169.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.83 -30.79 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.99 -32.8 7.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -141.64 178.82 7.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.883 0.373 . . . . 0.0 110.831 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.74 -89.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.527 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -175.71 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.809 0.338 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.36 159.3 28.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.19 138.12 43.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.86 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.924 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.765 0.317 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p -175.1 -41.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 61.73 117.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 pt -134.73 146.8 60.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 168.32 25.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.517 2.145 . . . . 0.0 112.321 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' C ' HG23 ' A' ' 7' ' ' VAL . 1.3 mt -122.06 21.92 10.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 6' ' ' LEU . 3.9 t 78.87 -4.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.838 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.3 p 47.23 -169.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.864 0.364 . . . . 0.0 111.305 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -150.88 -56.4 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.729 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 66.24 -71.81 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.41 89.07 0.11 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.83 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.19 157.97 2.69 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.606 2.204 . . . . 0.0 112.44 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -163.24 112.47 1.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.39 -164.34 16.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.596 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -81.82 94.0 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.818 HG23 ' HG2' ' A' ' 20' ' ' GLN . 35.8 m -87.62 144.88 26.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.92 84.18 2.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.108 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 60.37 80.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mt 60.07 109.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.818 ' HG2' HG23 ' A' ' 16' ' ' THR . 10.6 mm-40 -83.96 133.39 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.59 98.52 11.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 22' ' ' LEU . 17.6 mt -148.88 104.45 3.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.931 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.13 -22.05 14.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 67.77 178.58 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 62.6 27.15 16.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 56.09 177.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.68 31.73 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 59.86 104.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m80 58.9 93.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 6.8 tp -84.28 -29.17 0.43 Allowed Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 52.0 Cg_exo -53.3 -47.13 29.08 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 121.867 1.711 . . . . 0.0 112.608 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.487 ' O ' HG22 ' A' ' 33' ' ' THR . 7.7 Cg_exo -72.28 -67.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.428 2.085 . . . . 0.0 112.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 32' ' ' PRO . 14.8 t 45.55 28.9 0.56 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.392 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.94 39.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -71.61 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.809 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 1.2 t-20 -167.35 55.77 0.33 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 36' ' ' ASN . 93.6 Cg_endo -84.49 44.04 1.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.688 2.259 . . . . 0.0 112.76 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' HG3' ' HB1' ' A' ' 120' ' ' ALA . 15.0 mm-40 -102.29 86.71 0.94 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 37' ' ' PRO . 39.3 Cg_endo -66.68 -31.54 40.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.534 2.156 . . . . 0.0 112.11 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -70.47 -27.98 64.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.333 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG11 ' HA ' ' A' ' 120' ' ' ALA . 43.4 t -100.13 80.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.654 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.552 ' O ' HD11 ' A' ' 118' ' ' LEU . 5.5 mt -111.95 -44.03 3.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.594 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.744 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -77.03 -1.51 29.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.969 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.793 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -75.0 105.95 6.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 116' ' ' VAL . 15.3 mt -112.27 117.71 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 112.081 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.2 ttp -91.45 109.43 20.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.895 ' CG1' HD13 ' A' ' 59' ' ' LEU . 1.5 p -103.84 133.48 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.03 0.443 . . . . 0.0 111.368 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.4 t30 -142.31 147.33 36.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.239 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 112' ' ' LYS . 66.3 t80 -165.5 -59.13 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.346 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 53' ' ' THR . 0.3 OUTLIER -104.68 163.11 17.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.152 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.08 -98.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.476 2.117 . . . . 0.0 111.988 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.439 HG23 ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.56 -5.81 53.78 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 50' ' ' ILE . 8.3 m -94.57 14.19 21.72 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG11 ' HA ' ' A' ' 86' ' ' TYR . 4.5 m -69.23 121.69 19.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.699 0.285 . . . . 0.0 110.56 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.82 116.39 28.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.966 0.413 . . . . 0.0 111.708 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.865 ' N ' HD11 ' A' ' 74' ' ' ILE . 12.3 pt-20 -57.39 -23.75 51.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.534 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 59.9 t -70.7 -56.71 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.592 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 -49.9 -43.67 49.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.294 0.569 . . . . 0.0 109.852 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.895 HD13 ' CG1' ' A' ' 47' ' ' VAL . 5.1 mt -78.62 -27.24 45.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.488 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -58.99 -55.31 36.84 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.871 0.367 . . . . 0.0 110.721 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.5 mt-30 -72.19 -42.3 66.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.888 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.6 tp -67.56 -41.01 84.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.992 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.897 ' CE1' HD23 ' A' ' 114' ' ' LEU . 5.2 m-85 -84.1 -50.36 8.02 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.229 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 8.5 pt-20 -55.02 -28.73 54.35 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.784 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -56.41 -46.43 80.18 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.909 0.385 . . . . 0.0 110.453 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -84.72 -14.48 48.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.141 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -169.76 96.36 0.11 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.534 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -44.04 121.03 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.446 2.098 . . . . 0.0 112.129 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.677 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.09 145.71 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.505 -179.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.88 -40.18 7.03 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.12 106.21 4.17 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.641 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.64 ' CG2' HG12 ' A' ' 89' ' ' VAL . 1.6 p -106.33 139.43 27.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.167 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 88' ' ' PHE . 7.9 ttmt -155.53 146.13 22.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.405 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.865 HD11 ' N ' ' A' ' 56' ' ' GLU . 92.2 mt -98.87 137.28 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.893 0.378 . . . . 0.0 111.376 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.502 HG21 ' CE1' ' A' ' 88' ' ' PHE . 39.3 t -83.09 98.65 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.058 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 10.1 p -73.15 170.44 14.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.396 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.35 131.06 38.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.734 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -72.02 -9.5 58.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.498 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -51.2 19.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.792 0.329 . . . . 0.0 110.97 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 p -117.07 2.5 12.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.305 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 56.04 33.95 22.83 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.941 0.4 . . . . 0.0 110.765 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 mm-40 -110.47 160.67 16.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.9 m -64.71 75.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 52' ' ' THR . 0.0 OUTLIER -119.14 -160.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.12 -87.35 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.915 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.668 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -171.64 175.31 4.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.496 0.189 . . . . 0.0 110.575 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.785 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -117.08 152.15 17.93 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 119.925 -1.131 . . . . 0.0 113.329 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 73' ' ' LYS . 3.3 m-85 -112.56 139.55 48.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.402 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.64 HG12 ' CG2' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -135.2 109.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 0.0 110.197 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.01 116.99 27.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.831 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.934 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.2 m-30 -75.93 156.58 34.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.063 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -51.68 -54.89 23.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.968 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -124.41 146.72 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.473 ' HA3' ' HB2' ' A' ' 42' ' ' LEU . . . -52.35 -30.49 33.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.024 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.9 t -62.22 -17.88 59.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.737 0.303 . . . . 0.0 110.529 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 26.3 m -81.33 -28.96 34.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.002 0.43 . . . . 0.0 110.496 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.79 -42.71 93.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.071 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -54.97 -41.35 71.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.783 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -74.45 -28.75 61.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.934 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.56 -56.29 6.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.217 0.532 . . . . 0.0 110.333 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 118' ' ' LEU . 4.3 mt -62.81 -26.36 40.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.87 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.36 -34.01 63.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.157 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -129.27 20.46 5.29 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.792 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 15.2 mt -135.34 -35.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.301 0.551 . . . . 0.0 111.726 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -56.86 121.14 9.19 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.52 16.29 54.81 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.724 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.704 ' HD2' HD23 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -51.36 83.25 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.109 0.455 . . . . 0.0 110.516 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 106' ' ' GLY . 16.2 p-10 -70.23 78.76 0.52 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.066 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.808 HG23 ' H ' ' A' ' 112' ' ' LYS . 11.9 tt -78.11 160.95 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 109' ' ' ILE . 3.4 tp -50.67 -25.53 4.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.73 -46.17 5.5 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.808 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.5 mmtm -142.25 -173.75 3.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.408 0.623 . . . . 0.0 112.325 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -126.24 114.46 18.33 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.831 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.897 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.6 mp -80.29 91.46 5.63 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.599 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 9.3 ttmm -83.84 118.65 24.09 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 45' ' ' LEU . 2.3 t -129.34 131.02 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -134.99 137.4 42.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.242 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -60.57 117.35 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.89 0.376 . . . . 0.0 110.429 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' CB ' ' CE2' ' A' ' 88' ' ' PHE . . . -90.5 94.83 9.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.507 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.679 ' HA ' HG11 ' A' ' 41' ' ' VAL . . . -68.28 -31.11 70.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.3 m -162.86 163.89 26.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.24 -90.52 0.23 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.533 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.89 -175.11 5.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.782 0.325 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -63.45 149.22 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -134.84 145.98 56.93 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.78 -32.31 9.39 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.52 2.146 . . . . 0.0 112.257 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 86.02 -151.89 25.29 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.66 HD13 ' H ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -140.61 138.65 35.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.821 0.343 . . . . 0.0 111.105 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.65 138.11 31.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 111.01 -142.22 16.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.83 59.63 2.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 0.0 111.085 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.87 101.45 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.25 48.2 7.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.473 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 125.69 24.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.5 38.38 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.519 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 35.2 m-20 -86.97 -48.55 8.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -173.57 39.68 0.14 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -62.81 -51.48 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.356 . . . . 0.0 110.949 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.615 ' OXT' HD12 ' A' ' 139' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.886 0.374 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -120.95 121.18 37.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.831 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 60.46 171.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 4' ' ' ILE . 3.4 mp -65.02 136.48 96.78 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD2' HG23 ' A' ' 4' ' ' ILE . 49.0 Cg_endo -68.83 89.05 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.482 2.121 . . . . 0.0 112.234 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.62 31.14 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 7' ' ' VAL . 26.7 m -84.08 116.56 28.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m 60.22 -176.1 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -112.24 141.44 45.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -100.61 -176.72 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.45 133.97 23.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 112.47 3.54 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.527 2.151 . . . . 0.0 112.356 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -81.27 102.19 10.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.905 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.06 161.08 43.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.532 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.16 -72.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.804 0.335 . . . . 0.0 110.914 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.1 t -141.49 -50.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.42 125.56 38.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.07 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -81.48 71.78 8.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tp -120.04 121.43 38.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 64.55 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB3' HD23 ' A' ' 22' ' ' LEU . 22.0 mt-30 -144.16 -57.36 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -157.34 -73.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -170.56 123.93 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.762 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -135.63 129.55 33.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.937 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -154.37 177.76 10.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -112.07 48.13 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.86 90.3 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -84.93 152.18 23.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -86.49 -60.0 2.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.6 92.24 43.52 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.447 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 31.6 Cg_exo -57.84 -46.89 23.48 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.524 2.149 . . . . 0.0 112.633 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 91.4 Cg_endo -81.33 64.15 8.71 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.365 2.043 . . . . 0.0 112.56 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -104.2 88.52 3.01 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.83 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -164.81 -44.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.781 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.7 ttm -66.3 106.23 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.864 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -58.95 109.63 2.03 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.06 75.65 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.412 2.075 . . . . 0.0 112.235 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.86 110.82 3.56 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.93 -56.34 2.68 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.395 2.064 . . . . 0.0 112.275 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 43' ' ' ARG . 8.8 t70 -53.53 -25.04 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.397 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 120' ' ' ALA . 17.2 t -92.07 -36.06 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.899 0.38 . . . . 0.0 111.32 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -71.05 -47.73 56.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 7.2 ptm180 -58.94 -20.02 48.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.394 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -77.35 113.31 14.99 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.707 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.5 mm? -116.09 117.85 31.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 112.03 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 13.1 ttp -96.46 111.64 23.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.505 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 86' ' ' TYR . 2.5 p -103.06 139.04 25.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.216 0.531 . . . . 0.0 111.556 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 54.2 t30 -143.85 134.97 25.61 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.848 ' CD2' HG23 ' A' ' 50' ' ' ILE . 0.6 OUTLIER -154.13 -65.13 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.159 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.875 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -104.81 156.99 35.14 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.049 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 70.9 Cg_endo -73.95 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.265 1.977 . . . . 0.0 112.793 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 84' ' ' ARG . 14.6 t -78.37 -5.83 53.4 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.598 ' O ' HG22 ' A' ' 53' ' ' THR . 40.2 m -92.22 14.63 15.68 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.3 m -68.87 118.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.786 0.326 . . . . 0.0 110.65 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -114.91 114.32 25.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 111.761 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.854 ' N ' HD11 ' A' ' 74' ' ' ILE . 5.9 pt-20 -55.96 -23.8 34.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.526 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 45.2 t -69.2 -56.34 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.015 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -48.76 -48.46 40.91 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.287 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -78.37 -23.27 46.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.686 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.764 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.59 -55.28 36.86 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.351 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.6 mt-30 -77.31 -40.72 43.32 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD21 HD11 ' A' ' 114' ' ' LEU . 2.8 tp -65.87 -41.96 90.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.99 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.835 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.4 m-85 -84.36 -50.19 8.03 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.107 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -55.17 -25.55 33.07 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.918 -0.713 . . . . 0.0 110.957 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.92 -53.02 61.87 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -83.18 -6.3 59.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.374 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -175.19 96.17 0.1 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.899 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -44.05 122.73 3.72 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.544 2.162 . . . . 0.0 112.607 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.117 HD12 HG21 ' A' ' 72' ' ' VAL . 1.1 pt -80.71 146.05 8.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.904 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.34 -52.68 2.73 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.7 t -120.79 106.18 11.43 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.074 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.117 HG21 HD12 ' A' ' 69' ' ' ILE . 4.3 t -108.74 132.41 56.76 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.542 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' PHE . 9.6 tttp -156.9 142.67 17.73 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.781 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.854 HD11 ' N ' ' A' ' 56' ' ' GLU . 74.8 mt -97.84 137.21 26.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 0.0 111.022 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' TYR . 33.1 t -82.02 95.0 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.237 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 82' ' ' GLN . 11.6 m -89.48 165.61 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.057 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.14 120.2 19.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.806 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.43 -9.87 59.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.464 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.59 -51.16 30.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 33.2 p -116.95 10.03 13.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 52.18 29.76 6.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 76' ' ' CYS . 19.0 mm-40 -101.12 147.62 26.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.704 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -64.35 120.16 11.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.614 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -170.14 -164.66 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.352 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.54 -88.15 0.13 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.282 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.659 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.7 175.39 4.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.3 -175.31 20.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.908 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -147.28 128.74 14.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.688 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -126.08 109.66 21.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.168 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.413 ' HG3' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -89.58 109.92 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.445 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.844 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.4 m-30 -71.18 150.93 44.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.125 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -51.76 -23.7 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -159.09 149.8 19.77 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.485 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.86 -26.79 41.92 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.034 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.0 -26.73 64.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.738 0.304 . . . . 0.0 110.58 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.2 m -79.56 -28.89 41.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.437 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.79 -44.56 73.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.028 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 34.9 mt-30 -52.1 -38.21 56.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.433 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -77.1 -28.83 54.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.844 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.29 -55.61 8.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.365 0.602 . . . . 0.0 110.329 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.576 HG13 HD21 ' A' ' 118' ' ' LEU . 38.2 mm -65.96 -26.19 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.64 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.51 -42.49 58.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.434 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.43 25.43 4.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.027 -1.082 . . . . 0.0 114.48 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.835 HD11 ' HA ' ' A' ' 63' ' ' PHE . 3.3 mt -136.23 -42.19 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 0.0 111.623 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -60.41 121.33 11.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 0.0 110.233 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.82 14.93 70.89 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.754 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 114' ' ' LEU . 1.0 OUTLIER -46.35 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.99 0.395 . . . . 0.0 110.597 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.3 p30 -74.47 81.58 1.95 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.892 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.762 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.5 tt -78.48 161.56 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.482 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.13 -25.13 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -177.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -102.79 -44.42 5.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.762 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.97 -173.4 3.89 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -126.66 114.85 18.57 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.306 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.83 HD11 HD21 ' A' ' 62' ' ' LEU . 12.1 mt -80.15 98.65 7.4 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.487 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 17.7 tttt -85.48 119.26 25.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.454 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.707 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.3 t -129.44 126.37 63.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.389 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -134.2 136.71 43.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.028 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.576 HD21 HG13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -60.24 149.42 33.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.857 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.53 85.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.278 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' HA ' ' CG1' ' A' ' 41' ' ' VAL . . . 61.16 105.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.056 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -142.16 132.5 25.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.83 -149.38 7.17 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.514 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -115.85 150.26 37.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 0.0 110.879 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.52 38.26 3.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 62.56 140.03 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.97 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.22 -167.82 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.541 2.161 . . . . 0.0 112.3 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -58.3 -93.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.6 mm 69.73 -65.24 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 111.253 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -95.3 39.21 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.252 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.04 33.89 65.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.651 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 58.76 -179.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.358 . . . . 0.0 111.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.49 -46.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.181 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.4 -110.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.514 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 60.72 34.59 19.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.62 142.23 4.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.87 113.99 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.796 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.75 176.46 41.39 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.503 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -132.36 140.68 48.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.88 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.774 0.321 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -138.16 131.35 30.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.5 106.07 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.659 HD13 ' CG2' ' A' ' 7' ' ' VAL . 1.6 pp -93.15 104.18 11.33 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HG2' HD23 ' A' ' 6' ' ' LEU . 38.7 Cg_endo -66.99 -13.9 41.65 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.446 2.097 . . . . 0.0 112.638 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.419 HD23 ' HG2' ' A' ' 5' ' ' PRO . 2.6 pt? -162.07 177.54 9.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.761 0.315 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.659 ' CG2' HD13 ' A' ' 4' ' ' ILE . 39.4 t -154.15 -46.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.2 -166.0 0.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.75 172.96 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 61.18 97.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 62.41 149.48 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.35 -57.41 2.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.538 2.159 . . . . 0.0 112.315 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -64.49 -178.22 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.11 -126.28 2.43 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.433 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -134.06 -179.04 5.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.93 152.81 38.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.55 -27.92 9.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.19 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.94 -78.12 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.961 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.49 82.77 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.4 -30.31 8.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.33 170.86 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.598 HD12 ' HB2' ' A' ' 23' ' ' GLN . 2.8 pp -169.27 157.36 7.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.598 ' HB2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER 61.48 -178.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.817 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -85.58 -62.82 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -78.09 178.31 7.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.9 -65.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -171.26 -71.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 55.07 41.76 31.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.057 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -126.45 28.41 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.986 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 33' ' ' THR . 2.9 mp 55.81 87.93 0.13 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.202 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 32.0 Cg_exo -57.35 -45.49 34.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.609 2.206 . . . . 0.0 112.572 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 52.5 Cg_exo -52.75 -38.63 77.68 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.402 2.068 . . . . 0.0 112.274 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 30' ' ' ILE . 32.9 m -115.77 113.32 23.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -103.52 -37.47 7.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.51 71.83 8.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.825 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.39 123.82 88.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -57.96 81.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.547 2.164 . . . . 0.0 112.326 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.1 mm-40 -85.97 110.35 29.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.841 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.83 -12.97 37.17 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.428 2.085 . . . . 0.0 112.5 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.21 -29.4 63.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.05 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 38' ' ' GLU . 33.5 m -84.64 -9.71 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.558 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.7 mt -71.1 -49.33 45.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.849 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.1 ptm180 -53.17 -21.78 5.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.502 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.614 ' HB3' ' HB3' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -74.8 105.82 6.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.795 0.331 . . . . 0.0 110.251 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.651 HD23 ' CD1' ' A' ' 118' ' ' LEU . 55.6 mt -104.71 121.84 44.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.78 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 88' ' ' PHE . 5.2 tmm? -90.71 109.59 20.77 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.692 HG21 HD13 ' A' ' 59' ' ' LEU . 23.4 m -103.79 137.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.716 0.769 . . . . 0.0 112.974 -177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.646 ' O ' ' HD1' ' A' ' 49' ' ' TYR . 42.6 t30 -146.29 132.03 18.97 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.451 -1.25 . . . . 0.0 107.818 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.948 ' CZ ' HD22 ' A' ' 114' ' ' LEU . 9.9 m-30 -138.41 -70.56 0.42 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD13 ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.81 141.29 22.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.072 178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.617 ' HD2' HG22 ' A' ' 50' ' ' ILE . 14.7 Cg_endo -55.78 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 121.632 1.555 . . . . 0.0 111.747 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 m -79.19 -18.44 52.99 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.627 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.47 14.56 9.48 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -178.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.5 p -69.51 109.48 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.743 0.306 . . . . 0.0 110.781 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -114.64 130.81 56.84 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.883 0.373 . . . . 0.0 111.511 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.89 ' N ' HD11 ' A' ' 74' ' ' ILE . 9.8 pt-20 -60.01 -24.14 64.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.359 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 29.4 t -70.9 -56.39 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.212 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.03 -42.15 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 109.696 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.692 HD13 HG21 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -78.58 -28.54 45.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.824 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.95 -55.51 33.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.559 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.4 mt-30 -72.44 -44.22 62.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD23 ' HE2' ' A' ' 49' ' ' TYR . 9.6 tp -62.87 -44.93 94.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.109 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.687 ' CE2' HG12 ' A' ' 47' ' ' VAL . 18.4 m-85 -84.5 -49.98 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.678 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.8 pt-20 -54.04 -25.21 20.21 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.65 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.7 OUTLIER -59.36 -36.33 75.54 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.96 0.41 . . . . 0.0 110.521 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -95.81 -13.76 23.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.46 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -171.43 97.3 0.12 Allowed Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.526 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -44.06 123.36 4.12 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.352 2.035 . . . . 0.0 112.176 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.824 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -80.2 145.86 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.765 -179.278 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.0 -42.36 6.43 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -144.11 106.37 4.38 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.599 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 88' ' ' PHE . 2.6 p -106.44 140.21 25.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.52 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 29.2 tttm -155.67 153.42 29.97 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.57 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.89 HD11 ' N ' ' A' ' 56' ' ' GLU . 55.6 mt -108.13 147.96 12.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.077 0.465 . . . . 0.0 111.903 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.5 t -93.01 105.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.117 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 96.5 m -75.82 173.19 11.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.163 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.14 123.82 33.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -71.25 -9.73 58.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.472 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.15 -51.13 22.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.819 0.342 . . . . 0.0 110.798 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.6 p -116.64 4.22 13.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.265 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 55.97 30.26 15.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.773 0.321 . . . . 0.0 110.831 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -110.49 164.56 12.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.083 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.73 115.59 5.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.478 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -170.07 -158.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.258 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.81 -87.92 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.83 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.477 ' HB3' ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -171.79 175.71 3.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.218 -0.193 . . . . 0.0 110.636 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.91 -173.68 16.82 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.142 -1.028 . . . . 0.0 113.513 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.687 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 7.3 m-85 -145.84 142.78 29.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.193 -0.503 . . . . 0.0 109.935 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.589 HG12 HG21 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -134.21 109.79 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -86.38 109.94 19.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.704 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.902 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-30 -74.72 153.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.984 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -51.61 -54.87 23.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.61 145.92 47.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 0.0 111.387 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.41 -27.28 32.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.964 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 55.5 m -63.33 -22.39 66.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.657 0.265 . . . . 0.0 110.694 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.5 m -80.96 -31.72 34.76 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.493 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.849 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.49 -41.48 89.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.626 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -39.45 81.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.334 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -74.64 -30.61 61.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.347 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.902 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.46 -56.07 7.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.29 0.567 . . . . 0.0 110.03 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.652 HG13 HD21 ' A' ' 118' ' ' LEU . 30.5 mm -61.07 -26.11 38.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.908 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.2 -40.58 62.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.834 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.45 13.09 23.29 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.566 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.677 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 26.9 mt -135.71 -34.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.113 0.456 . . . . 0.0 112.225 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.57 ' HB2' HG23 ' A' ' 101' ' ' ILE . 38.1 t-20 -58.58 121.22 10.44 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 114' ' ' LEU . . . 56.94 21.86 39.44 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.654 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.442 ' HB3' ' CG ' ' A' ' 114' ' ' LEU . 1.9 t80 -56.9 87.04 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.034 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' GLY . 43.8 p-10 -67.46 85.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.894 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.3 tt -83.25 161.05 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -30.13 17.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -88.12 -54.21 4.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.964 0.412 . . . . 0.0 111.73 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.681 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.13 -169.01 2.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.499 -179.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -118.02 114.29 22.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.425 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.948 HD22 ' CZ ' ' A' ' 49' ' ' TYR . 18.8 mt -69.23 114.97 7.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.32 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -104.12 119.52 39.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.003 0.43 . . . . 0.0 111.86 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 104' ' ' LEU . 1.4 t -129.81 123.92 57.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.773 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.28 132.44 50.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.884 0.373 . . . . 0.0 111.559 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 HG13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -68.25 126.99 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.862 0.363 . . . . 0.0 110.847 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.687 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -70.11 65.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.01 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -86.4 83.9 7.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.167 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.74 -174.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.022 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.49 118.49 1.89 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 177.48 7.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.842 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 68.46 -67.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.971 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 112.65 47.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.869 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.26 -39.91 63.86 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.469 2.113 . . . . 0.0 112.222 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 110.1 72.73 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.302 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 tt -55.73 140.27 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.84 0.352 . . . . 0.0 111.255 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.29 -46.16 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 157.21 -28.43 0.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.55 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.06 77.11 1.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.336 . . . . 0.0 111.063 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.1 m -111.36 -32.23 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.6 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.51 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.45 34.24 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.374 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.38 169.32 21.76 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.491 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.91 171.68 11.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.26 -69.34 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -114.6 -71.45 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.812 0.339 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 24.6 mt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.923 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.794 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -153.92 -55.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -128.19 -45.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.992 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.4 tp -168.22 108.42 0.55 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.84 68.15 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.72 2.28 . . . . 0.0 112.201 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' ILE . 28.9 mt -152.55 -44.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 t 70.94 103.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m 60.94 158.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? 62.11 116.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' CD1' ' HD3' ' A' ' 12' ' ' PRO . 17.3 p90 -134.05 -176.21 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.907 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -127.58 97.73 30.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 10' ' ' TYR . 51.9 Cg_endo -69.26 148.31 68.0 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.422 2.081 . . . . 0.0 112.253 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -139.63 142.1 37.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.7 157.36 53.5 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -86.6 90.13 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.77 0.319 . . . . 0.0 110.912 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -65.18 98.77 0.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.42 -62.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -171.63 141.26 1.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.52 -37.29 6.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 61.07 112.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -131.76 31.38 4.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.27 -70.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 61.86 151.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -176.26 88.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.18 16.36 14.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.261 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 53.74 33.06 15.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.093 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -153.05 126.73 8.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -128.84 75.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.792 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -99.03 -24.96 14.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.929 HG22 ' HD2' ' A' ' 32' ' ' PRO . 5.5 mm 64.44 121.52 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB2' ' HD3' ' A' ' 32' ' ' PRO . 45.4 Cg_exo -54.92 -50.0 14.76 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.465 2.11 . . . . 0.0 112.764 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.929 ' HD2' HG22 ' A' ' 30' ' ' ILE . 82.1 Cg_endo -77.29 4.55 5.79 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.351 2.034 . . . . 0.0 112.872 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.2 t 43.67 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 111.554 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 37.1 91.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -48.63 80.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.76 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.463 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 179.96 -52.47 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.089 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 23.4 Cg_exo -64.31 73.76 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.792 2.328 . . . . 0.0 112.239 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 43.2 mm-40 -102.04 105.49 42.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.32 -26.59 82.41 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.496 2.131 . . . . 0.0 112.171 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.55 -30.04 68.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.6 m -97.72 31.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.258 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.73 ' O ' HD21 ' A' ' 118' ' ' LEU . 11.1 mt -78.38 -24.7 46.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.94 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -66.99 -7.87 25.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.859 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.99 105.87 6.21 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.741 HD22 ' CG1' ' A' ' 116' ' ' VAL . 35.4 mt -110.6 121.79 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.917 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.526 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 10.7 tmm? -91.53 112.18 23.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 59' ' ' LEU . 2.9 m -102.51 130.75 51.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.241 0.543 . . . . 0.0 111.649 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -139.69 134.93 32.65 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.236 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' CD2' HD11 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -162.78 -65.9 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.291 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.612 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -104.57 137.78 19.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.689 179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD2' HG22 ' A' ' 50' ' ' ILE . 32.2 Cg_endo -64.43 -86.28 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.135 1.89 . . . . 0.0 112.533 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -78.48 -18.81 54.3 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.598 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -88.82 14.43 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.9 p -69.42 111.26 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -114.74 119.11 35.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.002 0.43 . . . . 0.0 111.822 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.796 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.6 pt-20 -54.67 -24.6 22.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.988 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 24.6 t -68.84 -55.83 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.893 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -47.79 -48.35 30.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.088 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.19 -24.55 47.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.584 179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.904 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -56.89 -55.23 37.18 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.492 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 mt-30 -75.11 -43.25 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.192 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.822 HD21 HD11 ' A' ' 114' ' ' LEU . 9.0 tp -64.67 -42.66 95.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.974 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.5 m-85 -84.22 -49.8 8.47 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.349 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 10.4 pt-20 -54.03 -26.88 28.76 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.661 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.63 -53.1 60.64 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 110.659 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -78.8 -9.55 59.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.279 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.86 98.29 0.12 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.739 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -44.12 123.62 4.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.532 2.154 . . . . 0.0 112.35 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.904 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.72 145.65 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.643 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -101.25 -45.45 5.35 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.3 t -137.79 105.68 5.65 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.437 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.634 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -108.1 138.48 34.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.623 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 88' ' ' PHE . 24.7 tttp -156.04 155.6 32.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.639 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.796 HD11 ' N ' ' A' ' 56' ' ' GLU . 41.1 mt -107.34 145.74 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.967 0.413 . . . . 0.0 111.397 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG23 ' HD1' ' A' ' 88' ' ' PHE . 94.0 t -92.49 108.62 20.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.326 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 4.2 p -101.64 171.41 7.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.065 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.48 117.8 15.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -9.95 58.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.45 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -73.32 -51.14 18.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.6 p -116.92 5.29 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.374 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 54.05 35.5 22.33 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.853 0.358 . . . . 0.0 111.122 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 8.2 mm100 -98.03 138.51 35.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.4 111.34 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.926 0.393 . . . . 0.0 110.6 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -170.13 -163.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.35 -85.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.93 -0.652 . . . . 0.0 113.129 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.541 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -171.57 175.21 4.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.514 0.197 . . . . 0.0 110.607 -179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.752 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -118.4 -172.37 15.55 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.447 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.724 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 2.7 m-85 -146.96 151.82 37.63 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.65 0.38 . . . . 0.0 110.453 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.513 HG13 HD12 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.5 109.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.319 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 ttmm -91.71 112.57 24.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.916 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -74.26 154.86 38.79 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.87 -54.82 24.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.753 -178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -119.45 138.41 53.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.825 0.345 . . . . 0.0 110.98 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.54 -26.72 10.57 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.114 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.1 m -63.62 -24.65 67.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 110.652 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 8.6 t -77.09 -28.89 54.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.882 0.372 . . . . 0.0 110.523 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.94 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.05 -40.72 90.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -54.71 -45.81 74.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.639 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -72.24 -26.96 62.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.404 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.916 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.43 -56.16 7.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.15 0.5 . . . . 0.0 110.256 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.041 HD11 HD23 ' A' ' 118' ' ' LEU . 44.3 mt -61.35 -26.45 39.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.071 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.15 -41.04 62.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.753 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.74 13.81 24.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.482 -0.865 . . . . 0.0 113.466 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.707 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 41.6 mt -135.35 -36.06 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 117.132 0.466 . . . . 0.0 112.1 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.573 ' HB2' HG23 ' A' ' 101' ' ' ILE . 39.6 t-20 -58.93 121.26 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.853 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.54 16.24 58.38 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.512 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' HD12 ' A' ' 114' ' ' LEU . 1.7 t80 -50.39 86.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 117.029 0.415 . . . . 0.0 110.37 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 106' ' ' GLY . 9.3 p-10 -77.18 83.75 3.66 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.655 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' H ' ' A' ' 112' ' ' LYS . 21.0 tt -78.43 161.85 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -49.95 -21.09 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -106.59 -42.56 4.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.639 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.96 -174.11 4.09 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 43.7 ttp180 -126.59 114.55 18.22 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.765 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.822 HD11 HD21 ' A' ' 62' ' ' LEU . 23.5 mt -77.46 101.5 6.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.694 0.283 . . . . 0.0 110.825 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -88.33 119.77 29.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.729 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.741 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -128.7 123.8 60.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.14 134.61 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.62 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.041 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -63.25 135.19 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.824 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.724 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -70.97 -44.63 65.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 119' ' ' ALA . . . 69.33 -67.16 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.027 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.6 t -149.92 102.34 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.855 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -93.55 -82.27 1.53 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.6 147.3 32.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -93.31 134.06 35.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.63 114.09 1.51 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.945 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.69 -27.12 38.6 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.485 2.124 . . . . 0.0 112.289 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.65 40.91 0.3 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 128' ' ' ILE . 30.5 mt 57.79 55.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.195 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -135.61 -50.36 0.72 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.52 46.82 66.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.581 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -93.29 -170.26 2.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.104 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -114.07 -38.32 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 117.96 -92.69 0.55 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -119.97 102.04 8.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.41 -50.23 0.23 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 60.67 164.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.332 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -174.22 131.48 2.03 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.513 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.05 -58.42 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.806 0.336 . . . . 0.0 110.87 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.877 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttp . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.797 0.332 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -166.94 111.32 0.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -108.48 167.26 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 43.3 pt -146.63 145.5 23.44 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.182 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.67 61.98 4.56 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.601 2.201 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mt -149.99 -66.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 7' ' ' VAL . 16.0 t 65.6 15.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.375 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m 173.78 163.6 0.17 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.783 0.325 . . . . 0.0 110.849 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.65 73.89 1.21 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.01 -49.65 5.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.16 144.9 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.12 168.09 24.27 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.398 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -96.55 117.77 31.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.36 45.54 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.511 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.4 -172.27 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 60.62 40.88 16.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.03 164.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -112.49 147.95 35.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 122.06 16.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -144.47 161.28 39.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.96 108.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 22' ' ' LEU . 4.9 mp -80.16 142.65 34.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -148.52 27.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.97 52.33 9.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.97 138.66 57.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -176.01 40.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.21 171.12 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.55 -32.86 19.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.36 145.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.496 HD12 ' HG2' ' A' ' 32' ' ' PRO . 28.8 pt -122.31 152.45 60.82 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 51.4 Cg_exo -53.25 -46.85 30.88 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.685 2.257 . . . . 0.0 112.904 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HG2' HD12 ' A' ' 30' ' ' ILE . 91.7 Cg_endo -79.04 53.27 4.63 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.281 1.988 . . . . 0.0 112.691 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 33' ' ' THR . 62.6 m -121.2 49.19 1.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.911 0.386 . . . . 0.0 110.806 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 -166.76 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.945 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.09 95.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -68.17 111.25 7.35 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' HIS . 21.6 Cg_exo -65.57 67.89 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.591 2.194 . . . . 0.0 112.258 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.3 mm-40 -101.92 151.27 37.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.914 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.28 -25.11 13.76 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.601 2.201 . . . . 0.0 112.374 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -59.64 -31.41 69.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.7 m -86.03 66.27 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.247 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.614 ' O ' HD11 ' A' ' 118' ' ' LEU . 3.2 mt -96.94 -29.71 13.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.736 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -73.35 0.38 12.31 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.057 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.664 ' O ' HD13 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -78.28 105.75 9.73 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 HD22 ' A' ' 118' ' ' LEU . 4.2 mm? -112.0 118.29 35.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 38.8 ttp -91.66 109.58 20.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 59' ' ' LEU . 2.8 p -104.32 137.76 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.089 0.471 . . . . 0.0 111.771 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -143.05 134.71 26.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.195 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -154.96 -63.29 0.12 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.331 179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -104.59 161.95 21.28 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.162 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' ILE . 87.9 Cg_endo -80.96 -96.92 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.318 2.012 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.35 -20.1 52.06 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.507 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 8.9 t -87.62 14.51 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' HA ' ' CG1' ' A' ' 50' ' ' ILE . 10.5 p -69.31 120.27 16.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.657 0.265 . . . . 0.0 110.329 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.06 122.11 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.939 0.4 . . . . 0.0 111.967 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.863 ' N ' HD11 ' A' ' 74' ' ' ILE . 6.3 pt-20 -59.44 -23.49 62.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.592 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 48.5 t -71.11 -56.63 9.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.611 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -51.02 -42.06 60.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 109.577 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -78.24 -27.1 47.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.289 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -59.36 -55.21 37.67 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.472 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 4.3 mt-30 -67.89 -45.48 74.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.814 HD23 HD11 ' A' ' 114' ' ' LEU . 2.2 tp -65.78 -41.3 92.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.969 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.776 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.3 m-85 -84.56 -50.52 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 6.2 pt-20 -56.25 -25.57 48.28 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.572 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.5 ttp180 -59.0 -38.36 79.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.047 0.451 . . . . 0.0 110.331 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -91.85 -14.1 30.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -170.88 98.25 0.13 Allowed Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.418 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -44.05 119.6 2.09 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.418 2.079 . . . . 0.0 112.234 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.616 HD11 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -80.02 145.9 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.642 -179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -101.34 -40.76 6.96 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -144.7 106.15 4.24 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.631 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 69' ' ' ILE . 2.1 p -106.71 139.48 28.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.296 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' PHE . 6.6 tttp -155.87 161.59 40.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.866 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.863 HD11 ' N ' ' A' ' 56' ' ' GLU . 38.8 mt -113.37 142.58 25.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.128 0.49 . . . . 0.0 111.38 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.572 HG23 ' HD1' ' A' ' 88' ' ' PHE . 84.5 t -84.88 99.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.263 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.5 p -90.14 167.4 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.176 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -81.53 121.92 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.69 -9.53 58.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.49 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.37 -51.07 32.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.765 0.317 . . . . 0.0 110.966 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -113.62 6.98 17.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 54.5 mmm-85 52.21 33.33 12.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.941 0.401 . . . . 0.0 110.976 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 7.8 mm-40 -110.41 149.34 30.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 52' ' ' THR . 32.2 m -64.38 121.6 14.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.538 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -169.91 -159.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.33 -85.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.072 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -171.3 175.39 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.58 0.228 . . . . 0.0 110.609 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.14 -177.09 20.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.233 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.675 ' HE2' ' HB2' ' A' ' 119' ' ' ALA . 1.6 m-85 -147.13 138.5 24.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.343 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.465 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -135.26 109.79 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.787 0.327 . . . . 0.0 110.211 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -90.77 113.31 25.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.466 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.917 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 8.2 m-30 -75.52 154.88 36.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.407 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -51.91 -53.12 44.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.996 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.3 m -124.08 143.96 50.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.79 -26.28 25.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.128 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -63.71 -22.7 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.7 0.286 . . . . 0.0 110.74 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 7.2 t -78.94 -28.96 43.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.538 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -58.44 -44.85 89.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -53.1 -40.25 64.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.578 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -75.22 -28.16 59.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.366 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.917 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.39 -56.21 7.22 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.177 0.513 . . . . 0.0 110.259 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 118' ' ' LEU . 36.0 mt -63.07 -26.3 40.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.983 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.32 -33.89 63.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -125.64 16.8 6.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.279 -0.963 . . . . 0.0 113.705 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.776 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 14.2 mt -135.5 -38.38 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.192 0.496 . . . . 0.0 111.996 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.507 ' HB2' HG23 ' A' ' 101' ' ' ILE . 57.5 t30 -54.44 121.14 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.62 18.7 45.97 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.734 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 5.2 t80 -51.48 88.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.136 0.468 . . . . 0.0 110.329 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.5 p30 -73.08 88.05 1.41 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.491 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 ' H ' ' A' ' 112' ' ' LYS . 9.4 tt -80.04 161.84 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.481 ' N ' HG12 ' A' ' 109' ' ' ILE . 5.8 tp -50.02 -22.53 1.63 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -106.81 -44.11 4.52 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.154 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.817 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.8 -175.0 4.32 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -126.52 114.94 18.79 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.814 HD11 HD23 ' A' ' 62' ' ' LEU . 14.2 mt -76.34 103.5 6.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.648 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.35 118.72 30.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' MET . 1.5 t -129.95 127.59 63.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.29 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -133.69 136.99 45.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.457 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.987 HD23 HD11 ' A' ' 101' ' ' ILE . 0.3 OUTLIER -59.85 136.06 57.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.675 ' HB2' ' HE2' ' A' ' 88' ' ' PHE . . . -62.07 -47.04 86.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 41' ' ' VAL . . . -127.41 175.91 7.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -176.27 -40.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.61 142.55 3.43 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.482 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.449 ' CD2' ' HG2' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -74.59 178.3 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -129.31 74.23 1.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -119.32 147.68 43.7 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.838 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.02 153.47 20.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.485 2.124 . . . . 0.0 112.275 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -102.75 21.93 38.9 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.591 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 26.8 mt 56.04 87.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.797 0.332 . . . . 0.0 111.263 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 91.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.094 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.99 -123.37 5.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.515 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.83 34.64 19.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.338 . . . . 0.0 111.108 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.4 t 68.82 -67.59 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.219 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.72 -143.36 8.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -156.07 112.89 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.93 -59.8 1.65 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.458 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -60.46 155.08 19.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.769 0.319 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 103.51 167.77 25.55 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -65.01 -56.29 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.853 0.358 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.919 -179.955 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.836 0.351 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 59.72 93.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -58.74 145.38 40.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -127.92 144.02 49.89 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.28 130.79 15.61 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.488 2.126 . . . . 0.0 112.39 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.1 mt -102.85 31.1 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.782 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.02 125.49 74.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.035 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.37 -169.43 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 61.05 -178.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.71 102.07 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -153.37 81.0 5.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.88 -171.76 0.52 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.58 2.187 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -101.67 31.1 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -110.37 -111.36 3.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.536 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.81 159.69 13.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.329 . . . . 0.0 110.871 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.435 ' CG2' HD12 ' A' ' 19' ' ' LEU . 26.6 m -147.57 156.84 43.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.72 161.58 13.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.73 35.76 19.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 HD12 ' CG2' ' A' ' 16' ' ' THR . 11.3 mt -149.49 178.4 8.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.993 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 62.8 120.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.968 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.3 18.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.271 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 mp 48.29 53.05 12.47 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.866 0.365 . . . . 0.0 111.205 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 60.41 77.75 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -130.55 148.4 52.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 60.92 156.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.36 97.25 4.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -119.76 30.72 6.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -65.32 -166.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.68 38.11 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.005 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 1.2 mp -66.76 -54.22 23.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.294 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 30' ' ' ILE . 34.1 Cg_endo -64.63 173.08 5.92 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.111 1.874 . . . . 0.0 111.872 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.16 63.71 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.446 2.097 . . . . 0.0 112.166 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.808 HG22 ' OE1' ' A' ' 34' ' ' GLN . 0.5 OUTLIER -107.63 117.58 34.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.026 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.808 ' OE1' HG22 ' A' ' 33' ' ' THR . 6.4 pm0 44.78 -166.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.444 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.27 29.74 13.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 18.8 m-20 56.69 65.84 3.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.069 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.68 55.83 5.68 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.654 2.236 . . . . 0.0 112.423 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.61 112.5 34.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.947 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 42' ' ' LEU . 25.3 Cg_exo -62.77 -26.77 75.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.45 2.1 . . . . 0.0 112.221 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.93 -31.41 69.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.4 t -93.87 16.7 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.487 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.5 mt -71.99 -36.09 69.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.874 0.369 . . . . 0.0 110.385 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.4 ptt180 -55.1 -26.95 41.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.269 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.539 ' O ' HD12 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.65 125.44 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.732 HD22 ' CG1' ' A' ' 116' ' ' VAL . 32.9 mt -127.54 122.34 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 7.3 tmm? -91.24 112.6 24.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' CG1' ' CE2' ' A' ' 63' ' ' PHE . 2.4 m -102.81 129.97 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.442 0.639 . . . . 0.0 112.668 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -132.56 134.81 45.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.806 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CZ ' ' CB ' ' A' ' 112' ' ' LYS . 5.5 t80 -162.14 -59.55 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.39 0.614 . . . . 0.0 110.552 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -104.43 165.98 12.38 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.227 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -89.04 -98.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.865 2.376 . . . . 0.0 111.736 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.607 HG22 ' HG3' ' A' ' 84' ' ' ARG . 19.6 p -78.42 -14.01 59.58 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.71 0.29 . . . . 0.0 110.936 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.914 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -89.01 14.73 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.86 -179.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.7 m -68.64 112.34 3.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.859 0.361 . . . . 0.0 110.945 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -114.83 123.79 50.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.995 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.902 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -57.43 -23.78 51.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.148 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 44.1 t -73.05 -56.29 10.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.333 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.88 -46.5 31.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.09 -22.5 48.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.743 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -62.57 -55.17 29.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.283 179.555 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.8 mt-30 -69.76 -40.05 76.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.827 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.702 ' CD2' HD21 ' A' ' 114' ' ' LEU . 4.9 tp -70.61 -42.47 70.9 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.341 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.0 m-85 -84.9 -45.1 12.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.599 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 4.8 pt-20 -60.59 -33.01 72.1 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.342 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.63 ' HD3' HD12 ' A' ' 62' ' ' LEU . 6.1 ptm180 -54.7 -37.85 66.32 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.481 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -87.62 -15.75 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.069 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.443 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -168.9 98.35 0.14 Allowed Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -43.64 121.21 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.397 2.064 . . . . 0.0 112.436 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD13 HG11 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -80.1 146.28 7.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.082 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -103.57 -37.94 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -151.93 107.15 3.29 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.859 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 89' ' ' VAL . 4.1 m -105.73 147.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.939 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 88' ' ' PHE . 10.5 tttt -156.03 160.29 39.89 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.204 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.902 HD11 ' N ' ' A' ' 56' ' ' GLU . 51.6 mt -110.59 143.77 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.837 0.351 . . . . 0.0 110.908 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' TYR . 42.0 t -92.59 95.43 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.148 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 15.3 p -79.93 167.64 20.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.262 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.39 124.33 29.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.729 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.18 -9.71 58.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.468 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -71.63 -51.18 24.56 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.984 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.9 p -116.92 3.36 12.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 56.36 34.96 25.08 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 14.5 mm100 -110.45 157.19 19.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.7 t -64.49 116.2 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.504 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.607 ' HG3' HG22 ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.06 -159.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.168 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.82 -87.01 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.913 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 0.2 OUTLIER -171.71 175.48 3.97 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.611 0.244 . . . . 0.0 110.637 -179.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.99 -177.15 21.04 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.019 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -147.16 139.17 24.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.908 HG12 HG12 ' A' ' 72' ' ' VAL . 12.6 m -141.62 109.88 2.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.038 0.446 . . . . 0.0 111.804 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -88.21 115.45 25.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.336 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.831 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 9.1 m-30 -77.18 160.08 29.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.099 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.53 -51.29 56.51 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.9 m -132.72 154.42 50.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.883 0.373 . . . . 0.0 111.433 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -30.41 56.04 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.992 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -60.03 -23.27 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.779 0.323 . . . . 0.0 110.574 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.34 -30.63 48.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.29 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -58.84 -38.69 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.731 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.43 -40.05 77.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.358 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -74.43 -32.45 62.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.248 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.53 -56.01 7.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.257 0.551 . . . . 0.0 110.117 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 118' ' ' LEU . 6.2 mt -60.12 -26.45 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.845 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.05 41.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.405 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.405 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -116.73 19.52 12.4 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.218 -0.991 . . . . 0.0 114.249 -178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 63' ' ' PHE . 13.5 mt -135.75 -38.94 0.72 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.379 0.589 . . . . 0.0 111.529 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.667 ' OD1' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -53.04 121.16 6.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 110.255 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 60.48 18.77 52.0 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.298 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -47.41 90.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.483 0.642 . . . . 0.0 110.169 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 106' ' ' GLY . 12.1 p-10 -72.94 81.71 1.2 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.268 -178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.9 tt -82.24 161.31 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.1 mp -51.11 -37.83 48.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -80.0 -56.19 4.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.904 0.383 . . . . 0.0 111.689 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.3 -168.1 2.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.553 -179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -124.12 114.84 20.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.718 HD23 ' CE1' ' A' ' 63' ' ' PHE . 7.1 mp -72.11 97.64 1.96 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.567 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -88.16 119.76 28.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.68 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.732 ' CG1' HD22 ' A' ' 45' ' ' LEU . 1.7 t -121.95 123.58 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.993 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.82 132.82 37.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.106 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -62.88 147.65 49.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.81 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -75.32 -31.0 60.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.207 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 36' ' ' ASN . . . 62.18 166.21 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.01 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.0 t -59.7 127.04 30.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -179.84 -157.58 20.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.56 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 t60 61.02 98.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.821 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -86.97 159.41 19.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 1.5 mtt-85 -72.8 -60.74 1.82 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.5 Cg_endo -72.19 -176.53 2.2 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.571 2.18 . . . . 0.0 112.286 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -113.16 -90.58 1.87 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.438 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 tp -152.97 133.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.086 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -175.18 117.39 0.17 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -129.09 77.33 0.4 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.482 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 59.89 84.02 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 111.161 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.52 167.87 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.75 -41.92 0.36 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -153.88 61.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.822 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.87 -175.68 14.98 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.71 144.51 10.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.859 0.361 . . . . 0.0 110.944 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -74.07 103.06 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.552 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.97 -36.1 14.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.846 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.859 0.361 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 p -76.83 175.17 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.791 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -105.11 128.2 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 pt -59.24 146.8 77.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.066 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' VAL . 91.1 Cg_endo -83.43 48.66 2.72 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.778 2.319 . . . . 0.0 112.821 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 6.8 mt 65.17 -66.2 0.14 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.403 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 5' ' ' PRO . 15.1 t 73.11 -67.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.085 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.07 -71.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.993 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -137.64 -175.73 4.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.96 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.72 31.46 3.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.58 148.41 55.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.52 -168.17 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.49 2.127 . . . . 0.0 112.312 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -135.47 -179.46 5.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.29 -71.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.537 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 107.57 18.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.86 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 p -152.94 85.71 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.08 137.82 47.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.21 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 mt -148.61 -50.55 0.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -153.86 -175.07 5.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -153.43 -46.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.39 -175.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.86 41.74 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 61.11 100.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.748 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 135.69 46.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.35 -70.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 68.89 -67.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.019 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -150.02 -174.47 4.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -132.4 118.88 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 33' ' ' THR . 4.9 pt -110.12 96.53 26.09 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.7 Cg_exo -51.64 -47.91 23.98 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.579 2.186 . . . . 0.0 112.695 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 31' ' ' PRO . 57.9 Cg_endo -71.67 -7.81 21.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.188 1.925 . . . . 0.0 112.611 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.678 ' HA ' HD12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER 63.5 -163.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 70.91 -166.41 0.15 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.916 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.2 ttp 65.6 40.82 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -103.4 161.61 22.53 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.15 73.44 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.107 . . . . 0.0 112.231 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB2' HG22 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -82.33 154.48 69.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.839 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 42' ' ' LEU . 58.2 Cg_endo -71.55 -27.36 18.88 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.552 2.168 . . . . 0.0 112.344 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -69.8 -34.59 73.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.998 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 38' ' ' GLU . 35.5 m -97.92 28.86 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.669 HD23 ' HG ' ' A' ' 118' ' ' LEU . 9.2 mt -98.19 -51.79 3.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -50.48 -26.89 5.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.519 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.8 105.95 6.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.658 HD23 HD13 ' A' ' 118' ' ' LEU . 18.3 mt -110.73 121.07 44.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.031 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.0 tmm? -91.1 110.94 22.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 116' ' ' VAL . 2.5 m -103.11 131.35 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 5.0 t-20 -131.72 134.82 46.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.026 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.574 ' CD2' HD23 ' A' ' 114' ' ' LEU . 5.9 t80 -164.95 -54.69 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.089 0.471 . . . . 0.0 111.061 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.945 HG22 ' HD2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -103.44 150.98 38.56 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.721 -179.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.945 ' HD2' HG22 ' A' ' 50' ' ' ILE . 51.8 Cg_endo -89.86 -88.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.47 2.113 . . . . 0.0 111.679 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 m -78.55 -11.97 59.99 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.646 0.26 . . . . 0.0 111.47 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.795 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -106.39 15.15 26.41 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.238 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.889 HG22 HD11 ' A' ' 74' ' ' ILE . 7.4 p -68.64 105.51 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 55' ' ' ASP . 10.3 p30 -115.18 127.68 55.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.502 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 11.3 pt-20 -57.64 -23.79 53.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.835 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 37.1 t -70.15 -56.16 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.256 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -51.6 -43.8 62.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.207 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -78.08 -23.27 48.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.695 179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -62.66 -54.97 31.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.149 0.499 . . . . 0.0 110.108 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.4 mt-30 -66.67 -42.92 85.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.594 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD21 HD11 ' A' ' 114' ' ' LEU . 13.9 tp -67.87 -42.32 81.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.067 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CD2' HD13 ' A' ' 104' ' ' LEU . 13.1 m-85 -84.13 -47.34 10.98 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.37 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 11.9 pt-20 -56.38 -29.95 62.11 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.572 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -55.62 -41.23 73.2 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 121.081 0.467 . . . . 0.0 110.349 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -83.93 -16.29 44.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' CD2' ' A' ' 91' ' ' PHE . . . -170.52 99.82 0.15 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.306 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -43.67 121.38 2.7 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.385 2.057 . . . . 0.0 112.116 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.723 ' HB ' HG13 ' A' ' 72' ' ' VAL . 0.7 OUTLIER -79.9 145.36 9.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.373 -178.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -106.61 -48.27 3.57 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.6 p -137.54 106.54 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.111 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.723 HG13 ' HB ' ' A' ' 69' ' ' ILE . 10.5 m -113.12 156.12 14.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.698 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 50.1 tttm -156.2 163.05 40.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.255 -1.339 . . . . 0.0 111.311 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.889 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.88 129.72 75.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.575 178.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.7 t -81.35 97.93 3.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.82 0.343 . . . . 0.0 111.136 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 20.3 m -72.23 167.08 21.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.35 130.94 35.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.786 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 78' ' ' ARG . 2.9 ptm85 -73.28 -9.71 58.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.385 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -51.03 14.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.751 0.31 . . . . 0.0 110.946 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -116.99 4.5 12.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.281 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 55.1 28.89 11.55 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.878 0.371 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -110.57 177.14 4.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.062 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -64.86 113.87 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.414 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 1.4 ttt180 -166.24 -158.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.205 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.93 -91.67 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.602 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.639 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.38 175.07 4.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.547 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.82 173.36 16.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.985 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.82 ' CZ ' ' HB2' ' A' ' 119' ' ' ALA . 0.1 OUTLIER -137.16 128.57 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.673 ' HA ' HG12 ' A' ' 72' ' ' VAL . 6.9 m -129.59 109.97 19.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.029 0.442 . . . . 0.0 111.842 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.33 114.08 26.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.447 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.852 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.9 m-30 -77.0 158.68 30.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.242 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.63 -25.3 6.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.7 m -160.01 154.7 24.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 111.567 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.56 -30.19 58.69 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.6 p -57.97 -27.41 63.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.919 0.39 . . . . 0.0 110.535 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 1.4 m -81.06 -30.46 34.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.429 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.704 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.67 -49.97 74.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -53.33 -35.86 60.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.467 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -74.87 -33.4 62.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.08 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.852 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.51 -56.07 7.44 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.953 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.899 HD11 HD11 ' A' ' 118' ' ' LEU . 2.3 mt -59.46 -26.37 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.046 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -43.18 58.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.957 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.41 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -112.8 14.7 24.25 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.645 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.736 HD23 ' HD2' ' A' ' 107' ' ' PHE . 33.1 mt -135.56 -38.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.253 0.527 . . . . 0.0 111.785 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 116' ' ' VAL . 38.6 t-20 -51.73 121.12 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.204 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 59.78 18.13 44.94 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.283 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.82 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -47.31 89.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.602 0.701 . . . . 0.0 110.047 179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.7 p30 -72.29 80.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.372 -178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 112' ' ' LYS . 18.7 tt -82.47 161.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -51.18 -38.48 52.48 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.795 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -79.75 -55.65 4.84 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.009 0.433 . . . . 0.0 111.82 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.28 -168.03 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.423 -178.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.94 114.87 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.675 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.4 mt -70.94 96.66 1.31 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.569 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -87.7 119.67 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.494 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -124.73 123.68 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 111.078 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.33 132.96 44.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.009 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 HD11 ' A' ' 101' ' ' ILE . 1.6 mm? -64.75 135.91 56.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.944 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.82 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . . . -70.07 66.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.39 125.67 25.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.9 m 60.52 178.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.928 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 176.97 -60.04 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -135.97 117.43 14.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.778 0.323 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -105.51 32.23 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.4 ' CD ' ' HD2' ' A' ' 126' ' ' PRO . 17.3 mmt85 -123.8 161.08 48.46 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.4 ' HD2' ' CD ' ' A' ' 125' ' ' ARG . 33.6 Cg_endo -64.51 -43.14 14.32 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.562 2.175 . . . . 0.0 112.296 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.71 -63.04 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.547 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 10.1 mt 69.04 -67.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 111.162 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.37 124.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.125 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 147.18 -111.15 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.591 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -110.85 173.98 6.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -154.75 153.0 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.061 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.35 -57.69 5.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.535 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.89 140.56 46.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.765 0.317 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.95 162.08 33.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.487 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -97.21 -32.34 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.776 0.322 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.72 72.11 0.86 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -64.73 -67.16 0.46 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.891 0.377 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.896 179.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.831 0.348 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 m -144.58 39.83 1.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.56 157.35 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 4' ' ' ILE . 17.9 tt -134.8 100.55 12.08 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' C ' HD23 ' A' ' 6' ' ' LEU . 77.8 Cg_exo -50.62 114.13 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.428 2.085 . . . . 0.0 112.411 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.457 HD23 ' C ' ' A' ' 5' ' ' PRO . 0.6 OUTLIER 43.9 -166.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.473 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 7' ' ' VAL . 11.1 p -162.87 126.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.061 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.0 m -105.44 -66.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.31 155.7 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -125.38 143.41 50.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -72.81 -60.65 1.86 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 11' ' ' ASP . 59.7 Cg_endo -72.53 -43.89 0.86 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.554 2.169 . . . . 0.0 112.315 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.94 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.975 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.44 141.34 2.26 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.528 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -101.6 -49.56 3.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -176.42 -40.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.77 -170.51 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.069 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -122.34 92.62 3.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.87 124.0 24.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -142.69 179.87 6.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -31.56 14.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.999 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.4 mt 60.07 178.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -134.04 173.35 11.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -76.41 166.08 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -111.77 106.13 14.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -165.82 34.73 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -150.1 122.72 8.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.938 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 63.86 130.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -60.26 165.57 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -133.67 89.3 31.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.66 156.71 6.13 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.578 2.186 . . . . 0.0 112.295 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 63.38 1.9 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.543 2.162 . . . . 0.0 112.252 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -127.73 164.77 21.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.63 -174.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.57 68.22 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -124.79 62.8 36.25 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.819 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.93 61.32 3.82 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.548 2.165 . . . . 0.0 112.318 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.3 mm-40 -101.92 141.67 23.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 73.9 Cg_endo -74.98 -22.01 15.3 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.513 2.142 . . . . 0.0 112.438 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.34 -26.5 52.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.195 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 38' ' ' GLU . 27.1 m -96.83 29.07 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.258 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' PRO . 63.6 mt -103.05 -33.82 9.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.771 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.831 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.7 OUTLIER -65.86 -10.73 40.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.714 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.97 106.01 6.27 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.812 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.6 mm? -110.76 119.88 40.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 112.078 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 tmm? -93.5 109.81 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.38 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.938 HG21 HD22 ' A' ' 59' ' ' LEU . 1.8 p -103.5 138.68 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.105 0.479 . . . . 0.0 111.409 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 86' ' ' TYR . 43.1 t30 -145.7 148.89 33.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.987 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.9 t80 -165.59 -65.43 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.87 178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.765 HD13 ' C ' ' A' ' 53' ' ' THR . 0.4 OUTLIER -105.2 170.04 6.4 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.898 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.55 ' CD ' HG22 ' A' ' 50' ' ' ILE . 46.6 Cg_endo -89.79 -84.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.866 2.377 . . . . 0.0 111.575 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.422 ' CA ' ' HG2' ' A' ' 84' ' ' ARG . 19.9 m -78.49 -13.46 59.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.7 0.286 . . . . 0.0 111.26 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.765 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -86.8 9.85 17.77 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 54' ' ' VAL . 9.8 p -69.57 110.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.782 0.325 . . . . 0.0 110.643 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.81 113.14 23.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.925 0.393 . . . . 0.0 111.481 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.783 ' N ' HD11 ' A' ' 74' ' ' ILE . 17.8 pt-20 -54.94 -23.7 20.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.861 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 57.9 t -69.27 -56.48 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.22 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -50.11 -41.06 47.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.209 0.528 . . . . 0.0 109.82 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.938 HD22 HG21 ' A' ' 47' ' ' VAL . 3.0 mt -78.57 -29.38 46.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.263 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -56.83 -54.35 47.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.323 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.572 ' O ' ' OE1' ' A' ' 64' ' ' GLU . 3.0 mt-30 -78.63 -39.01 38.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.322 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.891 HD21 HD11 ' A' ' 114' ' ' LEU . 9.4 tp -69.18 -39.46 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.184 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.666 ' HA ' HD11 ' A' ' 104' ' ' LEU . 4.8 m-85 -86.19 -50.03 7.29 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.632 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -60.13 -23.19 63.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.68 -178.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLU . 12.9 ptm180 -52.15 -37.58 54.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -91.7 -14.98 29.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.359 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.46 100.48 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 30.5 Cg_exo -43.63 130.84 7.36 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.546 2.164 . . . . 0.0 112.886 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.661 HD12 ' CG1' ' A' ' 72' ' ' VAL . 1.2 pt -80.9 145.92 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.74 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -98.96 -46.88 5.46 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 64.6 m -137.65 105.76 5.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.307 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.661 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -107.63 136.06 44.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.763 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 88' ' ' PHE . 8.7 tttp -156.27 157.52 35.93 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.156 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.783 HD11 ' N ' ' A' ' 56' ' ' GLU . 69.3 mt -107.04 142.49 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 0.0 111.026 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG23 ' HD2' ' A' ' 88' ' ' PHE . 38.0 t -92.07 103.75 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.507 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.79 174.52 8.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.017 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.26 122.41 28.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.717 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -74.82 -13.89 60.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.52 -50.97 32.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.819 0.342 . . . . 0.0 110.989 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.4 p -116.86 7.8 13.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.384 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 54.47 31.23 14.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.75 0.31 . . . . 0.0 111.111 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -99.9 144.94 28.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -64.73 84.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.801 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.422 ' HG2' ' CA ' ' A' ' 52' ' ' THR . 68.7 mtp180 -149.96 -165.52 2.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.11 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.83 -82.75 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.589 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 1.7 p90 -171.91 175.13 3.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.676 0.274 . . . . 0.0 110.755 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -114.21 -174.1 18.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.915 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.692 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 1.0 OUTLIER -147.08 147.02 30.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.446 -0.377 . . . . 0.0 110.534 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -144.34 109.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.887 179.086 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -93.54 112.74 24.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.726 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.943 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.2 m-30 -72.74 156.67 38.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.968 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -51.8 -52.16 51.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.87 144.33 49.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.887 0.375 . . . . 0.0 111.28 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.43 -25.12 26.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.18 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.3 p -65.04 -23.62 67.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.785 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 9.1 t -77.73 -28.87 50.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -56.82 -44.23 81.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -53.2 -40.79 64.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.75 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.68 -28.97 61.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.691 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.943 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.7 -56.3 6.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.127 0.489 . . . . 0.0 110.221 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.741 HD12 ' O ' ' A' ' 97' ' ' ALA . 1.8 mt -62.61 -26.4 40.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.05 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.3 -33.48 63.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.947 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -126.57 18.34 6.39 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.584 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.759 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 19.1 mt -135.23 -38.63 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.189 0.494 . . . . 0.0 111.781 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.433 ' HB2' HG23 ' A' ' 101' ' ' ILE . 63.5 t-20 -58.37 121.12 10.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 64.73 18.19 63.65 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.305 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 2.1 t80 -57.7 73.26 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.254 0.549 . . . . 0.0 109.855 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 106' ' ' GLY . 11.6 t-20 -67.29 80.63 0.14 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.108 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.738 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.5 tt -78.09 161.28 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -50.42 -21.92 1.66 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -177.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 6.9 m-20 -101.77 -44.14 5.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.738 ' H ' HG23 ' A' ' 109' ' ' ILE . 4.9 mptt -142.71 -172.25 3.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.391 0.615 . . . . 0.0 112.595 -178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 0.4 OUTLIER -126.41 114.42 18.17 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.805 178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.891 HD11 HD21 ' A' ' 62' ' ' LEU . 21.3 mt -83.75 89.42 7.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.888 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 21.6 tttp -83.6 118.61 23.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.812 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -129.73 127.83 64.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.931 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.63 42.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.831 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 101' ' ' ILE . 2.3 mm? -58.73 153.13 17.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.743 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -94.34 28.69 2.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.335 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.51 136.72 56.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.172 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.24 161.19 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.9 -139.12 6.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.569 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -118.3 -43.69 2.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.8 0.333 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.15 -170.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -128.94 140.56 38.96 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.45 -43.76 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.447 2.098 . . . . 0.0 112.332 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.24 -67.61 0.36 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.421 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 128' ' ' ILE . 22.1 mm 59.29 37.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -163.5 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.9 -171.88 18.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.442 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -119.7 89.68 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.27 132.91 25.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -105.29 -45.72 1.31 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.544 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 64.3 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 120.49 -126.25 6.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -80.45 159.92 25.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -175.08 76.89 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -65.71 -32.89 74.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.896 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.821 0.343 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.13 143.77 33.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 60.31 102.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.62 HG23 ' O ' ' A' ' 4' ' ' ILE . 6.7 tp -157.65 70.84 4.27 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.12 -57.3 2.09 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.619 2.213 . . . . 0.0 112.279 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 mt -71.19 143.54 50.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 7' ' ' VAL . 7.1 p -154.85 82.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.104 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 67.78 -70.09 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.921 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.01 -74.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.996 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -153.32 -178.38 6.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -110.55 96.11 26.09 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.61 -25.03 13.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.629 2.22 . . . . 0.0 112.438 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -55.91 -45.76 78.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -98.57 36.0 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.434 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 95.36 6.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.5 p -98.81 110.31 22.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.59 171.52 7.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.006 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.49 156.2 18.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.93 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 65.91 38.07 5.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.39 -179.2 4.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.6 mt -72.83 -55.03 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 59.7 31.66 20.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -107.25 169.28 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.871 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -143.4 114.7 7.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.24 42.87 1.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.41 98.94 9.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 60.16 159.4 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -87.72 117.43 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.0 mt -144.42 76.95 14.3 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.045 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.37 170.17 19.9 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.599 2.2 . . . . 0.0 112.323 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.38 42.54 0.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.865 2.376 . . . . 0.0 112.699 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -121.56 70.36 0.94 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 110.791 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.75 -39.05 4.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.817 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.9 mmt -85.28 -30.68 23.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 31.9 m-20 60.39 53.22 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.021 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 36' ' ' ASN . 74.3 Cg_endo -74.89 60.65 5.41 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.573 2.182 . . . . 0.0 112.327 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.762 ' O ' HG22 ' A' ' 41' ' ' VAL . 10.8 mm-40 -100.58 122.75 48.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.93 -19.53 23.24 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.458 2.105 . . . . 0.0 112.442 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.98 -26.48 36.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 38' ' ' GLU . 31.7 m -70.78 64.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.24 -32.17 8.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.52 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -67.88 -10.21 51.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.605 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -74.89 105.94 6.17 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.782 HD22 ' CG1' ' A' ' 116' ' ' VAL . 38.5 mt -113.47 119.14 36.56 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.427 ' HG3' ' CE1' ' A' ' 88' ' ' PHE . 24.1 ttp -91.07 109.49 20.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.939 HG11 ' CE2' ' A' ' 63' ' ' PHE . 9.3 m -105.15 135.46 43.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.599 0.714 . . . . 0.0 112.912 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 53.9 t-20 -132.82 134.01 44.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.137 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.77 ' CD2' HD22 ' A' ' 114' ' ' LEU . 4.7 t80 -165.96 -61.37 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.215 0.531 . . . . 0.0 110.768 -179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.874 HG22 ' HD2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -103.61 150.16 37.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.143 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.874 ' HD2' HG22 ' A' ' 50' ' ' ILE . 37.4 Cg_endo -91.9 -82.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.87 2.38 . . . . 0.0 111.421 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' CG ' ' A' ' 84' ' ' ARG . 1.6 m -78.68 -28.17 45.25 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.903 0.382 . . . . 0.0 110.996 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.745 ' HB ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -91.06 14.98 12.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.709 -179.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.7 p -68.59 105.0 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.0 110.331 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -115.26 133.36 56.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.928 ' N ' HD11 ' A' ' 74' ' ' ILE . 4.5 pt-20 -64.11 -23.35 67.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.534 178.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 36.4 t -72.8 -56.59 9.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.441 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -52.11 -39.33 59.68 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.312 0.577 . . . . 0.0 109.535 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.603 HD22 ' CZ ' ' A' ' 63' ' ' PHE . 6.8 mt -78.22 -26.34 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.241 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.985 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -61.44 -54.98 36.35 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.025 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.8 mt-30 -65.53 -45.55 83.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.521 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.7 tp -64.16 -42.87 96.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.925 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.939 ' CE2' HG11 ' A' ' 47' ' ' VAL . 21.2 m-30 -83.99 -49.66 8.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.6 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 60' ' ' ARG . 9.3 pt-20 -55.38 -25.36 34.9 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.822 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 3.6 tmt_? -59.14 -46.49 88.21 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.87 0.367 . . . . 0.0 110.574 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -82.89 -10.57 58.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.436 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.4 102.18 0.15 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.82 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -44.11 118.46 1.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.467 2.111 . . . . 0.0 112.27 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.985 HD11 ' HG2' ' A' ' 60' ' ' ARG . 2.9 pt -80.66 146.03 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.73 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -93.42 -51.37 5.0 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.2 m -139.95 105.55 5.11 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.006 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.687 ' HB ' HD12 ' A' ' 69' ' ' ILE . 7.1 p -106.59 149.9 9.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.688 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 88' ' ' PHE . 30.4 tttt -155.79 166.58 33.08 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.568 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.928 HD11 ' N ' ' A' ' 56' ' ' GLU . 61.0 mt -117.62 142.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.765 0.317 . . . . 0.0 110.922 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 88' ' ' PHE . 47.4 t -99.34 116.75 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.813 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 27.3 p -81.18 -175.18 5.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.004 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.38 120.83 41.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -10.17 59.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.365 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.37 -51.0 14.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.5 p -111.91 -0.62 15.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.439 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.67 31.69 20.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.854 0.359 . . . . 0.0 110.95 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -103.73 138.26 40.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 73.6 m -65.01 75.91 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.148 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' CG ' ' HA ' ' A' ' 52' ' ' THR . 1.8 mtp180 -146.19 -171.89 3.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.86 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.43 -77.1 0.43 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.718 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -172.02 175.78 3.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.883 ' O ' HG22 ' A' ' 47' ' ' VAL . . . -126.82 150.41 17.9 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.717 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.2 m-85 -106.24 127.87 53.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.922 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -123.73 117.63 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.001 0.429 . . . . 0.0 111.554 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.35 111.98 23.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.62 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 1.003 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 4.5 m-30 -73.06 157.69 36.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -24.66 5.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.6 m -160.04 148.17 16.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.879 0.371 . . . . 0.0 111.374 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.19 -33.26 45.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.878 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -21.63 66.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.405 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 62.6 m -78.54 -29.13 46.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.88 -34.03 69.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.67 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -59.79 -38.93 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.459 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.55 -31.47 63.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.318 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.003 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.36 -55.43 9.13 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.31 0.576 . . . . 0.0 110.257 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.66 HD11 ' CD2' ' A' ' 45' ' ' LEU . 42.2 mm -61.05 -26.12 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.856 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.22 -45.76 46.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.558 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.402 ' O ' ' CE1' ' A' ' 107' ' ' PHE . . . -124.2 20.39 7.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.113 -1.042 . . . . 0.0 114.28 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.643 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 7.0 mt -136.0 -33.92 0.82 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.246 0.523 . . . . 0.0 111.692 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.499 ' HA ' HG23 ' A' ' 116' ' ' VAL . 26.5 t30 -65.69 121.43 14.97 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 71.58 12.48 73.75 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.538 -179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 0.4 OUTLIER -51.02 88.36 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.248 0.524 . . . . 0.0 109.716 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 10.5 p-10 -67.49 81.61 0.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.482 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 112' ' ' LYS . 13.9 tt -78.54 161.93 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.64 -39.97 52.0 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -79.82 -54.87 5.42 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.589 ' O ' HG22 ' A' ' 109' ' ' ILE . 3.9 mmtt -143.37 -167.44 2.56 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.512 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -122.82 118.02 26.99 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 49' ' ' TYR . 4.1 mm? -68.86 85.16 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.509 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 5.6 ttmt -80.8 119.59 23.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.782 ' CG1' HD22 ' A' ' 45' ' ' LEU . 2.2 t -126.34 123.57 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.62 134.64 45.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.684 HD13 HD23 ' A' ' 45' ' ' LEU . 2.4 mm? -66.36 114.52 5.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.595 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.68 -77.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.415 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.636 ' HB1' HG21 ' A' ' 41' ' ' VAL . . . -58.97 106.24 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.2 p -174.5 36.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 153.24 -58.14 0.41 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.442 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 6.2 t60 60.18 101.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.846 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -135.44 -172.03 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.972 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 53.5 mtt-85 -143.98 107.87 4.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.66 -47.13 2.16 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.397 2.065 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.12 -70.97 0.49 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.558 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.5 mm 69.33 -66.95 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 -53.14 39.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.26 128.82 6.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.579 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.73 125.58 25.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.788 0.327 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 133' ' ' GLY . 22.9 m -122.18 -42.62 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 132' ' ' VAL . . . 59.74 87.28 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.438 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 62.67 146.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.32 -164.41 10.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -172.72 -41.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.6 -28.47 57.27 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -59.5 134.6 57.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.905 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptm . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.694 0.283 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -118.92 103.74 9.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.817 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -170.09 109.23 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 mt 63.29 95.55 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.29 97.81 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.464 2.11 . . . . 0.0 112.327 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 mt -103.69 73.66 1.19 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.94 138.08 46.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.146 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.0 p -157.81 160.73 38.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -98.56 30.58 3.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.69 79.6 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.813 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.85 117.22 50.82 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.823 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.54 155.71 62.82 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.338 2.025 . . . . 0.0 112.368 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 6.6 p90 -170.41 90.31 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.88 -126.46 8.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.492 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 60.25 100.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.807 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -130.22 -46.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.0 177.62 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -96.63 145.59 25.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.01 152.54 22.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.87 141.57 28.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.858 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -98.82 85.19 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.0 mt -106.35 -53.51 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.893 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 59.92 30.24 19.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -69.88 94.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -98.73 76.36 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -96.47 20.44 10.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -117.42 -31.55 5.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.043 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 27' ' ' GLN . 24.7 pt20 46.52 -172.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -127.8 37.77 4.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.026 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD13 ' OE1' ' A' ' 28' ' ' GLN . 3.7 mp -134.85 71.01 70.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.096 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.97 158.63 54.87 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.147 . . . . 0.0 112.255 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.72 73.13 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.623 2.216 . . . . 0.0 112.318 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 34' ' ' GLN . 1.3 t 178.82 -52.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' H ' HG23 ' A' ' 33' ' ' THR . 29.7 mt-30 -90.75 81.5 5.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.903 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.0 ttp -68.8 92.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.5 127.83 85.21 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.98 81.78 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.427 2.085 . . . . 0.0 112.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.8 mm-40 -74.0 144.88 82.91 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.26 -6.86 17.62 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.489 2.126 . . . . 0.0 112.715 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -70.11 -29.37 66.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.19 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 38' ' ' GLU . 34.5 m -76.14 61.51 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.923 0.392 . . . . 0.0 111.388 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mt -89.67 -36.62 15.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.997 0.427 . . . . 0.0 110.428 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.92 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.3 -13.09 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.859 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 2.0 t30 -74.52 105.96 5.88 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 118' ' ' LEU . 30.4 mt -119.93 118.38 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 5.1 ttp -91.26 113.67 25.99 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.706 HG12 HG13 ' A' ' 116' ' ' VAL . 3.2 m -102.57 132.47 48.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 4.6 t-20 -134.99 134.73 40.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.639 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.751 ' CD2' HD13 ' A' ' 114' ' ' LEU . 5.4 t80 -158.61 -57.91 0.07 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.303 0.573 . . . . 0.0 110.57 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -104.48 164.34 15.43 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.113 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.11 -101.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.531 2.154 . . . . 0.0 111.663 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 t -78.59 -6.04 54.49 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.722 0.296 . . . . 0.0 111.176 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -93.67 14.59 18.59 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 74' ' ' ILE . 3.8 m -68.71 108.44 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.942 0.401 . . . . 0.0 110.761 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -115.04 127.07 55.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.787 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.671 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 10.3 pt-20 -57.68 -23.89 53.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.388 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 39.0 t -71.53 -56.26 10.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.137 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -44.88 39.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.13 0.49 . . . . 0.0 110.012 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 47' ' ' VAL . 1.7 pp -78.14 -26.98 48.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.531 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.943 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -57.2 -55.33 36.17 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.433 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 8.6 mt-30 -74.01 -43.1 59.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.33 -44.44 94.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.039 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.702 ' CD2' HD13 ' A' ' 104' ' ' LEU . 17.0 m-85 -84.49 -50.12 8.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.521 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.504 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.1 pt-20 -53.93 -25.13 18.89 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.576 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -55.34 -51.66 66.02 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.87 0.367 . . . . 0.0 110.854 179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -82.43 -8.16 59.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.401 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -176.35 98.21 0.12 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.824 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.18 123.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.528 2.152 . . . . 0.0 112.347 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.943 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.6 pt -80.76 145.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.14 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -102.94 -48.58 4.02 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.5 p -130.86 105.73 7.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.414 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.667 ' CG1' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -110.65 145.82 16.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.733 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 49.9 tttt -152.8 161.41 42.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.096 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.831 HD11 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -121.85 125.66 73.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.633 0.254 . . . . 0.0 110.99 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 86' ' ' TYR . 14.0 t -74.34 94.84 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.857 0.36 . . . . 0.0 110.691 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 14.9 p -90.25 158.12 17.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.134 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.1 120.83 13.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -9.81 58.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.8 -51.1 14.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.791 0.329 . . . . 0.0 111.001 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.5 p -115.54 3.9 14.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.421 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 55.89 31.64 18.17 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.834 0.35 . . . . 0.0 110.943 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 2.5 mt-30 -106.02 161.0 14.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.6 m -64.53 120.23 11.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.622 ' O ' HG21 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -169.31 -161.4 0.3 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.109 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.41 -91.87 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.683 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.29 175.28 4.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.389 -179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -109.63 -173.74 20.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.145 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 73' ' ' LYS . 27.0 t80 -147.07 143.44 28.34 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.692 0.397 . . . . 0.0 110.255 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG13 HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -144.57 113.68 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.815 0.341 . . . . 0.0 111.218 179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -98.84 111.07 23.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.918 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-30 -71.94 153.47 41.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -52.05 -53.59 40.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.966 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.0 m -120.54 141.49 50.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.841 0.353 . . . . 0.0 111.132 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.3 -26.02 20.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.064 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.0 t -64.54 -23.81 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 0.0 110.671 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.54 -30.32 41.71 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.497 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.92 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -60.47 -41.02 93.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -55.25 -44.95 76.0 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.57 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.32 -27.07 62.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.464 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.918 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.5 -56.1 7.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 0.0 110.173 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.77 HD11 HD11 ' A' ' 118' ' ' LEU . 3.9 mt -61.14 -26.31 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.925 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.34 -41.71 60.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.926 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -112.45 13.49 25.53 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.668 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.718 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 17.9 mt -135.53 -37.55 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.315 0.557 . . . . 0.0 112.018 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.536 ' HB2' HG23 ' A' ' 101' ' ' ILE . 42.9 t30 -56.66 121.23 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.983 0.42 . . . . 0.0 110.005 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 63.04 16.77 57.98 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.0 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 1.4 t80 -50.28 88.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 117.414 0.607 . . . . 0.0 109.979 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.8 p30 -69.79 90.65 0.6 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.249 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 ' H ' ' A' ' 112' ' ' LYS . 17.8 tt -88.77 161.25 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.31 -29.21 14.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -91.79 -53.13 4.41 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.809 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.669 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -143.23 -167.9 2.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.389 -179.007 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.69 115.27 19.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.799 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.751 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.3 mm? -67.87 92.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.402 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 ttmm -83.98 119.99 25.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.896 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 47' ' ' VAL . 1.3 t -128.56 123.72 60.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.48 133.61 32.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.55 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -62.47 119.6 9.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.537 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' A' ' 44' ' ' ASN . . . -49.59 -29.44 7.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.494 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . . . -108.04 -63.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.126 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.36 -65.73 0.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.34 -28.07 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.631 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 64.21 116.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -93.0 -31.41 14.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -65.87 154.93 88.07 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 -38.02 7.58 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.512 2.141 . . . . 0.0 112.341 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.95 78.9 1.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mt 63.96 119.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -159.06 -45.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.095 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 161.62 123.73 0.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.601 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.47 -18.43 61.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.383 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.596 ' O ' HG12 ' A' ' 132' ' ' VAL . 15.3 t 67.11 26.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.165 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 93.17 -40.52 2.8 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.634 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 t0 62.02 63.33 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 110.736 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.55 -22.68 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.511 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.7 t30 64.32 79.54 0.25 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.826 0.346 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -164.73 -100.77 0.15 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.529 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -127.63 -50.2 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.851 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 mtp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.868 0.366 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -103.15 45.81 0.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -81.21 73.7 8.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 4.1 mt -76.77 -48.26 2.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.715 ' HB2' HG23 ' A' ' 7' ' ' VAL . 91.3 Cg_endo -78.83 -24.89 6.75 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.265 1.977 . . . . 0.0 112.442 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.43 34.53 12.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 5' ' ' PRO . 29.7 t -99.37 133.23 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -96.05 119.1 33.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.84 104.08 3.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.05 -62.75 0.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -59.0 109.77 2.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.32 140.79 41.36 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.404 2.069 . . . . 0.0 112.285 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -101.19 129.11 47.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.5 -51.36 0.63 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.538 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.98 40.41 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -30.09 70.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.993 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.38 132.46 53.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 60.17 165.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.848 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.7 tp -173.45 -57.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.665 ' O ' HD12 ' A' ' 22' ' ' LEU . 1.4 tm0? -177.07 -39.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.46 127.98 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 20' ' ' GLN . 4.8 mp -129.51 92.0 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 60.22 175.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -176.49 120.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.762 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -154.13 95.63 1.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -117.39 30.61 7.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -136.6 -45.7 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 65.02 98.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 30' ' ' ILE . 3.3 mp -119.25 75.54 15.94 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.93 177.65 1.32 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.541 2.16 . . . . 0.0 112.139 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -51.76 -22.05 12.73 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.524 2.149 . . . . 0.0 112.466 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 36' ' ' ASN . 0.2 OUTLIER 62.88 83.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 110.747 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -89.97 99.9 12.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.049 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 mtp 47.67 29.15 1.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.741 ' HB2' HG22 ' A' ' 33' ' ' THR . 1.1 m120 -59.71 -61.03 8.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 36' ' ' ASN . 73.7 Cg_endo -85.22 46.74 1.87 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.776 2.318 . . . . 0.0 112.512 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 41' ' ' VAL . 11.7 mm-40 -94.48 123.19 59.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.932 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.17 -12.51 25.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.08 . . . . 0.0 112.517 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -55.26 -32.01 62.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.824 0.345 . . . . 0.0 111.095 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.889 HG23 ' HB2' ' A' ' 120' ' ' ALA . 10.6 m -75.95 62.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.43 -31.34 29.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -71.85 -0.36 11.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.042 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.76 106.02 12.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.82 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.4 mm? -111.3 124.78 52.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.035 0.445 . . . . 0.0 111.922 -179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 9.2 ttt -99.81 113.41 25.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.056 HG21 HD13 ' A' ' 59' ' ' LEU . 10.4 m -102.36 136.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.245 0.545 . . . . 0.0 111.711 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.54 142.27 25.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.202 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.653 ' CE2' ' HB3' ' A' ' 112' ' ' LYS . 31.8 t80 -165.36 -63.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.199 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.791 HG22 ' CD ' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -104.46 168.67 8.18 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.142 179.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.791 ' CD ' HG22 ' A' ' 50' ' ' ILE . 69.4 Cg_endo -88.56 -92.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.442 2.095 . . . . 0.0 112.089 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 83' ' ' SER . 0.2 OUTLIER -78.61 -5.74 53.71 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.593 ' O ' HD12 ' A' ' 50' ' ' ILE . 33.9 m -99.09 9.42 43.53 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 50' ' ' ILE . 3.1 m -69.76 124.6 26.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.358 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.87 116.55 28.74 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.0 0.429 . . . . 0.0 112.115 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.795 ' H ' HD11 ' A' ' 74' ' ' ILE . 10.1 pt-20 -56.3 -23.71 38.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 61.5 t -71.95 -56.31 10.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.32 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -47.91 -43.71 29.1 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.166 0.508 . . . . 0.0 110.008 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.056 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.45 -27.45 46.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.262 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.922 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -57.76 -55.19 38.05 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.441 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 12.2 mt-30 -70.19 -45.64 66.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.031 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 114' ' ' LEU . 2.0 tp -64.89 -40.31 94.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.879 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.751 ' HA ' HD11 ' A' ' 104' ' ' LEU . 5.2 m-85 -84.39 -50.24 7.97 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.445 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 7.3 pt-20 -58.52 -21.3 51.73 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.057 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -59.7 -52.32 66.0 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.965 0.412 . . . . 0.0 110.623 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -84.64 -6.6 59.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.359 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.35 95.92 0.1 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.443 -0.885 . . . . 0.0 112.083 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -44.33 119.92 2.36 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.539 2.159 . . . . 0.0 112.216 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.945 HG21 ' CG2' ' A' ' 89' ' ' VAL . 2.1 pt -80.56 145.95 8.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.403 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.93 -45.29 8.03 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.3 t -147.91 105.86 3.72 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.974 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.677 ' HB ' HG23 ' A' ' 89' ' ' VAL . 6.7 p -105.87 138.45 31.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.513 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -156.47 142.82 18.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.558 -179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.797 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 32.8 mt -87.49 145.91 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.974 0.416 . . . . 0.0 111.393 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 21.4 t -94.53 107.42 19.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.377 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.2 p -93.55 172.76 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.155 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.25 119.29 21.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.8 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.18 -9.87 58.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.42 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -72.7 -51.04 20.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.826 0.346 . . . . 0.0 111.068 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 82' ' ' GLN . 10.1 t -117.02 7.5 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.436 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 52.74 35.16 17.82 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 76' ' ' CYS . 17.0 mm100 -102.63 140.82 36.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.708 ' O ' HG23 ' A' ' 52' ' ' THR . 1.4 p -64.19 113.03 3.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.953 0.406 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.7 ttm-85 -170.04 -161.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.02 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.6 -85.37 0.35 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.12 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' CE1' ' CE ' ' A' ' 46' ' ' MET . 0.1 OUTLIER -171.88 175.73 3.8 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.797 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -113.95 161.39 12.73 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.426 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -120.64 145.01 47.85 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.945 ' CG2' HG21 ' A' ' 69' ' ' ILE . 9.2 p -144.56 109.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 ttpt -90.18 112.45 23.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.988 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 5.1 m-30 -72.49 156.35 39.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.52 -54.98 21.64 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.08 147.96 50.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.845 0.355 . . . . 0.0 111.216 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.49 -30.16 33.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.06 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -63.93 -20.27 65.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.569 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.3 -29.48 38.16 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -57.66 -37.02 72.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.762 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.4 mm-40 -56.68 -36.28 69.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.313 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -76.09 -30.84 58.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.323 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.988 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.33 -55.45 9.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 110.024 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.741 HG12 HD21 ' A' ' 118' ' ' LEU . 3.4 mt -62.91 -26.14 40.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.75 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.12 -34.42 63.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.509 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -144.42 30.89 1.84 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.648 -1.263 . . . . 0.0 114.395 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 63' ' ' PHE . 5.1 mt -135.78 -37.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.355 0.577 . . . . 0.0 111.517 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.3 p-10 -64.33 121.14 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 69.73 16.17 71.88 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.129 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -54.1 82.51 0.0 OUTLIER 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.082 0.468 . . . . 0.0 110.088 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 106' ' ' GLY . 14.7 p-10 -67.5 86.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.412 -178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.832 HG23 ' H ' ' A' ' 112' ' ' LYS . 6.0 tt -77.93 161.74 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.475 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -49.59 -24.33 2.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -120.28 -22.11 6.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.832 ' H ' HG23 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -142.38 175.18 9.97 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.139 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 114.33 17.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.729 177.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 62' ' ' LEU . 1.1 mt -88.24 90.0 8.22 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.196 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HA ' ' H ' ' A' ' 106' ' ' GLY . 5.7 tttt -80.94 119.53 23.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.144 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.82 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.5 t -126.87 123.76 63.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.956 0.408 . . . . 0.0 111.633 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -127.47 138.41 52.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.058 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.741 HD21 HG12 ' A' ' 101' ' ' ILE . 2.4 mm? -70.04 118.43 12.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB2' ' CE2' ' A' ' 88' ' ' PHE . . . -59.22 -25.65 64.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.251 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.889 ' HB2' HG23 ' A' ' 41' ' ' VAL . . . -55.13 145.83 20.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.243 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.3 m -67.72 -169.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 106.82 29.46 4.64 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -75.87 -41.83 51.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.24 -47.58 0.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -96.37 109.2 46.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -51.87 -47.98 23.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.425 2.083 . . . . 0.0 112.305 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 134.42 43.34 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 128' ' ' ILE . 19.5 mt 59.24 30.58 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.921 0.391 . . . . 0.0 111.157 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 59.16 -169.49 0.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 164.91 -145.49 10.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.506 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 60.69 106.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.799 0.333 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.2 m -127.4 144.74 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -169.42 -43.97 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.492 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -65.4 79.34 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 128.92 171.14 12.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.02 109.52 16.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.597 ' O ' HD12 ' A' ' 139' ' ' LEU . . . -99.87 156.15 19.69 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 65.28 -73.78 0.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 111.081 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.848 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.792 0.33 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.89 124.39 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.51 -79.46 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 1.7 mt -84.43 -47.22 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.571 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 85.2 Cg_endo -82.28 165.38 16.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.33 2.02 . . . . 0.0 112.481 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mt -133.21 -46.14 0.84 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 t 64.98 128.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.0 p -75.18 130.11 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -150.2 166.58 29.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.64 -48.79 4.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -57.33 108.75 1.35 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.974 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.76 128.79 30.47 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.461 2.108 . . . . 0.0 112.227 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -132.95 159.44 39.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.67 96.98 0.17 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -73.57 -59.6 2.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.874 0.369 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.47 114.51 27.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.29 145.87 29.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.29 101.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.06 -65.53 0.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.22 127.53 32.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -98.27 -46.92 5.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 mp 59.84 75.77 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.86 -63.61 1.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -76.46 178.97 6.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -104.69 -34.93 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -145.46 151.64 38.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -91.21 -31.05 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.853 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -135.89 119.31 16.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.449 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -160.1 164.57 32.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.705 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 14.9 mm -95.71 -46.07 0.26 Allowed Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 61.6 Cg_exo -50.37 -45.74 32.63 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.287 1.991 . . . . 0.0 113.031 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 13.1 Cg_exo -69.93 -30.83 20.86 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.447 2.098 . . . . 0.0 112.289 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m 62.24 35.13 15.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -89.08 107.19 18.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.4 ptp -163.16 79.81 0.46 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -54.93 108.45 1.16 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.37 52.23 3.53 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.653 2.235 . . . . 0.0 112.502 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -88.65 149.0 43.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.94 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.705 ' HA ' HD12 ' A' ' 42' ' ' LEU . 53.2 Cg_exo -52.66 -39.05 77.13 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.69 2.26 . . . . 0.0 112.453 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -58.99 -34.41 71.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.979 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 121' ' ' SER . 14.3 m -106.59 27.91 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.249 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 39' ' ' PRO . 11.2 mt -98.1 -48.77 4.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.88 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -52.72 -26.16 13.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.578 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -80.34 105.91 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 0.0 110.272 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 118' ' ' LEU . 4.1 mm? -107.67 122.26 46.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.683 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 117' ' ' ALA . 58.4 ttp -91.23 113.42 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.668 HG21 HD22 ' A' ' 59' ' ' LEU . 20.2 m -102.91 135.56 39.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.427 0.632 . . . . 0.0 111.899 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -147.48 134.75 20.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.961 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -156.88 -63.83 0.1 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.783 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.862 ' O ' HG13 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.21 145.93 31.61 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.505 179.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.771 ' HD2' HG22 ' A' ' 50' ' ' ILE . 33.7 Cg_endo -63.74 -89.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 121.973 1.782 . . . . 0.0 111.747 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 52' ' ' THR . 31.2 m -78.84 -5.85 54.54 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -94.33 14.21 21.15 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 50' ' ' ILE . 1.4 m -69.71 107.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.831 0.348 . . . . 0.0 110.563 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.728 ' O ' HD12 ' A' ' 59' ' ' LEU . 95.4 m-20 -114.93 120.63 40.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.952 0.406 . . . . 0.0 111.67 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 7.0 pt-20 -55.69 -24.01 31.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.271 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 42.5 t -71.36 -56.35 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.388 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -48.91 -45.65 41.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.109 0.48 . . . . 0.0 109.892 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -78.47 -26.82 46.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.54 179.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.867 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.85 -55.12 36.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.388 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.2 mt-30 -76.32 -42.5 44.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD21 HD11 ' A' ' 114' ' ' LEU . 15.1 tp -63.49 -44.1 95.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.989 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.744 ' CD2' HD13 ' A' ' 104' ' ' LEU . 19.1 m-85 -84.26 -50.07 8.2 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.467 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.7 pt-20 -53.98 -25.07 18.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.574 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -57.31 -52.21 66.25 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.981 0.42 . . . . 0.0 110.594 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -80.54 -9.49 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.334 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.57 98.56 0.12 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.68 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -44.21 124.46 5.0 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.478 2.119 . . . . 0.0 112.204 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.867 HD11 ' HG2' ' A' ' 60' ' ' ARG . 1.7 pt -80.52 145.25 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.755 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -99.45 -47.12 5.25 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.2 t -140.34 105.82 5.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.184 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -107.95 144.01 17.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.451 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 9.2 tttp -149.29 158.19 43.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.659 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.628 ' HA ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.28 126.46 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.345 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.488 HG21 ' CE1' ' A' ' 88' ' ' PHE . 42.7 t -79.89 98.03 3.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.965 0.412 . . . . 0.0 110.817 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 84' ' ' ARG . 8.9 m -86.04 165.58 16.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.041 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.06 120.5 14.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.773 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.26 -15.36 60.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -70.46 -51.03 32.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.162 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.454 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.8 t -116.84 7.37 13.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.495 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 57.18 31.76 20.57 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.454 ' HG2' HG23 ' A' ' 80' ' ' THR . 10.3 mm100 -101.39 146.02 28.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.6 t -64.52 94.6 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 0.0 110.818 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.424 ' H ' ' HA ' ' A' ' 76' ' ' CYS . 10.1 mtt-85 -141.53 -158.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.246 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.45 -94.39 0.13 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.907 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.86 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -171.47 175.61 4.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.911 -179.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -116.49 178.61 17.41 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.479 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CE1' HG21 ' A' ' 75' ' ' VAL . 25.7 m-85 -144.95 128.97 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.66 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -124.58 109.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.871 0.367 . . . . 0.0 111.058 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -87.73 116.43 25.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.746 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.935 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 6.8 m-30 -79.14 159.47 27.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.177 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -51.68 -55.11 21.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -124.96 150.01 47.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 111.269 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.68 -30.07 50.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.039 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.97 -23.95 65.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.7 t -76.09 -30.6 58.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.449 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.625 ' O ' HD12 ' A' ' 101' ' ' ILE . . . -57.95 -38.67 76.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.792 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -40.79 84.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.408 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -73.96 -32.95 63.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.309 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.935 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.45 -56.14 7.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.108 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.725 HD11 HD11 ' A' ' 118' ' ' LEU . 4.3 mt -59.52 -26.38 34.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.015 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.4 -45.16 48.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.071 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.409 ' O ' ' CD1' ' A' ' 107' ' ' PHE . . . -113.71 17.44 20.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.852 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.744 HD13 ' CD2' ' A' ' 63' ' ' PHE . 36.9 mt -135.59 -39.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.302 0.551 . . . . 0.0 111.875 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.629 HD22 HG23 ' A' ' 101' ' ' ILE . 45.8 t-20 -60.47 121.21 11.54 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 62.48 21.86 62.95 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.132 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 3.3 t80 -57.63 72.62 0.01 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.21 0.529 . . . . 0.0 109.953 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 106' ' ' GLY . 8.6 t30 -67.44 83.45 0.16 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.492 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 112' ' ' LYS . 20.2 tt -78.31 161.82 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 110' ' ' LEU . 1.3 tt -50.03 -20.78 1.03 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -177.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.98 -43.55 5.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.644 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.88 -175.03 4.34 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 108' ' ' ASN . 4.5 ttp-105 -126.49 114.66 18.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.996 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.726 HD11 HD21 ' A' ' 62' ' ' LEU . 26.5 mt -79.71 101.51 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.628 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -88.6 119.74 29.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 45' ' ' LEU . 1.6 t -129.07 123.86 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.053 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 46' ' ' MET . . . -132.64 134.48 44.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.725 HD11 HD11 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -63.58 123.91 20.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.361 . . . . 0.0 110.49 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -81.99 -74.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.604 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 173.27 -169.57 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.858 0.361 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.738 ' N ' HG12 ' A' ' 41' ' ' VAL . 83.3 p -135.43 171.83 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.27 68.98 1.43 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.536 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -125.58 110.88 14.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.786 0.327 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -59.17 165.62 2.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.426 ' N ' ' HD2' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -177.7 -61.63 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 125' ' ' ARG . 36.5 Cg_endo -65.39 -26.83 55.34 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.359 2.039 . . . . 0.0 112.181 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.14 86.75 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.55 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.4 tt -78.71 132.16 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.352 . . . . 0.0 110.991 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.4 -175.86 5.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.093 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 129.8 91.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.93 -171.55 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.051 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.4 m -88.23 160.16 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.143 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -144.79 153.21 25.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 60.52 36.71 19.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.48 139.73 7.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.494 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -72.48 125.52 27.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.61 -115.0 4.95 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.452 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -149.26 -66.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.805 0.336 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.905 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -171.96 -64.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.46 110.47 6.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.1 tt -134.48 122.73 15.98 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.083 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.35 148.34 73.64 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.407 2.071 . . . . 0.0 112.287 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -140.26 -63.83 0.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.24 137.83 46.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.01 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t 61.09 -173.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.25 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.967 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.69 -172.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -111.92 99.88 46.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.15 172.31 11.21 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.421 2.081 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.3 t80 61.16 93.35 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.01 116.79 7.51 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.467 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -109.14 95.93 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 0.0 110.869 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -137.14 -169.66 2.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 16' ' ' THR . . . -124.03 -44.12 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.99 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.63 -66.35 0.87 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.832 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.43 160.45 14.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.23 31.61 1.54 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.478 ' HB3' HD22 ' A' ' 22' ' ' LEU . 2.4 mt-30 64.76 -78.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.5 mm? -68.36 85.2 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -107.69 -29.27 9.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.96 102.96 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.909 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -96.43 -74.6 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -89.11 84.74 6.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -104.9 -61.63 1.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -135.11 -73.99 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.644 ' C ' HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -79.54 -171.44 2.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.644 HD12 ' C ' ' A' ' 29' ' ' HIS . 3.7 mp 65.42 91.69 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.3 171.64 11.29 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.495 2.13 . . . . 0.0 112.212 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.42 67.54 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.575 2.184 . . . . 0.0 112.321 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.84 -35.68 5.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 60.66 81.39 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.3 mtm -110.62 -30.17 7.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.001 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 62.22 67.31 1.24 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -73.19 73.5 3.21 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.643 2.228 . . . . 0.0 112.427 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 41' ' ' VAL . 31.4 mm-40 -101.97 105.77 43.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.478 ' HB3' HD12 ' A' ' 42' ' ' LEU . 21.4 Cg_exo -65.35 -13.15 38.31 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.631 2.22 . . . . 0.0 112.622 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' OD1' HG13 ' A' ' 41' ' ' VAL . 44.3 p-10 -56.54 -27.61 58.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.354 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 40' ' ' ASP . 30.1 m -97.58 31.48 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.432 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 39' ' ' PRO . 16.4 mt -93.18 -29.34 15.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.848 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.87 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -63.4 -9.57 12.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.025 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' ND2' ' CD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -76.32 105.62 7.48 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.788 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.0 mm? -107.08 119.31 39.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 111.577 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.451 ' HG3' ' CE2' ' A' ' 88' ' ' PHE . 4.0 tmm? -91.22 113.16 25.36 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.791 HG21 HD13 ' A' ' 59' ' ' LEU . 6.0 m -102.49 133.62 45.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.179 0.514 . . . . 0.0 111.886 -178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -146.46 144.43 29.66 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.821 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.524 ' CE2' ' HG2' ' A' ' 112' ' ' LYS . 32.6 t80 -165.37 -62.52 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.703 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.669 HD12 ' O ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -104.23 170.72 5.76 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.269 -179.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD2' HG22 ' A' ' 53' ' ' THR . 73.6 Cg_endo -90.14 -93.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.637 2.224 . . . . 0.0 112.704 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.642 HG23 ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -78.69 -23.34 45.65 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.669 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.7 t -85.04 14.69 4.7 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG12 HG13 ' A' ' 50' ' ' ILE . 6.2 m -69.08 122.08 19.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -114.98 116.32 28.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.845 0.355 . . . . 0.0 111.617 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.829 ' N ' HD11 ' A' ' 74' ' ' ILE . 11.6 pt-20 -56.52 -23.58 40.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.973 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -72.75 -56.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.172 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -51.98 -40.29 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.275 0.56 . . . . 0.0 110.108 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 47' ' ' VAL . 4.0 mt -78.55 -28.04 45.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.631 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' HB2' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -61.23 -55.48 31.56 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.559 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 9.6 mt-30 -67.19 -43.78 81.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.606 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.746 ' CD2' HD21 ' A' ' 114' ' ' LEU . 7.4 tp -65.14 -41.62 94.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.842 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.723 ' HD1' HD13 ' A' ' 104' ' ' LEU . 36.4 m-85 -84.22 -50.28 8.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.176 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 5.4 pt-20 -55.36 -24.21 28.25 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.603 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' GLN . 7.1 ptm180 -58.99 -45.59 90.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.148 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' ' HG3' ' A' ' 65' ' ' ARG . 69.8 m-85 -86.07 -10.54 54.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.59 99.69 0.14 Allowed Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -43.77 138.82 5.68 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.464 2.109 . . . . 0.0 112.108 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.579 HD12 ' CG2' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -93.54 146.58 6.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.772 -179.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -101.24 -40.36 7.19 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.3 t -138.1 106.51 5.82 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.166 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.814 HG13 ' CG1' ' A' ' 89' ' ' VAL . 10.2 t -106.07 127.7 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.987 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 1.4 ttpm? -156.31 154.66 30.98 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.382 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.829 HD11 ' N ' ' A' ' 56' ' ' GLU . 97.2 mt -107.47 134.92 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 121.032 0.444 . . . . 0.0 111.133 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 86' ' ' TYR . 20.3 t -79.47 98.5 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.229 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 8.4 p -78.7 167.91 20.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.198 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.56 126.99 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -9.62 58.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.514 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.5 -51.27 17.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.744 0.306 . . . . 0.0 111.064 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 82' ' ' GLN . 2.0 t -116.96 1.44 12.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.338 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 56.83 35.45 26.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.882 0.372 . . . . 0.0 110.72 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' A' ' 80' ' ' THR . 8.7 mm-40 -108.8 158.97 17.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.991 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 m -64.31 112.49 3.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.407 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.642 ' HD2' HG23 ' A' ' 52' ' ' THR . 0.3 OUTLIER -167.51 -162.04 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.059 -179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.03 -87.67 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.126 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -171.5 175.62 4.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.808 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -111.33 -177.34 20.36 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.971 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.455 ' CD1' ' ND2' ' A' ' 44' ' ' ASN . 0.1 OUTLIER -147.43 128.95 15.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.814 ' CG1' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -128.31 109.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.05 0.452 . . . . 0.0 111.301 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -90.09 109.77 20.81 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.283 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.827 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 12.0 m-30 -68.92 153.14 44.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.838 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -51.52 -31.3 23.52 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.8 m -147.18 145.53 29.54 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.603 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.13 -27.6 23.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.834 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.67 -24.38 67.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.532 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 73.1 m -79.81 -31.14 40.67 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.334 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.87 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.77 -39.12 83.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.669 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 2.0 mt-30 -57.38 -37.66 73.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.537 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.08 -30.04 55.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.567 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.827 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.35 9.27 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.378 0.608 . . . . 0.0 110.387 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.776 HG13 HD21 ' A' ' 118' ' ' LEU . 32.4 mm -66.1 -26.22 37.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.861 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 98' ' ' GLN . . . -74.26 -42.96 58.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.401 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -130.01 22.49 4.8 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 119.823 -1.179 . . . . 0.0 114.286 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.748 ' CD2' HD22 ' A' ' 114' ' ' LEU . 3.1 mt -135.98 -23.35 1.35 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.293 0.546 . . . . 0.0 112.046 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.571 ' HA ' HG23 ' A' ' 116' ' ' VAL . 43.1 t30 -70.14 121.43 17.51 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.67 12.14 63.8 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.808 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -52.63 84.3 0.0 OUTLIER 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.964 0.411 . . . . 0.0 110.66 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLY . 13.4 p-10 -70.29 81.09 0.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.925 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.769 HG23 ' H ' ' A' ' 112' ' ' LYS . 16.8 tt -77.92 161.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.446 -0.502 . . . . 0.0 109.773 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -50.39 -22.21 1.76 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -177.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 3.7 m-80 -104.35 -42.93 5.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.769 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -142.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.615 0.722 . . . . 0.0 112.69 -178.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HD3' ' HB3' ' A' ' 108' ' ' ASN . 0.6 OUTLIER -126.59 114.71 18.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.717 178.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.748 HD22 ' CD2' ' A' ' 104' ' ' LEU . 5.7 mp -84.55 89.68 7.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 46.0 tttt -80.92 119.34 23.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.788 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.4 t -124.65 123.82 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.953 0.406 . . . . 0.0 111.78 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.11 132.73 46.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.115 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.776 HD21 HG13 ' A' ' 101' ' ' ILE . 1.4 mm? -66.09 139.63 58.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 110.663 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -57.51 -85.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.213 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 173.05 -70.84 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.93 0.395 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.03 70.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.812 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.21 -159.14 14.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -128.3 146.61 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.0 148.67 26.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' CB ' ' CD ' ' A' ' 126' ' ' PRO . 0.0 OUTLIER -175.21 -62.29 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 125' ' ' ARG . 59.9 Cg_endo -72.47 -44.74 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.488 2.125 . . . . 0.0 112.319 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.98 54.37 2.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mt 64.06 113.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.749 0.309 . . . . 0.0 111.077 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 164.65 17.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.1 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 167.46 -93.37 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.418 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -171.9 124.44 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -41.35 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.87 -28.88 2.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.529 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.19 164.86 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.791 0.329 . . . . 0.0 110.949 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 134.98 77.16 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -82.04 96.07 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.859 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.65 -33.73 2.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.475 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 63.55 -78.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.749 0.309 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.851 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.76 0.314 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -88.36 -53.97 4.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.65 -60.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tt -118.73 134.1 23.56 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.969 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 95.27 0.65 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.509 2.14 . . . . 0.0 112.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.4 mt -88.6 85.19 6.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.916 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.75 147.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.129 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.1 -175.77 5.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.893 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 69.01 -65.87 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.64 143.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.24 74.45 67.69 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.36 150.81 19.35 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.6 2.2 . . . . 0.0 112.29 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -126.84 169.02 13.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.08 -152.61 31.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.08 75.73 7.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.4 m -143.7 98.81 3.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.24 158.75 21.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 60.29 85.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.65 -31.06 46.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -91.71 -3.51 56.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.439 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 65.91 -76.37 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.769 0.319 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.4 mt 60.66 111.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -106.83 135.42 48.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -149.56 169.91 19.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 103.2 0.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.972 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 60.11 179.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.51 136.77 32.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.96 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -109.19 116.61 32.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.976 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.426 ' HB3' ' CD ' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -108.01 146.45 32.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 19.0 mt -92.68 -44.58 0.34 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 30' ' ' ILE . 72.7 Cg_exo -48.01 -45.57 24.69 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.299 1.999 . . . . 0.0 113.178 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 31' ' ' PRO . 11.3 Cg_exo -71.43 -66.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.465 2.11 . . . . 0.0 112.222 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -60.08 159.84 8.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -165.59 -67.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.752 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.4 tmm? 54.67 31.33 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.028 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -106.72 131.91 21.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.13 54.26 5.13 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.56 2.173 . . . . 0.0 112.434 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HB2' HG22 ' A' ' 41' ' ' VAL . 19.2 mm-40 -101.99 120.34 54.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.925 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.22 -26.2 7.8 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.406 2.07 . . . . 0.0 112.417 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.24 -27.74 68.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.192 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.572 HG12 ' CA ' ' A' ' 121' ' ' SER . 30.3 m -96.38 27.29 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.286 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.5 mt -95.53 -50.44 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.837 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -54.1 -22.73 11.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.553 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -77.44 105.78 8.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.856 HD12 HG12 ' A' ' 116' ' ' VAL . 4.3 mm? -113.12 122.87 48.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.95 0.405 . . . . 0.0 111.904 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 39.4 ttm -91.25 111.74 23.35 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.608 HG21 HD22 ' A' ' 59' ' ' LEU . 2.3 m -103.56 125.63 58.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HA ' ' HB3' ' A' ' 86' ' ' TYR . 61.0 t-20 -127.31 134.6 49.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.904 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.567 ' CD2' HD23 ' A' ' 114' ' ' LEU . 4.3 t80 -164.95 -53.11 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.0 110.991 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -103.51 140.36 20.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.667 -179.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 50' ' ' ILE . 61.6 Cg_endo -70.87 -99.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 121.864 1.709 . . . . 0.0 112.005 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.85 -5.85 54.57 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.557 ' O ' HG22 ' A' ' 53' ' ' THR . 25.0 m -108.94 14.99 23.79 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.793 ' HA ' HD12 ' A' ' 50' ' ' ILE . 3.2 p -69.03 114.65 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.875 0.369 . . . . 0.0 110.269 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.15 138.45 50.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.078 0.466 . . . . 0.0 112.123 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 12.4 pt-20 -58.42 -27.82 64.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.229 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 21.6 t -69.32 -54.35 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.066 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -47.61 -49.1 27.87 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.098 0.475 . . . . 0.0 109.955 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -78.17 -24.41 47.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.416 178.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.854 ' HG2' HD11 ' A' ' 69' ' ' ILE . 2.1 tmm_? -55.44 -55.06 36.13 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.509 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 13.3 mt-30 -76.77 -42.78 39.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.204 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 HD21 HD11 ' A' ' 114' ' ' LEU . 11.9 tp -63.79 -44.26 93.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.144 -179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.682 ' HA ' HD11 ' A' ' 104' ' ' LEU . 6.1 m-85 -84.49 -48.6 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.567 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 60' ' ' ARG . 8.9 pt-20 -54.63 -25.97 30.01 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.547 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -53.64 -52.84 58.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.944 0.402 . . . . 0.0 110.884 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -82.14 -7.82 59.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.494 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 91' ' ' PHE . . . -172.8 95.57 0.11 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.866 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -44.24 122.91 3.99 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.591 2.194 . . . . 0.0 112.312 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.964 HD12 HG11 ' A' ' 72' ' ' VAL . 2.0 pt -80.77 145.66 8.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.063 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -103.76 -48.82 3.82 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -132.55 106.21 7.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.053 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.964 HG11 HD12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -112.91 147.29 16.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.158 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 74' ' ' ILE . 17.5 tttp -155.48 165.55 36.24 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.783 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -121.53 132.17 71.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 121.331 -0.148 . . . . 0.0 110.773 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.478 HG21 ' CE1' ' A' ' 88' ' ' PHE . 28.7 t -86.59 99.67 8.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 p -76.99 168.72 19.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.98 131.94 37.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -75.07 -9.63 58.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -71.28 -51.05 26.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 82' ' ' GLN . 4.4 t -116.99 3.24 12.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.275 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 57.19 31.26 19.74 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' A' ' 80' ' ' THR . 2.0 mt-30 -110.52 161.95 15.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.071 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -64.9 79.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.538 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 8.5 ttt180 -119.64 -156.41 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.18 -93.16 0.04 OUTLIER Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.682 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.624 ' O ' HD13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -171.63 175.09 4.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.566 -0.317 . . . . 0.0 110.936 -179.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -110.63 165.14 12.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.055 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 75' ' ' VAL . 3.6 m-85 -124.07 128.87 49.95 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.511 0.324 . . . . 0.0 110.158 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.561 HG13 ' CD1' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -130.05 109.91 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.85 0.357 . . . . 0.0 111.363 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -89.44 110.08 20.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 7.0 m-30 -71.04 154.09 42.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.157 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -51.78 -24.22 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.13 153.49 22.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.945 0.403 . . . . 0.0 111.453 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.82 -30.02 59.31 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.957 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 t -60.07 -26.1 65.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.457 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 50.3 m -81.06 -28.98 35.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.442 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.64 -47.8 81.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -56.83 -34.35 67.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.307 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.86 -32.99 63.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.153 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.919 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.41 -55.87 8.01 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.304 0.573 . . . . 0.0 109.921 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 45' ' ' LEU . 32.9 mm -59.07 -25.94 31.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.908 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.18 -38.45 63.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.916 -0.583 . . . . 0.0 112.168 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 107' ' ' PHE . . . -122.58 16.62 8.43 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.772 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HA ' ' A' ' 63' ' ' PHE . 14.7 mt -135.81 -39.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.203 0.501 . . . . 0.0 111.748 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' HB2' HG23 ' A' ' 101' ' ' ILE . 44.6 t30 -50.89 121.31 5.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.366 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 58.66 18.61 38.99 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.365 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.797 ' HB3' HD12 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -46.85 90.2 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.554 0.677 . . . . 0.0 110.114 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 106' ' ' GLY . 7.0 p30 -72.26 81.65 1.01 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.213 -178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.623 HG23 ' H ' ' A' ' 112' ' ' LYS . 19.3 tt -83.94 161.28 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -51.23 -38.7 53.96 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -177.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -79.88 -55.34 5.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.895 0.379 . . . . 0.0 111.693 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.623 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -143.25 -168.24 2.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.493 -179.123 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -125.3 114.66 19.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.356 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.797 HD12 ' HB3' ' A' ' 107' ' ' PHE . 8.1 mt -71.07 97.97 1.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.648 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 22.9 tttt -88.4 119.64 29.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.775 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG12 HD12 ' A' ' 45' ' ' LEU . 1.4 t -125.02 123.53 65.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.73 43.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.609 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.621 HD13 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.19 113.43 5.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.559 179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -62.08 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.231 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 119' ' ' ALA . . . 174.9 -165.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.909 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.572 ' CA ' HG12 ' A' ' 41' ' ' VAL . 22.6 t -71.7 -32.14 67.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 58.95 85.85 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.553 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -65.76 171.51 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -105.81 -49.42 3.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.826 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 126' ' ' PRO . 1.2 ttt85 -172.36 63.46 0.33 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 52.8 Cg_exo -55.0 -39.94 88.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.565 2.177 . . . . 0.0 112.284 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.743 ' HA3' ' HB2' ' A' ' 131' ' ' ALA . . . 110.27 52.14 0.61 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.393 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 127' ' ' GLY . 1.8 tt 43.67 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.532 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . 60.67 38.49 18.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.43 76.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.516 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.743 ' HB2' ' HA3' ' A' ' 127' ' ' GLY . . . -87.09 175.07 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 0.0 111.071 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.0 p -142.18 112.82 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.105 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -117.99 61.26 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.452 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -162.14 87.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.805 0.336 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.15 -87.05 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.516 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.35 174.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.94 -139.03 7.1 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.18 -45.79 58.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.868 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.876 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.794 0.331 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.82 109.27 12.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -92.22 -69.27 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -151.71 87.88 4.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.19 150.77 18.62 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.509 2.139 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 6' ' ' LEU . 1.1 mp -121.69 -58.63 1.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.7 m -111.22 -31.61 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.184 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.34 168.43 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -161.35 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -162.62 109.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.802 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -177.59 -62.19 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.033 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 11' ' ' ASP . 17.9 Cg_endo -59.63 -25.25 78.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.463 2.109 . . . . 0.0 112.392 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -172.28 153.12 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -125.39 170.79 17.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.408 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -119.52 -49.64 2.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 m 60.65 105.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 61.95 116.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.1 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.17 111.84 18.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.57 172.4 8.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -124.03 117.13 24.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -152.15 -46.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt 68.66 -67.57 0.2 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.24 84.13 2.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.881 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -80.62 -68.24 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.816 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -68.68 -177.47 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 62.83 37.58 12.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -120.72 160.64 22.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -99.58 166.26 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -92.66 -175.44 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt 41.66 62.12 7.49 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.723 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -51.25 156.95 4.88 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.567 2.178 . . . . 0.0 112.368 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.3 64.84 1.53 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.577 2.185 . . . . 0.0 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 p -142.91 -47.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.18 172.47 13.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 60.21 31.39 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -110.53 88.7 7.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.48 80.82 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.612 2.208 . . . . 0.0 112.357 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -89.32 149.4 42.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.78 -25.22 24.13 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.371 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.25 -28.83 67.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.036 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.2 38.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.296 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 118' ' ' LEU . 5.9 mt -89.78 -34.41 16.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.72 ' HA ' ' HB2' ' A' ' 97' ' ' ALA . 2.9 ptp180 -62.32 -13.47 29.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.929 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -74.89 105.81 6.11 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.829 HD12 ' CG1' ' A' ' 116' ' ' VAL . 4.3 mm? -106.48 121.88 45.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 112.028 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.0 OUTLIER -92.41 112.51 24.48 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.871 HG21 HD13 ' A' ' 59' ' ' LEU . 30.9 m -102.76 135.87 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.154 0.502 . . . . 0.0 111.694 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' LYS . 41.4 t30 -154.43 147.47 24.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.508 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 112' ' ' LYS . 54.9 t80 -165.91 -64.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.533 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 ' C ' ' A' ' 53' ' ' THR . 0.5 OUTLIER -104.57 169.69 6.9 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.157 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 50' ' ' ILE . 72.5 Cg_endo -80.37 -94.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.472 2.114 . . . . 0.0 112.122 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 84' ' ' ARG . 15.3 t -78.44 -5.86 53.63 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.836 ' C ' HD13 ' A' ' 50' ' ' ILE . 0.7 OUTLIER -88.02 11.7 15.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 86' ' ' TYR . 3.8 m -69.21 115.38 7.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.855 0.36 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -114.68 109.45 18.23 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.954 0.407 . . . . 0.0 111.77 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.843 ' N ' HD11 ' A' ' 74' ' ' ILE . 8.7 pt-20 -53.82 -24.81 16.79 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 ' HA ' ' HB2' ' A' ' 60' ' ' ARG . 55.3 t -68.35 -56.14 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.856 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -46.09 -48.73 17.06 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.978 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.871 HD13 HG21 ' A' ' 47' ' ' VAL . 0.2 OUTLIER -78.4 -25.9 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.587 178.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.81 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -56.01 -55.11 36.76 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.1 mt-30 -76.71 -42.71 40.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -65.68 -41.92 91.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.973 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.783 ' HA ' HD11 ' A' ' 104' ' ' LEU . 3.8 m-85 -84.39 -50.42 7.81 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.503 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 9.0 pt-20 -54.62 -28.89 49.95 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.144 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -58.15 -53.07 62.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.898 0.38 . . . . 0.0 110.523 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -77.65 -7.61 56.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.88 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -179.47 97.81 0.11 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.663 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.02 126.58 6.23 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.535 2.157 . . . . 0.0 112.355 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.878 HD12 HG11 ' A' ' 72' ' ' VAL . 1.2 pt -80.58 145.29 9.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.421 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -99.55 -44.22 6.23 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.59 105.83 4.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.3 177.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.878 HG11 HD12 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -109.45 135.67 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.604 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -156.19 160.13 39.57 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.437 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.843 HD11 ' N ' ' A' ' 56' ' ' GLU . 67.1 mt -111.69 140.6 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.97 0.415 . . . . 0.0 111.309 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 86' ' ' TYR . 78.0 t -81.86 99.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.185 178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.8 m -77.08 169.45 18.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.26 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -84.95 122.04 28.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.773 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -71.22 -9.77 58.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.443 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -51.02 28.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.96 2.61 12.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.314 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 58.25 32.47 22.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -110.44 160.76 16.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.978 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.61 116.28 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.561 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.442 ' HG3' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -170.07 -159.27 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.003 0.43 . . . . 0.0 111.377 -179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.14 -85.68 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.953 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.748 ' HA ' HG11 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -171.74 175.42 3.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.472 0.177 . . . . 0.0 110.627 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 74' ' ' ILE . . . -115.83 -179.53 18.22 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.102 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.785 ' CE1' ' HB2' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -147.03 142.49 27.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.4 -0.4 . . . . 0.0 110.287 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.685 HG12 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -139.34 109.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 110.374 179.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -88.98 111.33 22.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.862 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.799 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 10.4 m-30 -71.92 154.34 41.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.913 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -51.73 -51.42 56.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 m -128.96 149.91 50.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.902 0.382 . . . . 0.0 111.44 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.15 -28.58 42.38 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.001 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -60.25 -22.51 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 0.0 110.587 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 91' ' ' PHE . 71.0 m -79.57 -30.44 41.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.869 0.366 . . . . 0.0 110.504 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.72 ' HB2' ' HA ' ' A' ' 43' ' ' ARG . . . -59.46 -44.7 92.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.827 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -52.07 -42.05 62.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -74.45 -29.56 61.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.279 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.799 ' HB2' ' CE2' ' A' ' 91' ' ' PHE . . . -70.32 -55.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.337 0.589 . . . . 0.0 110.264 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.606 HG12 HD21 ' A' ' 118' ' ' LEU . 2.7 mt -62.3 -26.46 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.834 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.36 41.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.487 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -124.91 25.93 5.72 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.319 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -135.95 -31.59 0.92 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.307 0.553 . . . . 0.0 111.776 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.45 ' HA ' HG23 ' A' ' 116' ' ' VAL . 51.1 t30 -62.27 121.19 12.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' ASN . . . 68.16 12.26 62.74 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.583 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 114' ' ' LEU . 5.7 t80 -46.87 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.902 0.382 . . . . 0.0 110.674 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' GLY . 6.2 p30 -75.06 79.33 2.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.768 HG23 ' H ' ' A' ' 112' ' ' LYS . 12.6 tt -78.19 161.08 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.455 ' N ' HG12 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.86 -25.78 4.97 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB3' ' CE ' ' A' ' 112' ' ' LYS . 35.9 m-20 -97.23 -48.39 5.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.768 ' H ' HG23 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -142.91 -172.77 3.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.245 0.545 . . . . 0.0 112.152 -178.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.457 ' HB3' ' CE1' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -125.96 114.57 18.66 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 62' ' ' LEU . 17.3 mt -80.5 90.93 5.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.71 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' ASN . 32.4 ttmt -80.69 119.04 22.78 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.829 ' CG1' HD12 ' A' ' 45' ' ' LEU . 2.1 t -122.95 123.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 111.864 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' MET . . . -128.86 132.76 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.21 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.723 HD13 HD13 ' A' ' 45' ' ' LEU . 2.3 mm? -65.08 131.43 46.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 0.0 110.95 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.785 ' HB2' ' CE1' ' A' ' 88' ' ' PHE . . . -74.17 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.231 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 66.38 161.59 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.35 -77.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.94 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 154.11 -133.02 3.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.97 160.05 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.769 0.318 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -71.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.24 96.73 49.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.18 -27.36 35.28 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.517 2.145 . . . . 0.0 112.272 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 128' ' ' ILE . . . 97.97 66.25 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.594 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 129' ' ' ALA . 2.5 pp -157.77 -44.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.739 0.305 . . . . 0.0 111.142 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 128' ' ' ILE . . . -83.7 79.18 9.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.078 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.6 -158.62 15.24 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.92 147.1 24.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.342 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.59 166.2 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -95.17 -32.5 7.03 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.6 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -173.03 -65.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 166.76 -72.03 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.509 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -155.92 170.03 23.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 168.74 -124.37 1.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.753 ' HB3' HD23 ' A' ' 139' ' ' LEU . 0.2 OUTLIER 68.11 -69.85 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.753 HD23 ' HB3' ' A' ' 138' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.894 -179.923 . . . . . . . . 2 2 . 1 stop_ save_